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Most cells throughout their existence are constantly subjected to enormous amounts of 
endogenous and exogenous DNA damage. The cellular response to genotoxic stressors 
ultimately either leads to adaptive processes that mediate cellular repair and allow for continuous 
cellular function or leads to cell malfunction and death. In some theories of aging this cellular 
malfunction is due to accumulation of unrepaired DNA damage which over time leads to 
progressive deterioration of tissue/organ homoeostasis and function resulting in organismal 
aging. The overall goal of my studies is to understand the responses to DNA damage in corneal 
endothelial (CE) cells whose pump and barrier functions are essential for corneal transparency 
and which in vivo display age-related degeneration and accumulation of DNA damage.  In three 
complementary and related studies I have focused on how the CE is affected by genotoxic stress.  
In the first study I have examined the clinical application of the DNA crosslinking agent 
mitomycin C during photorefractive keratectomy and documented its effects on the CE such as 
significant accumulation of DNA lesions and elevated levels of apoptosis.  In the second study I 
have examined the long term consequences resulting from failure to repair endogenous DNA 
damage in vivo.  Using a DNA repair-deficient mouse strain I have observed significant 
premature age-related dystrophic changes in the CE that only occur in very old mice.  This 
suggests that the CE is sensitive and vulnerable to the effects of accumulating endogenous 
genotoxic stress and that DNA damage may drive CE aging. In the third study I have examined 
how CE cell-cell communication mediated by gap junctions is affected by acute genotoxic stress.  
Given that gap junction intercellular communication  is essential for homeostasis and associated 
with cell proliferation, death and survival, alterations in the gap junction protein connexin-43 
may be crucial for CE cell function and viability during genotoxic stress. The key findings of all 
my studies elucidate the role of genotoxic stress in CE aging and identify novel responses to 
stresses from DNA damage.  Through a greater understanding of the responses to these stressors, 
efforts to preserve and improve CE viability and function can be achieved. 
NOVEL CORNEAL ENDOTHELIAL RESPONSES TO GENOTOXIC STRESS  
Daniel Sam Roh, Ph.D. 
University of Pittsburgh, 2011
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1.0  INTRODUCTION 
1.1 THE CORNEAL ENDOTHELIUM 
The cornea is the anterior most part of the eye which functions to provide refractive 
power and protection of more interior structures from environmental insults such as ultraviolet 
(UV) radiation, pathogens, and noxious particles (Fig. 1.1.A). Composed of three distinct layers 
(Fig. 1.1B) - a stratified epithelium, the stroma of primarily extracellular matrix and interspersed 
cells called keratocytes,  the corneal endothelium- each with distinct physiology and function, 
maintenance of corneal transparency is largely dependent upon a well-functioning corneal 
endothelium (CE). Accelerated CE cell loss through disease or damage leads to irreversible 
corneal edema and blindness with transplantation presently the only therapeutic option (Bourne 
and McLaren 2004).  As important as the CE monolayer is considered for corneal transparency, 
it is considered equally fragile and vulnerable to injury and insult for reasons not fully 
understood. 
 
 
 
 
 
Figure 1.1: The cornea. (A) The cornea is the front most part of the eye that provides protection and refraction.  
Image adapted from NEI. www.nei.nih.gov. (B) Distinct cellular layers of the cornea include 1) epithelium, 3) 
stroma, 5) endothelium. 2) Bowman’s and 4) Descemet’s membranes are extracellular matrix. Image adapted from 
Mission for Vision. www.missionforvisionusa.org. 
(A) (B) 
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1.1.1 CE functions in the cornea 
The CE monolayer provides essential barrier and pump functions that allow nutrients and 
metabolites to enter/leave the avascular cornea from the nutrient-rich aqueous humor while 
constantly maintaining optimal deturgescence of the stroma.  The barrier established by the CE  
is created by tight junction complex proteins such as  zonula occludens-1 (ZO-1), claudins, 
junctional adhesion molecules (JAM), and  occludins  (Srinivas 2010).   What is unique about the 
barrier formed by the CE is its “leakiness”, characterized by a very small trans-endothelial 
resistance (TER) of 15–25 Ω.cm2 (Edelhauser 2006) and permeability to macromolecules of 
molecular weight greater than 150 kilodaltons.  The “leaky” CE barrier and hydrophilic 
properties of the corneal stromal proteoglycans are countered by the action of the CE fluid pump.  
High metabolic activity of the CE is necessary to fuel abundant Na+/K+ ATPase pumps, 
estimated at 2.1x106/cell, located on basolateral cell surfaces (Geroski, Matsuda et al. 1985).   
The Na+/K+ ATPase pumps establish the ionic gradients for numerous channels and exchangers 
resulting in a net movement of fluid from the corneal stroma into the aqueous humor.  In 
addition, bicarbonate (HCO3-) and chloride (Cl-) ion transporters help to drive Na+ to the apical 
surface with carbonic anhydrases facilitating the conversion of CO2 to/from bicarbonate 
(Bonanno 2003; Bonanno 2011). 
 
 
 
 
 
 
 
 
 
 
Corneal transparency is contingent on the fine-tuned balance of “fluid pump” and “fluid 
leak” established by the CE (Fig. 1.2).  When either of these functions fails, the corneal stroma 
absorbs fluid and the lattice-like organization of  stromal collagen fibrils is disrupted resulting in 
Figure 1.2: Functions of the CE.  The 
CE has two major functions in the 
cornea including providing a barrier 
from the aqueous humor and pumping 
out fluid from the hydrophilic stroma.  
Image adapted from Srinivas 2010.   
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altered transmission of light (Hassell and Birk 2010).  A permanently damaged or diseased CE 
therefore leads to irreversible corneal edema and blindness. 
1.1.2 Age-related changes in CE 
CE cells in vivo do not replicate and normal aging is associated with a cell density loss at 
a rate of 0.6% per year, increasing polymegathism and pleomorphism, and decreased pump 
function and permeability (Bourne and McLaren 2004). In vitro, human CE cells have limited 
proliferative potential and display features of age-related senescence that is not related to 
replicative-induced telomere attrition (Konomi and Joyce 2007). Age-related differences 
between CE cells from older (>50 years) and younger (<30) corneal donors include decreased 
proliferative capacity in CE cells from older donors (Senoo and Joyce 2000), increased 
expression of cyclin-dependent kinase inhibitors (Enomoto, Mimura et al. 2006), increased 
senescence-associated -galactosidase staining (Mimura and Joyce 2006; Song, Wang et al. 
2008), and decreased sensitivity to mitogenic stimulation (Joyce 2005).  The causes for these 
age-related changes remain unknown as well as why the CE fails to regenerate in vivo.  
1.1.3 Exposures and responses to cellular stressors 
The CE is vulnerable to metabolic stress, systemic and ocular drugs including their 
preservatives, alterations in pH or osmolarity, intraocular pressure, and mechanical stress during 
surgery (Parikh and Edelhauser 2003; Bourne and McLaren 2004; Fraunfelder 2006; DelMonte 
and Kim 2011).  For example, hyperglycemic stress from diabetes (Roszkowska, Tringali et al. 
1999) and high intraocular pressure from glaucoma (Setala 1980; Gagnon, Boisjoly et al. 1997) 
results in decreased CE cell density compared to age-matched controls.  The rate of CE cell loss 
is accelerated to 10% at 1 year after cataract surgery (Bourne, Nelson et al. 1997) and 34% at 1 
year after penetrating keratoplasty (Ing, Ing et al. 1998).  Endothelial cell loss one year after 
Descemet’s Stripping Endothelial Keratoplasty, the most advanced procedure for CE 
transplantation, averaged 41% at 1 year even with experienced surgeons (Lee, Jacobs et al. 
2009).  Accelerated CE cell loss can lead to bullous keratopathy (BK), a condition resulting from 
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CE dysfunction or damage which leads to corneal edema, subepithelial corneal scarring, and 
painful epithelial blistering (Smolin, Foster et al. 2005). Common ocular procedures and 
conditions associated with CE loss in BK are cataract extraction, primary or secondary (immune 
rejection) corneal graft failure, glaucoma surgery, and endothelial dystrophies (Smolin, Foster et 
al. 2005). BK is consistently the leading cause for corneal transplantation in the United States 
(Ghosheh, Cremona et al. 2008).  
A more recent consideration of the aging and non-proliferative nature of the CE is the 
exposure of the CE to genotoxic stress (Joyce, Zhu et al. 2008; Joyce, Harris et al. 2010).  In 
one’s lifetime, the sources of potential DNA damage to the CE are numerous and may include 
the production of reactive oxygen species from high metabolic activity required for continuous 
pump function, UV absorbance (Kolozsvari, Nogradi et al. 2002), exposure to DNA-damaging 
drugs during ocular procedures such as mitomycin C (MMC) (Roh, Cook et al. 2008), and free 
radicals generated during cataract surgery (Takahashi 2005). The accumulation of DNA damage 
with age has recently been proposed based on increased endogenous presence of the oxidative 
DNA lesion, 8-hydroxy-2'-deoxyguanosine (8-OHdG)  (Joyce, Zhu et al. 2009) as well as 
increased -H2AX foci representing DNA double strand breaks (Joyce, Harris et al. 2010) in 
older donor tissue. In Fuchs’ dystrophy, characterized by premature loss of CE cells and 
considered an accelerated aging disease (Bergmanson, Sheldon et al. 1999), there is growing 
evidence that oxidative DNA damage plays a role in accelerated CE loss (Jurkunas, Bitar et al. 
2010). With no identified source of stem cells renewing this monolayer, aging CE cells must  
maintain pump and barrier functions throughout their lifetime despite being subjected to many 
potential DNA damaging agents.  In spite of this, little is known about how the CE responds to 
genotoxic stressors through stress responses, adaptation, and/or DNA repair mechanisms.  
Studies of the CE response to cellular stressors have mostly focused on the resulting 
accommodation (including cell migration and spreading of existing cells) rather than how CE 
cells actually respond during exposure to various stressors. Only more recent studies have 
suggested that the unfolded protein response is a central CE response to disease states such as 
Fuchs’ dystrophy (Engler, Kelliher et al. 2010) as well as in ex vivo storage conditions (Corwin, 
Baust et al. 2011).  Proteomic approaches have revealed decreased peroxiredoxin expression 
(Jurkunas, Rawe et al. 2008) and increased clusterin expression (Jurkunas, Bitar et al. 2008) in 
CE affected by Fuchs’ dystrophy. Donor CE in storage has been found to release ciliary 
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neurotrophic factor through a vasoactive intestinal peptide-induced autocrine loop resulting in 
increased integrity and upregulation of Cx43 mRNA (Koh 2002; Koh, Celeste et al. 2008). 
Because the CE is a unique and fragile layer critical to corneal transparency, understanding the 
pathways that are integrated in the response to stress before cell death may prove beneficial for 
preservation efforts.   
 
1.1.3.1 Special focus on mitomycin C 
The following section focuses on the clinical use of mitomycin C during photorefractive 
keratectomy and as is adapted, with copyright permission from SLACK Incorporated, from a 
published review.  Roh, D.S., & Funderburgh, J.L. (2009). Impact on the corneal 
endothelium of mitomycin C during photorefractive keratectomy. Journal of Refractive 
Surgery, (25)10, 894-898. 
 
Introduction 
Mitomycin C (MMC) was proposed to be an effective modulator of the wound healing response 
after corneal stromal ablation as early as 1991 (Talamo, Gollamudi et al. 1991).  Since then, 
MMC usage has expanded significantly within the field of refractive surgery, especially during 
photorefractive keratectomy (PRK), for prevention of recurrence of corneal haze and as 
prophylaxis to prevent initial haze development (Lacayo and Majmudar 2005).  Despite the 
growing popularity of MMC usage during refractive procedures, there has been inconsistency in 
the conclusions of studies regarding the impact of MMC on the corneal endothelium.  Because of 
the non-regenerative nature of the human corneal endothelium, it is imperative to understand 
how this vital cell layer responds to potential stressors at both the cellular and clinical levels.  
This brief review will examine both basic science and clinical studies to evaluate the potential 
impact of MMC usage during PRK on the health of the corneal endothelium. 
 
Mechanism of Action of Mitomycin C  
MMC is an antibiotic derived from Streptomyces caespitosus and is generally classified as a 
DNA alkylating agent.   Cellular toxicity after MMC exposure can occur from MMC-induced 
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insults such as the generation of free radicals or DNA monoadducts; however, the most 
significant effects are due to the accumulation of covalent DNA interstrand cross-links (Tomasz 
1995).  A brief explanation of the mechanism of action of MMC is essential to understand the 
potential impact of MMC used during PRK on the corneal endothelium.   
 
MMC Activation by Enzymatic Reduction 
MMC by itself is non-reactive with DNA and after entering the cell must undergo bioreductive 
enzymatic activation. Numerous intracellular enzymes can activate MMC such as 
NAD(P)H:quinone oxidoreductase 1 (NQO1) which is present throughout all layers of the cornea 
(Schelonka, Siegel et al. 2000).  Intracellular bioreductive activation results in the production of 
an unstable intermediate with high alkylating activity and formation of a covalent monoadduct 
with DNA.  Subsequently, this activated MMC will form a second alkylating center which 
completes the DNA cross-link.  The result is a covalent bond between two complementary 
strands of DNA which if not removed prevents DNA replication and transcription.   These 
MMC-DNA cross-links occur within the minor groove of DNA causing relatively little DNA 
duplex distortion. The location of adducts is guanine specific and cross-links are located at 
opposing sequences of 5’-CpG-3’ (CpG) (Tomasz 1995).  
 
Processing and Repair of DNA Interstrand Cross-links 
Specific recognition factors of the MMC-induced interstrand cross-link are not well defined, but 
may occur when DNA replication and/or transcription is blocked within the cell.  Importantly, 
the MMC-induced interstrand cross-link may not be easily repaired in non-replicating 
mammalian cells because a stalled replication fork typically serves as the signal for initiating 
DNA repair.  Although detailed repair mechanisms in mammalian cells have not been fully 
elucidated, interstrand cross-link repair is believed to involve a complex combination of 
nucleotide excision repair, DNA double strand break repair via homologous recombination or 
non-homologous end joining, and/or translesion DNA synthesis (Dronkert and Kanaar 2001; 
McHugh, Spanswick et al. 2001; Noll, Mason et al. 2006).  One of the intermediates in 
interstrand cross-link repair, the DNA double-strand break, is known to be a potentially lethal 
lesion.  Such breaks can be visualized as -H2AX nuclear foci (De Silva, McHugh et al. 2000; 
Niedernhofer, Odijk et al. 2004).   
 17 
 
Consequences of MMC-induced DNA Interstrand Cross-links 
Cytotoxicity of MMC-induced interstrand cross-links is most severe in cells undergoing active 
proliferation, although the details of the responses are specific to the cell type.   The presence of 
a DNA interstrand cross-link during replication induces a stalled replication fork triggering 
multiple signaling pathways for cell cycle arrest, repair, or apoptosis. Initial responses to MMC 
induced interstrand cross-links include a strong activation of p53 and genes downstream (Abbas, 
Olivier et al. 2002; Boamah, White et al. 2007). Longer term consequences of such interstrand 
cross-links include increased apoptosis, cellular senescence and premature aging (Grillari, 
Katinger et al. 2007).   
 
Review of Basic Science and Animal Studies 
The effects of MMC exposure on corneal endothelium have been studied in both in vitro and 
animal models and have generated informative data about MMC corneal penetration and 
endothelial toxicity.  In three separate studies the corneal penetration of a single topical 
application of MMC has been observed during protocols emulating PRK.  Using high-
performance liquid chromatography (HPLC), Torres et al. demonstrated the presence of MMC in 
hen aqueous humor after a single 0.02% intraoperative application during PRK (Torres, Merayo-
Lloves et al. 2006).    Song et al. also used HPLC to demonstrate the presence of  MMC in both 
cornea and aqueous humor after a single 0.02% MMC application in a rabbit model of epithelial 
debridement (Song, Kim et al. 2006).  Our recent study used a bioassay to demonstrate 
significant MMC concentrations at the depth of the corneal endothelium after a single topical 
0.02% application in ex vivo goat corneas (Roh, Cook et al. 2008).  It is clear from these studies 
that refractive surgery procedures such as photorefractive keratectomy (PRK) that involve the 
mechanical removal of the corneal epithelial barrier, excimer laser stromal ablation, and 
subsequent MMC treatment, expose the corneal endothelium to biologically substantial levels of 
MMC.  Length of exposure and MMC concentration in the endothelium and aqueous are directly 
related to the amount of MMC applied to the anterior surface (Song, Kim et al. 2006; Torres, 
Merayo-Lloves et al. 2006).  
 Surprisingly, despite the widespread use of MMC during refractive surgery, only a few 
studies that have specifically focused on the effects of MMC on the corneal endothelium at the 
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cellular level.  Although many more studies describe the keratocyte response to MMC, the 
response of the corneal endothelium should not be inferred from those results.  An early 1991 
study by McDermott et al. (McDermott, Wang et al. 1994) using four pairs of ex vivo human 
corneas found few changes in mean swelling rate or corneal endothelial ultrastructure after 
perfusion with 20 g/ml MMC but found significant irreversible changes at 200 g/ml.  Later in 
vitro studies have shown dose-dependent toxic effects of MMC on corneal endothelial 
proliferation (Wu, Hong et al. 1999; Garweg, Wegmann-Burns et al. 2006).  Perhaps the most 
cited study demonstrating MMC toxicity to corneal endothelium was by Chang (Chang 2004) in 
2004, using a rabbit model of mechanical epithelial debridement followed by 0.02% MMC 
treatments.  Over a 2-week period, MMC resulted in dose-dependent apoptosis of the 
endothelium resulting in increased corneal thickness and decreased corneal clarity.  Our recent 
study (Roh, Cook et al. 2008) demonstrated that even a small and brief dose of MMC 
significantly alters corneal endothelial DNA producing significant potential downstream effects.  
Using MMC concentrations and exposure times that the corneal endothelium is most likely to 
encounter during intraoperative treatment, we found significant DNA cross-linking and 
persistent DNA double-strand breaks in goat corneas ex vivo (Roh, Cook et al. 2008).  The 
proportion of apoptotic cells significantly increased in MMC treated cells; however, this number 
was smaller than the proportion of cells that had DNA double-strand breaks.  Thus, MMC 
appears to generate living cells with an accumulation of unrepaired DNA damage.  Most 
important we found that very brief exposures and low concentrations of MMC consistently 
induced changes in the corneal endothelial monolayer (Roh, Cook et al. 2008).  Thus, it is highly 
likely that a single topical application of MMC alters corneal endothelial DNA generating 
downstream effects on cell viability.   It remains to be determined what the long-term fate of 
these DNA cross-links and double strand breaks is and if the same phenomenon occurs in the in 
vivo setting.  
 
 
Review of Clinical Studies 
In contrast to the relatively small number of laboratory studies described above, a larger number 
of clinical reports have focused on the effects of a single intraoperative dose of MMC during 
refractive surgery on the corneal endothelium.  Whereas a majority of the basic science studies 
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reported significant corneal endothelial toxicity after MMC exposure, the clinical studies have 
been less conclusive in their evaluation of corneal endothelial effects.  Corneal endothelial cell 
loss has been the major endpoint of these studies carried out by statistical comparisons of pre- 
and post-operative endothelial central density measurements with occasional use of pachymetry. 
The initial studies investigating this phenomenon generally reported that MMC treatment 
during PRK has no measurable effect on corneal endothelial central density.  These include a few 
retrospective (Lee, Chung et al. 2005) and prospective studies (Diakonis, Pallikaris et al. 2007; 
Goldsberry, Epstein et al. 2007).  Lee et al. (Lee, Chung et al. 2005) examined 1011 eyes in a 
noncomparative retrospective study and determined that endothelial density was not affected by 
0.02% MMC treatments ranging from 30 seconds to 2 minutes during PRK after 3, 6, and 16 
months.  Goldsberry et al. (Goldsberry, Epstein et al. 2007) found no changes in density or 
morphology after 1 year in 16 eyes treated with 0.02% MMC for 12 seconds.  Diakonis et al. 
(Diakonis, Pallikaris et al. 2007) followed 15 eyes after PRK with 0.02% MMC for 15 seconds 
and compared this to epi-LASIK in the fellow eyes.  They found a decrease in endothelial 
density at 1 and 3 months after surgery, however, it was not statistically significant (Diakonis, 
Pallikaris et al. 2007). 
In contrast, clinical studies associating MMC usage with significant corneal endothelial 
loss are fewer in number and more recent than those reporting no effect.  Two recent studies 
found significant decreases in endothelial central density after PRK with MMC (Morales, Zadok 
et al. 2006; Nassiri, Farahangiz et al. 2008).  Nassiri et al. (Nassiri, Farahangiz et al. 2008), in a 
nonrandomized prospective study of 162 eyes, determined that intraoperative 0.02% MMC 
caused significant corneal endothelial cell loss over a 6-month period that was correlated with 
the duration of MMC exposure during PRK.   In a prospective study of 18 eyes Morales et al. 
(Morales, Zadok et al. 2006) found that 0.02% MMC exposure of 30 seconds caused significant 
cell loss at 1 and 3 months.   
Although the results from PRK studies do not agree as to a detrimental effect of MMC 
treatment on corneal endothelial density, the potential for significant MMC toxicity on the 
corneal endothelium has been well documented in other ocular procedures.   Avisar et al. 
(Avisar, Avisar et al. 2008) found that a 5-minute 0.02% MMC treatment on bare sclera after 
pterygium resection lead to significant postoperative endothelial cell loss up to 3 months 
postoperatively.  A case report by Mohammadpour et al. (Mohammadpour, Jabbarvand et al. 
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2007) described irreversible focal corneal decompensation after filtering surgery with MMC.   
Mietz et al. (Mietz, Roters et al. 2005) reported two cases of bullous keratopathy after 
trabeculectomy with MMC.   Continued MMC treatment in the form of repeated drops after 
phototherapeutic keratectomy resulted in permanent corneal edema as reported by Pfister (Pfister 
2004).   These case reports validate the potential for MMC induced corneal endothelial damage 
across various settings.  
 
Explanation of Possible Differences and Future Research 
Based on the established mechanism of MMC action, in vitro and animal studies, and reports of 
endothelial cells loss after MMC treatment in non-PRK treatments, it is apparent that MMC has 
the intrinsic potential to damage the corneal endothelial DNA under conditions of current clinical 
use.   How can this vulnerability be consistent with the number of clinical reports that describe 
little or no loss of endothelial central density?   Our recent study showed that in goat corneas, the 
number of cells exhibiting long-term DNA damage by MMC greatly outnumbered the cells 
undergoing apoptosis in response to clinical concentrations of MMC (Roh, Cook et al. 2008). If 
similar DNA cross-linking is occurring in human eyes we might expect, ultimately, to see 
increased apoptosis in the monolayer of those cells that are unable to tolerate further DNA 
damage. However, the profoundly quiescent nature of the human endothelium may lead to less 
cell death in the short-term as a result of these insults. Thus, the corneal endothelium may simply 
‘silently’ accumulate this DNA damage without an immediate pathological response.  It remains 
to be determined how the corneal endothelium will eventually respond to such MMC-induced 
DNA damage over a period of years or decades.  Considering unequivocal data demonstrating 
irreversible DNA damage in endothelium at MMC concentrations now employed clinically, it 
will be important to initiate follow-up studies of treated individuals to identify any potential 
long-term effects. 
1.1.4 Efforts for CE protection and enhancement 
The importance of the CE for corneal transparency has led to significant efforts aimed at 
protecting the CE in vivo during intraocular procedures and ex vivo during donor cornea storage 
for future corneal transplants.   
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The advent of ophthalmic viscosurgical devices (OVD) and viscoelastic materials for use 
during intraocular surgery has greatly enhanced CE survival (Bissen-Miyajima 2008).  These 
OVDs protect the CE by coating it during intraocular procedures such as vitrectomy (for retinal 
detachments), trabeculectomy (for glaucoma), corneal lamellar surgery, and cataract 
phacoemulsification.  The coating provides a physical barrier to toxic substances, dry air 
exposure, and mechanical stressors encountered during these procedures (Tognetto, Cecchini et 
al. 2004).  There may also be some protection against free radicals formed during cataract 
phacoemulsification (Takahashi 2005). 
Descemet’s Stripping Endothelial Keratoplasty (DSEK) is a new surgical technique 
designed to replace diseased CE with donor grafts that contain healthy CE and a small portion of 
the posterior stroma.  This allows for preservation of the corneal surface topography or refractive 
power and rapid visual recovery compared to full penetrating keratoplasty (Price and Price 
2007). Due to the complex surgical technique and handling of donor tissue, there is a high rate of 
post-operative CE cell loss (Lee, Jacobs et al. 2009).    To combat this rapid loss of CE cells 
significant efforts have been focused on optimization of donor graft handling and delivery, 
surgical techniques, and donor tissue preparation and storage (Price and Price 2007; Price and 
Price 2008).  
A variety of storage solutions have been formulated to try to preserve CE cell viability 
during donor cornea storage.  Some examples include the addition of salubrinal, which 
dephosphorylates eIF2 and protects cells from ER stress-induced apoptosis, to decrease the 
unfolded protein response resulting in enhanced survival (Corwin, Baust et al. 2011). Treatment 
with aspirin-triggered lipoxin A4 (15-epi-LXA4), which is a lipid mediator involved in 
resolution of inflammation,  prior to storage resulted in increased viability (He, Kakazu et al. 
2011). The addition of vasoactive intestinal peptide (VIP), a neuropeptide with anti-
inflammatory properties,  decreased inflammatory potential and enhanced CE survival in organ 
culture (Koh, Cheng et al. 2009).  These studies provide examples of how understanding stress 
responses can be used to promote CE viability and protection from injury. 
Enhancement of CE cell viability and proliferation using gene targeting approaches has 
been attempted, however, with limited applicability in the clinical setting due to the use of viral 
vectors.  Lentiviral vectors expressing p35 or Bcl-xl, anti-apoptotic proteins, were able to extend 
donor storage times by prolonging CE survival (Fuchsluger, Jurkunas et al. 2011).  Adenoviral 
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delivery of catalase, an antioxidant enzyme, was able to protect rabbit CE from oxidative stress 
in ex vivo storage conditions (Hudde, Comer et al. 2002).  Despite the promise of enhanced 
survival, the limitations of viral delivery are the optimization of viral titer for adequate 
expression versus cell toxicity and the difficulty of targeting in vivo expression to CE cells 
exclusively and not other cells within the anatomical vicinity.  Determining the long term effects 
of viral transduction of exogenous genes will need to be performed prior to clinical usage.  
1.2 CELLULAR RESPONSES TO GENOTOXIC STRESS 
Most cells throughout their existence are constantly subjected to enormous amounts of 
endogenous and exogenous DNA damage. It is estimated that in any given cells, there are up to 
100,000 lesions in the nuclear DNA per cell per day (Garinis, van der Horst et al. 2008). .  In 
cells with greater exposure to environmental stressors such as the skin and eye, these estimates 
are even higher.  Thus it is not surprising to find many ocular manifestations including corneal 
dysfunction in inherited DNA repair disorders (Yamaguchi, Okabe et al. 1991; Goyal, Rao et al. 
1994; Jalali, Boghani et al. 1994; McElvanney, Wooldridge et al. 1996; Dollfus, Porto et al. 
2003). The cellular response to genotoxic stressors ultimately either leads to adaptive processes 
that mediate cellular repair and allow for continuous cellular function or leads to cell malfunction 
and death.   
1.2.1 The DNA Damage Response (DDR) 
A generalized response to DNA damage involves 1) DNA damage-sensing and signal 
initiating events, 2) signal transduction, and 3) a biological consequence or attenuation of the 
response (Yang, Yu et al. 2003).  There are numerous DNA repair pathways that focus on 
specific DNA lesions such as mismatch repair (MMR), base excision repair (BER), nucleotide 
excision repair (NER), double-strand break repair (DSB), and interstrand crosslink (ICL) repair; 
each with sensors and effectors that can overlap (Jackson and Bartek 2009).  
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The DNA damage response can vary according to the extent and type of DNA damage, 
cell cycle status, and the cell type.  Cells may repair DNA damage, undergo senescence, or 
apoptosis in different conditions.  For example, DNA repair in post-mitotic, terminally 
differentiated, or non-dividing cells is different from and not as well understood as repair in 
dividing cells.  A number of DNA damage response proteins are downregulated during terminal 
differentiation and these cells shift the focus of DNA repair to more important transcribed genes, 
via transcription-coupled NER, rather than the entire genome (Nouspikel and Hanawalt 2002; 
Nouspikel 2007).  As a result of this change in DNA repair, accumulation of DNA damage in 
non-transcribed regions has been predicted to occur with any re-entry into the cell cycle 
potentially leading to “mitotic catastrophe” due to the overwhelming amount of DNA damage 
encountered in these regions during replication (Nouspikel and Hanawalt 2002).   
One example of the variation in DNA repair between cycling and non-cycling cells is the 
complex process of ICL repair.  Covalent ICLs prevent both replication and transcription, thus 
are highly cytotoxic and are believed to contribute to aging (Grillari, Katinger et al. 2007).  A 
single ICL has been shown to induce checkpoint activation in mammalian cells (Ben-Yehoyada, 
Wang et al. 2009). ICL repair in cycling cells occurs during the S-phase of DNA synthesis.  
After a replication fork encounters the ICL,  a double strand break intermediate is formed which 
is subsequently repaired through homologous recombination or the more error-prone 
nonhomologous end joining or translesion bypass (Legerski 2010).  As most of the body’s cells 
are nondividing and because there are endogenous sources of ICLs (Grillari, Katinger et al. 
2007), there must be other ways to deal with ICLs that does not involve replication. In contrast to 
ICL repair in S-phase, ICL repair in the G1 phase is much less understood but involves both 
global genome-, but mostly transcription-coupled NER (Hlavin, Smeaton et al. 2010).   The 
error-prone translesion polymerase appears to be critical to ICL resolution in non-dividing cells 
(Sarkar, Davies et al. 2006).  
1.2.2 Alternative (non-DDR) stress responses to DNA damage 
Genome-wide studies of gene expression have shown that cells exposed to DNA-
damaging agents mount a robust and multifaceted response that involves many different cellular 
functions beyond just DNA repair (Workman, Mak et al. 2006; Matsuoka, Ballif et al. 2007). 
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Cellular protection from DNA damage appears to involve an intricate network of proteins 
involved in a multitude of cellular processes including protein turnover, cytoskeletal changes, 
and general stress pathways (Fry, Begley et al. 2005).  Therefore, it is not surprising that 
thousands of protein kinases respond rapidly to genotoxic stress in a manner that extends to 
multiple functions of the cell making the DNA damage response one of the most extensive 
signaling responses to cellular stimuli (Matsuoka, Ballif et al. 2007; Bensimon, Aebersold et al. 
2011).   
DNA damage can trigger signaling pathways related to inflammation, growth signaling, 
and survival (Niedernhofer and Robbins 2008).    NF-B is a family of transcription factors that 
can control proliferation and survival in response to stress and inflammatory cytokines.  NF-B 
is linked to the DDR and activated through ATM-dependent pathways promoting apoptotic-
related signaling (Janssens and Tschopp 2006).  Persistent DNA damage signaling has been 
shown to also promote inflammatory cytokine secretion related to senescence (Rodier, Coppe et 
al. 2009).   Genotoxic stress promotes transition of cellular resources from growth to 
conservation of energy for maintenance after DNA damage through reduced IGF-1 (insulin-like 
growth factor-1) (Niedernhofer, Garinis et al. 2006; van der Pluijm, Garinis et al. 2007; Garinis, 
Uittenboogaard et al. 2009) and mTOR (mammalian target of rapamycin) (Reiling and Sabatini 
2006) signaling pathways. 
In multicellular organisms, the physiological response to stressors typically involves the 
coordinated action of many cells, thus many of the genes induced by multiple diverse stresses 
have been consistently found to be involved in intercellular communication (Murray, Whitfield 
et al. 2004).  Understanding how cell-cell communication is affected by DNA damage may 
provide insights into how aging cells tolerate or succumb to genotoxic stress which ultimately 
effects tissue function and viability.  
1.2.3 Genotoxic stress and aging 
In some theories of aging cellular malfunction is due to accumulation of unrepaired DNA 
damage which over time leads to progressive deterioration of tissue/organ homoeostasis and 
function resulting in organismal aging (Niedernhofer, Garinis et al. 2006; Garinis, van der Horst 
et al. 2008; Niedernhofer 2008; Schumacher, van der Pluijm et al. 2008). Included in these 
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theories is the free radical theory of aging originally proposed in 1956 by Denham Harman, 
which postulated that reactive oxygen species (ROS) were the main cause of aging (Harman 
1956).  ROS, including hydrogen peroxide (H2O2), superoxide (O2-), hydroxyl radicals (OH-), 
could potentially damage macromolecules including DNA.  It is common for aging studies to 
detect elevated levels of oxidatively damaged DNA in older human and animal tissues and 
organs (Moller, Lohr et al. 2010; Sedelnikova, Redon et al. 2010).  Interestingly, in a meta-
analysis of 69 animal studies by Moller et al., organs containing more terminally differentiated 
cells such as the brain, heart, liver, lung, and pancreas had higher age-related accumulation of 
oxidatively damaged DNA than organs with higher proliferative capacity such as the intestine, 
spleen, and testis (Moller, Lohr et al. 2010).   
In addition to oxidative DNA damage, other DNA lesions have been linked to aging such 
as DSBs and ICLs.  Senescent human cells and aging mice were found to accumulate H2AX 
foci which indicated DSBs (Sedelnikova, Horikawa et al. 2004).  Numerous other studies have 
also demonstrated increased H2AX in aging cells, tissues and organs (Li, Mitchell et al. 2008; 
Wang, Jurk et al. 2009). Chemotherapy treatments with ICL agents have been associated with 
accelerated aging seen in acquired premature progeroid syndrome and endogenously formed 
ICLs are thought to increase with age (Grillari, Katinger et al. 2007).  As many DNA repair 
pathways also are decreased or altered with aging, it is postulated that this creates a cycle of 
DNA damage driving aging and aging driving accumulation of DNA damage (Gorbunova, 
Seluanov et al. 2007). 
Progeria, or premature and accelerated aging, has been consistently linked to some 
conditions of genomic instability.  Some examples of progeria resulting from failure to repair 
DNA damage include Cockayne syndrome and trichothiodystrophy which results from defects in 
NER, Werner syndrome which results from defects in the WRN helicase, a subset of xeroderma 
pigmentosa (XFE) which results from defects in ERCC1-XPF, and Hutchinson-Gilford 
syndrome which results from defects in nuclear lamin A (Burtner and Kennedy 2010; Gregg, 
Robinson et al. 2011).  The DNA repair deficiency drives tissue-specific degeneration and 
accelerated aging of tissues such as the skin, eye, bone marrow, nervous system, and endocrine 
axis (Niedernhofer 2008).  Fortunately, some of these diseases can be recapitulated in animal 
models which has allowed for a greater understanding of their pathogenesis as well as 
opportunities to study the impact of genotoxic stress on aging at the organism, organ, tissue, and 
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cellular levels (Niedernhofer, Garinis et al. 2006; Niedernhofer 2008; Vo, Seo et al. 2010; Goss, 
Beer Stolz et al. 2011; Gregg, Robinson et al. 2011; Wang, Vo et al. 2011).   
1.2.3.1  The Ercc1-/ mouse model of accelerated aging 
 
ERCC1-XPF is a heterodimeric complex involved in structure-specific endonuclease 
repair of DNA damage.  It functions in nucleotide excision repair especially for bulky UV –
induced lesions, interstrand crosslink repair, and double-strand break repair (Niedernhofer, Odijk 
et al. 2004; Ahmad, Robinson et al. 2008).  Humans that have XPF or ERCC1 mutations suffer 
from symptoms related to deficient DNA repair.  Remarkably, some of these mutations result in 
an accelerated aging phenotype.  An XPF patient was found to have accelerated aging of the 
brain, liver, musculoskeletal and hematopoietic systems (Niedernhofer, Garinis et al. 2006).   
Mutations in ERCC1 resulted in a patient with severe developmental failure and cerebro-oculo-
facio-skeletal syndrome (Jaspers, Raams et al. 2007). 
ERCC1 knockout mice were reported in 1993 (McWhir, Selfridge et al. 1993) and 1997 
(Weeda, Donker et al. 1997) and display severe growth retardation with spontaneous 
development of neurodegeneration, hematopoietic deficiency, liver abnormalities, and 
musculoskeletal defects (Niedernhofer, Garinis et al. 2006) similar to the patients with ERCC1-
XPF mutations.  Although the age-related changes in these mice significantly overlap with 
naturally old wild-type mice, they only live 21 to 28 days and are exceptionally frail 
(Niedernhofer, Garinis et al. 2006).  Generation of hypomorphic Ercc1-/ mice (null and mutant 
Ercc1 allele combination) increases maximum lifespan to 6 to 7 months and have been used as a 
model of accelerated aging in numerous tissues (Vo, Seo et al. 2010; Goss, Stolz et al. 2011; 
Gregg, Robinson et al. 2011).  The notable difference with these mice and the full knockout mice 
is that the hypomorphs grow and develop similarly to their wild type littermates until 
approximately 16 weeks at which point they rapidly deteriorate and display degenerative signs of 
aging (Gregg, Robinson et al. 2011).  This suggests that DNA damage accumulates in the Ercc1-
/  mice until an undefined threshold for damage is crossed at which point the overwhelming 
damage drives the progression of aging-related degenerative changes in vulnerable cells, tissues 
and organs. 
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1.3 CONNEXINS AND GAP JUNCTIONS 
1.3.1 Structure and organization 
The connexins are a multigene family of 21 isoforms of non-glycosylated polytopic 
integral membrane proteins.  Their common protein structure includes four conserved -helical 
transmembrane domains, two conserved extracellular loops interconnected by three disulfide 
bridges, a cytoplasmic loop, and cytoplasmic N- and C-termini (Fig. 1.3) (Laird 2006).  
Members of the connexin family have a diverse C-terminal which can contain multiple serine 
and tyrosine residues subject to kinase phosphorylation (Lampe and Lau 2004).   Many cells and 
tissues express one or more members of the connexin family; however, connexin-43 (Cx43) is 
the most ubiquitous and hence most well-studied member.  Connexins are the protein building 
blocks of gap junctions which permit the intercellular exchange of electrical signals, ions, small 
metabolites, second messengers, and molecules less than 1kDa in size (Laird 2006). 
 
 
 
 
 
 
 
1.3.2 Trafficking 
Cx43 is co-translationally inserted into the endoplasmic reticulum (ER) and follows the 
general secretory pathway for membrane proteins (Segretain and Falk 2004).  Upon completion 
of proper folding, Cx43 exits the ER and passes through the Golgi apparatus, where 
oligomerization into connexon hemichannels (six connexin proteins) occurs in the trans 
compartment (Koval 2006).   Vesicles containing Cx43 hemichannels, which can bind tubulin, 
are then transported along microtubules to the plasma membrane (Giepmans, Verlaan et al. 
Figure 1.3: Structure and membrane topology of 
Cx43.  Cx43 has an intracellular N-terminus, four 
transmembrane domains, two extracellular loops, a 
cytoplasmic loop, and a long and disordered intracellular 
C-terminus.  Six connexins oligomerize to form a 
connexon or hemichannel.  Image adapted from Laird 
2010. 
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2001).  Directed delivery to adherens junctions next to pre-existing GJs has been demonstrated 
(Shaw, Fay et al. 2007) although Cx43 may also be found at non-GJ regions and have lateral 
mobility within the membrane (Lauf, Giepmans et al. 2002). These hemichannels are believed to 
remain closed until they reach the plasma membrane at which they may transiently open after 
stimulation (Goodenough and Paul 2003).   
At the plasma membrane, Cx43 has been shown to have distinct mobility at all cell-
surface membranes and progressively forms into gap junctions (Simek, Churko et al. 2009).  
Hemichannels on apposing cells dock with one another through interactions between the 
extracellular loops forming gap junctions which permit intercellular exchange (Laird 2006).  
Clustering of individual hemichannels into gap junctions is a dynamic and continuous process in 
which new channels are added at the periphery and old channels are in the center of gap junction 
plaques (Gaietta, Deerinck et al. 2002).  Gap junction plaques are composed of Cx43 that is 
primarily in the P2 form on SDS-PAGE and increasingly Triton X-100 insoluble (Musil and 
Goodenough 1991).  Altered gap junction stability through interactions with Cx43-binding 
partners such as ZO-1 (Hunter, Barker et al. 2005) and caveolin-1 (Langlois, Cowan et al. 2008) 
have been observed.   
The mechanisms of internalization of gap junctions and degradation of connexins are still 
being defined.  Internalization by formation of annular gap junctions, which are large double-
membrane vesicular structures, is believed to be one mechanism of gap junction removal (Laird 
2006), while a more recent study demonstrated that there is also internalization of small 
endocytic double-membrane vesicles (Falk, Baker et al. 2009). Both of these processes involve a 
clathrin-mediated mechanism (Piehl, Lehmann et al. 2007; Nickel, DeFranco et al. 2008).  
Ubiquitin and the associated cellular machinery are believed to “tag” connexin for internalization 
and help guide it to lysosomes (Leykauf, Salek et al. 2006; Leithe, Kjenseth et al. 2009; 
Kjenseth, Fykerud et al. 2010; Catarino, Ramalho et al. 2011).  
With a short protein half-life of 1.5-5 hours, connexins are actively being synthesized and 
degraded. Newly synthesized misfolded Cx43 may be degraded by ER-associated degradation 
(ERAD), while degradation of Cx43 at the plasma membrane appears to involve both lysosomes 
and proteosomes (Berthoud, Minogue et al. 2004).  Steady-state mechanism of degradation are 
unknown however many phosphorylation events are involved in targeting membrane Cx43 for 
degradation (Berthoud, Minogue et al. 2004).  It is believed that the short half-life of connexins 
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is indicative of their ability to respond to physiological changes rapidly by either up or 
downregulating gap junction coupling.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.3 Regulation by phosphorylation 
The Cx43 C-terminal contains over 14 known phosphorylation sites, mostly on serine 
residues (Lampe and Lau 2004).  These phosphorylation events are often associated with rapid 
and dramatic changes in migration patterns on SDS-PAGE, gap junction assembly, detergent 
solubility, degradation, and GJIC.   
Cx43 migrates at different speeds in SDS-PAGE which include the fastest-migrating 
form called “P0” and typically two slower migrating forms, “P1” and “P2” (Musil and 
Figure 1.4:  Life cycle of Cx43. Key events related to gap junction assembly and turnover.  Cx43 is co-
translationally inserted into the ER and oligomerized into connexons at the trans-Golgi network. Pathway 1 shows 
delivery of Cx43 hemichannel-containing vesicles via microtubules to the cell surface where they proceed to 
coalesce at sites of gap junction assembly. Pathway 2 shows microtubule-dependent direct delivery of Cx43-
containing vesicles to adherens junctions in proximity to gap junctions. Internalization of gap junctions occurs via 
endocytotic processes from either the central regions of gap junction plaques or other regions.  Internalization 
results in large double membrane annular junctions or small endocytic vesicles.  The resulting vesicles fuse with the 
lysosome for degradation. Some unfolded or misfolded connexins are degraded via ERAD and the proteasomal 
system.  Image adapted from Laird 2010. 
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Goodenough 1991).  These general forms reflect sequential phosphorylation states in the 
maturation of Cx43 from synthesis to incorporation into gap junctions. P0 is considered nascent 
and non-phosphorylated progressing to P1 then P2 (Musil, Cunningham et al. 1990; Musil and 
Goodenough 1991).  Although phosphorylation of the C-terminus drives electrophoretic 
migration changes, it is not achieved through changes in molecular weight but instead structural 
and conformational changes in the Cx43 (Sosinsky, Solan et al. 2007; Solan and Lampe 2009).  
The development of phosphospecific antibodies have further distinguished specific residues that 
are phosphorylated on Cx43 that make up the P0, P1, and P2 forms (Solan and Lampe 2007).   
Known kinases that phosphorylate Cx43 include the tyrosine kinase src, and the 
serine/threonine kinases PKC, MAPK (ERK1/2), cdc2, PKA, and casein kinase 1 (Lampe and 
Lau 2004).   Most of these phosphorylation events result in decreased Cx43 and GJIC, however, 
PKA and casein kinase 1 are involved in promoting gap junction formation and GJIC through 
direct and/or indirect Cx43 phosphorylation on serine 364/365 and 325,328,330 respectively 
(Cooper and Lampe 2002; Lampe and Lau 2004).  While connexin phosphorylation is well-
studied, substantially less is known about dephosphorylation of Cx43 by cellular phosphatases.    
1.3.3.1 Casein kinase 1 delta and its proposed role in Cx43 regulation 
 
CK1 is a member of the ubiquitously expressed CK1 family of conserved 
serine/threonine specific protein kinases (Knippschild, Gocht et al. 2005; Lohler, Hirner et al. 
2009).  The seven CK1 members are monomeric, constitutively active enzymes that use ATP as 
their phosphate donor and have a wide array of functions dictated by their localization 
(Knippschild, Gocht et al. 2005).  The CK1 isoform is localized throughout the cell including 
the membrane, cytoplasm, and nucleus, indicative of many of its described functions including 
regulation of membrane transport, circadian rhythm, cell division, apoptosis, Wnt signaling, and 
DNA repair (Knippschild, Wolff et al. 2005). The known roles of CK1 in DNA damage and 
repair include phosphorylation of p53 on Thr18 which prevents its degradation by 
MDM2(Sakaguchi, Saito et al. 2000) and binding to the spindle apparatus and centrosomes to 
prevent mitosis(Behrend, Stoter et al. 2000). The activity and expression levels of CK1 have 
also been shown to be induced by many DNA damaging agents (Knippschild, Milne et al. 1997; 
Behrend, Stoter et al. 2000; Alsheich-Bartok, Haupt et al. 2008) through unknown mechanisms.  
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The subcellular localization of CK1 within the trans-Golgi apparatus, on microtubules, and 
transport vesicles on microtubules confirm CK1’s role in regulating protein trafficking 
(Behrend, Stoter et al. 2000; Milne, Looby et al. 2001).  CK1t was also recently identified as a 
binding partner of Cx43 (Cooper and Lampe 2002), however, where and how this interaction 
occurs has not been determined.  It may take place at the plasma membrane where other 
members of the CK1 family have been shown to interact and phosphorylate E-cadherin (Dupre-
Crochet, Figueroa et al. 2007) and occludins (McKenzie, Riento et al. 2006) at the cell-surface.  
Cx43 phosphorylation by CK1 on serines 325,328,330 is proposed to be crucial for the 
assembly of gap junctions resulting in increased gap junction stability and GJIC (Cooper and 
Lampe 2002).     The importance of phosphorylation of Cx43 on these residues is demonstrated 
in ischemic cardiomyocytes where the loss of serine 325,328,330 phosphorylation is associated 
with decreased gap junction stability, downregulation of intercellular communication, and 
dysfunctional electrical coupling (Lampe, Cooper et al. 2006).    
1.3.4 Gap junction-related functions of Cx43 
The gap junction channel connects the cytoplasms of adjacent cells leaving a very narrow 
2-3 nanometer gap (Goodenough and Paul 2009).  The channel created by Cx43 has a pore size 
roughly estimated at 40 Å, the widest of all connexin channels,  and allows for gap junction 
intercellular communication (GJIC) and the establishment of interconnectivity between cells 
(Saez, Berthoud et al. 2003; Harris 2007).  A principal function of GJIC is to share metabolic 
demands across groups of cells and buffer gradients of nutrients or signaling molecules.  Using 
metabolic labeling, endogenous metabolites such as glucose, ATP, ADP, AMP, adenosine, 
glutathione, and glutamate have been shown to transfer via Cx43 channels (Goldberg, Lampe et 
al. 1999; Goldberg, Moreno et al. 2002).  GJIC also allows for electrical transmission between 
adjacent cells through a relatively low-resistance pathway for ions such as K+ (Mese, Richard et 
al. 2007).   Imaging of fluorescent sensors to secondary messengers such as cAMP, inositol 
trisphosphate (IP3) and Ca2+ demonstrated that they are all transmitted via gap junctions and can 
regulate intercellular calcium levels and downstream signaling (Hernandez, Bortolozzi et al. 
2007).   
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1.3.5 Non gap junction-related functions of Cx43 
Cx43 has other functions that extend beyond cell-cell communication via gap junctions.  
With numerous direct and indirect protein-protein interactions, Cx43 belongs to part of a larger 
junctional and signaling complex within cells that controls diverse cellular processes such as cell 
signaling, migration, growth and proliferation, tumorigenicity, differentiation, injury and 
apoptosis (Jiang and Gu 2005).  Cx43 exists as hemichannels prior to docking with apposing 
cells forming a gap junction.  Some of these hemichannels have unitary conductance and 
participate in intercellular propagation of Ca2+ waves or NAD+ and ATP release which have 
roles in paracrine signaling (Goodenough and Paul 2003).  Cx43 has a proposed channel-
independent role in cytoskeletal regulation that appears related to cell injury and survival.  
Exogenous expression of Cx43 led to cytoskeletal reorganization and morphological changes 
even in the presence of gap junction inhibitors (Lin, Yang et al. 2003).  Connexin expression also 
influences reorganization of actin resulting in stress fiber formation, flattening, and adhesiveness 
of transfected cells(Cotrina, Lin et al. 2008).  This adhesiveness can play a role in migration that 
is independent of GJIC (Elias, Wang et al. 2007). Finally, an inverse relationship between 
connexin expression and proliferative capacity has generally been accepted as exogenous 
expression of Cx43 in cancer cell lines can reduce their proliferative and invasive capacity in a 
non-GJIC manner (Huang, Fan et al. 1998; Qin, Shao et al. 2002; Olbina and Eckhart 2003).   
 
.   
1.3.6 Role of Cx43 in tissue homeostasis and function 
 
The fundamental importance of Cx43 in life is evident by the fact that global Cx43 
knockout in mice is embryonic lethal (Reaume, de Sousa et al. 1995).  Mutations of Cx43 in the 
autosomal dominant developmental disorder oculodentodigital dysplasia (ODDD) demonstrate 
the wide array of tissues disturbed by decreased functional Cx43 such as various craniofacial 
abnormalities, limb defects, neurodegeneration, and cardiac abnormalities (Paznekas, Boyadjiev 
et al. 2003).  Expression of the known mutant forms of Cx43 from ODDD in cell models have 
demonstrated loss-of-function properties with a majority of mutant forms trafficked to the cell 
surface and incorporated into gap junction plaques but unable to transmit dye between cells 
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(Laird 2006).  The importance of Cx43 in ocular development and physiology is evident by the 
specific ocular defects in ODDD including micro-ophthalmia, microcornea, cataracts, iris 
defects, and glaucoma (Musa, Ratajczak et al. 2008).  One mouse model of ODDD also 
demonstrated significant corneal opacities (Flenniken, Osborne et al. 2005).  
Due to the lethality of total Cx43 knockout, conditional Cx43 knockouts have also 
provided valuable insight into the function of Cx43 in many other tissues and cell types.  
Specific conditional Cx43 knockout in cells/phenotypes include: sertoli cells/reduced 
spermatogenesis (Sridharan, Brehm et al. 2007), vascular smooth muscle cells/pathological 
hyperproliferation and neointima formation after injury(Liao, Regan et al. 2007), vascular 
endothelial cells/hypotension and bradycardia (Liao, Day et al. 2001), and osteoblasts/reduced 
bone formation and osteopenia (Chung, Castro et al. 2006).  Within the eye, Cx43 knockout in 
ciliary epithelium resulted in loss of aqueous humor production and abnormalities associated 
with loss of intraocular pressure (Calera, Topley et al. 2006).  Assessing the role of Cx43 and 
GJIC at the cellular level demonstrates that intrinsic functions and properties such as 
transepithelial resistance (Langlois, Maher et al. 2007), Na+/K+ ATPase pump function 
(Matchkov, Gustafsson et al. 2007), and fluid transport (Calera, Topley et al. 2006; Law, Candia 
et al. 2009) are intimately related to Cx43 and GJIC.  Thus, in cell types with high endogenous 
levels of connexins and GJIC, tight regulation of connexin expression and GJIC is imperative to 
maintenance of normal physiological function.  Downregulation of Cx43 and GJIC in these cells 
consistently leads to disruption of function and pathology. 
1.3.6.1 Role of Cx43 and GJIC in corneal endothelial homeostasis and function 
 
Changes in Cx43 expression and GJIC in CE cells have previously been observed after 
treatments that disrupted tissue homeostasis.  One example is the CE release of ciliary 
neurotrophic factor (CNTF) and its receptor complex upon exposure to low levels of hydrogen 
peroxide (Koh 2002).  The signaling events leading to the upregulation of Cx43 mRNA and 
protein (Koh, Celeste et al. 2008) have recently been  proposed to be involved in promoting 
survival of dying CE cells (Koh, Cheng et al. 2009).  Studies employing point mechanical 
stimulation of CE cells have shown that upon disruption there is a Cx43-dependent increase in 
ATP release and calcium-wave propagation between cells through both GJIC and paracrine 
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communication (Gomes, Srinivas et al. 2006).  Cx43 and GJIC appear to also have a reciprocal 
role in CE pump function as inhibition of the Na+/K+ ATPase pump with ouabain resulted in 
reduction in gap junctions plaques (Watsky, McCartney et al. 1990) and bicarbonate treatment, 
which stimulates CE pump function, resulted in increased dye diffusion between CE cells 
(Williams and Watsky 2004).  Thus, it is apparent that CE relies on Cx43 and GJIC changes 
during stress which is potentially coupled with the barrier and pump function of CE. 
1.3.7 Role of connexins and gap junctions during genotoxic stress 
Rapid increases in expression and phosphorylation of Cx43 have been observed after 
DNA damage with ionizing radiation, oxidative stress, and UV light and other stressors 
including hyperthermia and ER stress (Liu, Kasper et al. 1997; Azzam, de Toledo et al. 2003; 
Glover, Little et al. 2003; Gambichler, Rotterdam et al. 2008). One of the most well studied 
phenomena is the “radiation bystander effect” in which DNA damage with ionizing or -particle 
radiation to a few cells results in gene expression changes, genomic instability, mutations, and 
death in neighboring non-irradiated cells (Little 2006). Consistently, increased expression of 
Cx43 at the mRNA and/or protein levels is observed rapidly after exposure to irradiation and 
GJIC has been thought to mediate the changes observed in non-irradiated cells (Azzam, de 
Toledo et al. 2003; Glover, Little et al. 2003; Banaz-Yasar, Tischka et al. 2005). Examination of 
the Cx43 promoter after ionizing irradiation suggests that the activator protein (AP)-1 binding 
site is involved in the upregulation of Cx43 mRNA (Liu, Kasper et al. 1997; Glover, Little et al. 
2003). However, beyond ionizing radiation, the mechanisms of increased Cx43 expression after 
DNA damage have not been further explored and may be cell-type specific based on the function 
and necessity of Cx43 and GJIC in that cell.  
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1.4 SUMMARY & GOALS 
The eye is an ideal organ to study age-related changes and the effects of DNA damage 
due to its continuous exposure to environmental and endogenous stressors. Almost every 
specialized tissue in the eye including the cornea, trabecular meshwork, ciliary body, lens, and 
retina undergoes age-related degeneration that results in deterioration of vision (Salvi, Akhtar et 
al. 2006). Many of the tissues in the visual axis are non-proliferative which is believed to be 
important for maintenance of clear vision; however, these quiescent states also may permit the 
accumulation of DNA damage with time which may be especially detrimental to non-
regenerative tissues such as the corneal endothelium and retinal pigment epithelium. With age 
comes exposure to increasing amounts of potential DNA damage which may accumulate in time.  
As those suffering from corneal endothelial dysfunction are typically older and the source of 
corneal tissue for transplantation is generally from older donors, it is becoming increasingly 
evident that age affects the corneal endothelium and those that receive corneal transplantations.  
Whether DNA damage is a cause of the non-regenerative nature of the corneal endothelium or in 
fact a by-product of lack of proliferation remains to be determined. Regardless, the transparency 
of the cornea, which controls the very first entry of light on our visual system, depends upon the 
proper function of the corneal endothelium.   
The goals of this body of work are to establish a role for genotoxic stress and identify 
novel responses in corneal endothelium.  Specifically, I sought to determine and characterize: (1) 
novel exposures to genotoxic stress (Chapter 2), (2) the effects of unrepaired DNA damage in 
aging and vulnerability of the corneal endothelium (Chapter 3), and (3) novel acute cellular 
responses to genotoxic stress that mediate corneal endothelial survival (Chapters 4 and 5).  By 
studying the cellular and molecular mechanisms by which the corneal endothelium responds to 
DNA damage, we may begin to find ways to prevent its decline or protect it from future insults.    
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2.0  DNA CROSS-LINKING, DOUBLE-STRAND BREAKS, AND APOPTOSIS IN 
CORNEAL ENDOTHELIAL CELLS AFTER A SINGLE EXPOSURE TO 
MITOMYCIN-C 
Chapter 2 is adapted, with copyright permission from the Association for Research in Vision and 
Ophthalmology, from a published article.  Roh DS, Cook AL, Rhee SS, Joshi AB, Kowalski R, 
Dhaliwal DK, Funderburgh JL. (2008) DNA Cross-linking, Double-Strand Breaks, and 
Apoptosis in Corneal Endothelial Cells after a Single Exposure to Mitomycin C.  Invest 
Ophthalmol Vis Sci 49(11): 4837-4843.  Note that the figure numbers have changed. 
2.1 INTRODUCTION 
Mitomycin C (MMC), an antibiotic isolated from Streptomyces caespitosus, is classified 
as an alkylating agent capable of covalently binding DNA and inducing inter- and intrastrand 
cross-links. The presence of such cross-links results in inhibition of DNA synthesis primarily 
during late G1 and S phases, although it is not cell-cycle specific. In addition, MMC inhibits 
RNA and protein synthesis and interacts with molecular oxygen, generating free radical damage 
to DNA and protein (Chabner, Amrein et al. 2006).  MMC is predominantly used as a systemic 
chemotherapeutic agent; however, off-label usage of MMC is common during ophthalmic 
procedures, such as glaucoma filtering surgery, lacrimal surgery, treatment of ocular neoplasia, 
ocular cicatrization surgery, and corneal refractive surgery (Abraham, Selva et al. 2006).   
Currently, the use of adjuvant MMC as an intraoperative prophylactic for reducing haze 
has become increasingly widespread in photorefractive keratectomy (PRK)  (Majmudar, Forstot 
et al. 2000; Carones, Vigo et al. 2002; Lane, Swale et al. 2003; Gambato, Ghirlando et al. 2005; 
Lacayo and Majmudar 2005; Lee, Chung et al. 2005; Abraham, Selva et al. 2006; Bedei, 
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Marabotti et al. 2006; Nakano, Bains et al. 2007).  As a topical adjunct during refractive surgery, 
MMC is exclusively used to modulate corneal wound healing and, through its effects on stromal 
keratocytes, to prevent active fibrosis, abnormal collagen deposition, and haze formation. The 
induction of apoptosis of keratocytes by MMC seems to play a central role in preventing the 
formation of clinically significant haze (Kim, Tchah et al. 2003; Kim, Pak et al. 2004; Chang 
2005).  
MMC applied topically has been shown to penetrate the cornea and can be detected in 
corneal tissue and the aqueous humor well after initial application (Song, Kim et al. 2006; 
Torres, Merayo-Lloves et al. 2006; Song, Kim et al. 2007); thus, treatment with MMC during 
refractive surgery has the potential to impact ocular tissues other than the target keratocytes. Of 
particular interest is the corneal endothelium, a monolayer of nonregenerating cells essential to 
the clarity of the cornea. Initially, several clinical studies regarding corneal endothelial cell 
density and morphology indicate few short-term complications with the use of adjuvant MMC 
during refractive surgeries (de Benito-Llopis, Teus et al. 2007; Diakonis, Pallikaris et al. 2007; 
Goldsberry, Epstein et al. 2007); however, recent studies have suggested potential adverse 
effects of such treatments. The corneal endothelium appears to exhibit significant vulnerability to 
the toxicity of MMC. Single intraoperative MMC applications over a denuded stroma result in 
dose-dependent corneal edema and endothelial apoptosis (Chang 2004).  Similarly, significant 
endothelial cell loss has been reported in MMC-treated eyes within a few months after 
photorefractive keratectomy (Morales, Zadok et al. 2006). In addition, numerous case reports 
have suggested that a single intraoperative application of MMC during other ocular procedures 
may be responsible for corneal endothelial damage and loss (Sihota, Sharma et al. 1998; 
Fukuchi, Hayakawa et al. 2002; Mietz, Roters et al. 2005; Mohammadpour, Jabbarvand et al. 
2007).  Thus, as the surgical use of MMC increases, the need to define its cellular effects at 
relevant clinical applications and dosages on corneal endothelial cells is of high importance. 
In this study, we assessed the effects of a single MMC application on corneal endothelial 
cells, using concentrations and times relevant to current clinical practice. We used a modified 
version of the highly sensitive comet assay (single cell gel electrophoresis) to detect DNA cross-
linking and examined the phosphorylated histone variant H2AX (γ-H2AX) to demonstrate DNA 
double-strand breaks. Finally, we assessed MMC-treated cells for annexin V staining to detect 
apoptosis. Our results clearly demonstrate that exposure to MMC at the times and concentrations 
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commonly used in refractive surgery produced cross-linking of corneal endothelial DNA, 
persistent DNA damage, and endothelial death via apoptosis. 
 
2.2 MATERIALS AND METHODS 
Animals and Cell Culture 
Fresh whole goat eyes were obtained from a local butcher within a few hours of death. For 
indicated experiments, whole globes were used immediately as described below. To isolate 
corneal endothelial (CE) cells, we excised corneas with a scleral rim and placed them 
endothelium side up in plastic tube caps. The CE cells were enzymatically detached by direct 
application of 0.05% trypsin/0.5 mM EDTA (Sigma-Aldrich, St. Louis, MO) with incubation at 
37°C and harvested by gentle scraping. The CE cells were separated from Descemet’s membrane 
and cell suspensions were broken up by gentle pipetting and sieved through a 70-μm nylon mesh. 
The suspended CE cells were centrifuged, and pelleted cells used for comet assay were directly 
resuspended in 1% low-melting-point (LMP) agarose and used as described below. CE cells for 
culture were resuspended in DMEM (no. 1569; Invitrogen, Carlsbad, CA) supplemented with 
10% fetal bovine serum (Hyclone, Logan, UT), gentamicin, penicillin/streptomycin, and 
amphotericin B and cultured in 25 cm2 cell culture flasks at 37°C in 5% CO2 until 90% 
confluent. The cells were passaged on a cell dissociation enzyme (TrypLE Express; Invitrogen), 
centrifuged, resuspended, and plated on sterile glass coverslips for γ-H2AX detection or in six-
well plates for annexin V detection. Cell culture pellets used for the comet assay were directly 
resuspended in 1% LMP agarose and used as described later. Confluent passage-one or -two 
cells were used in all cell culture experiments. 
 
MMC Treatment 
MMC (Sigma-Aldrich) was dissolved to desired concentrations in phosphate-buffered saline 
(PBS) for whole globe treatments and in DMEM with 10% FBS for cell culture studies. We 
referred to established MMC treatment protocols used in refractive surgery for the treatment of 
whole intact globes (Majmudar, Forstot et al. 2000; Carones, Vigo et al. 2002; Lane, Swale et al. 
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2003; Gambato, Ghirlando et al. 2005).  First, the corneal epithelium was treated with 20% 
ethanol within an 8-mm trephine for 20 seconds followed by mechanical epithelium debridement 
of the 8-mm area with a beaver blade. Immediately after debridement, a corneal shield 
(Medtronic Solan, Jacksonville, FL) soaked with 200 μg/mL (0.02%) MMC in PBS was placed 
over the denuded area for 6, 12, 30, 60, or 120 seconds. The control globes were not treated with 
MMC. After the MMC sponge was removed, the eyes were copiously washed with 30 mL of 
PBS and then placed in a humid chamber for 30 minutes before isolation of CE cells as described 
earlier. Laser ablation was performed on a subset of intact whole globes before MMC treatment 
(Visx Star S4 Excimer Laser System; Visx Technology, Santa Clara, CA) with a fluence of 160 
mJ/cm2 per pulse at 10.0 Hz. The laser was programmed for a 75-μm ablation depth with a 6.0-
mm optical zone and a 0.3-mm transition zone. To allow for DNA repair in a subset of corneal 
buttons, we excised the corneas after MMC treatment, placed them in 35-mm2 tissue culture 
plates, and immersed them in culture medium at 37°C in 5% CO2 for 24 hours before CE cell 
isolation.  
For comet assay of cultured CE cells, we treated confluent cultures with MMC 
concentrations ranging from 0.02 to 200 μg/mL for 10, 30, or 60 minutes and isolated cells per 
the protocol above.  
For treatment of cultured CE cells to detect γ-H2AX and annexin V, we selected a MMC 
concentration of 0.4 μg/mL (0.00004%) which we determined via growth inhibition bioassay to 
be present in the corneal endothelium after topical treatment of intact globes with 0.02% MMC. 
Furthermore, this concentration was similar to those found in the aqueous humor 30 minutes to 1 
hour after MMC treatment in previous studies (Torres, Merayo-Lloves et al. 2006; Song, Kim et 
al. 2007).  We treated confluent monolayers of CE cells with 0.4 µg/ml MMC in DMEM/10% 
FBS for 30 minutes at 37ºC in 5% CO2 then immediately removed the medium, washed with 
PBS, and replaced it with fresh culture medium.  The cells were incubated 24, 48, or 72 hours 
before assaying for -H2AX or annexin. 
 
Determination of Radial and Posterior Diffusion of MMC  
Determination of the extent of radial and posterior diffusion of MMC in whole globes after 
topical exposure to 0.02% MMC was assayed by sectioning the excised cornea into radial or 
anterior to posterior (coronal) portions and estimating concentrations of MMC in the tissue with 
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an Escherichia coli growth-inhibition bioassay. For radial sectioning, MMC-treated corneas were 
immediately cut into concentric rings with 8-, 6-, and 4-mm trephines; minced; and placed into 
tubes containing PBS. For coronal sections, groups of five 40-μm-thick sections of treated 
corneas, cut with a sliding microtome, were combined, minced, and placed into tubes containing 
1 mL of PBS. Fifty microliters of each extract was pipetted onto a minimum inhibitory 
concentration (MIC) disc, which was then placed onto an E. coli plate, and incubated overnight. 
The resulting zone of inhibition of growth of E. coli was measured manually and compared to a 
standard curve to determine the concentration of MMC present in the extracts. Radial 
measurements were made from duplicate assays and coronal measurements were obtained from a 
single assay. 
 
Modified Alkaline Comet Assay and Analysis   
The CE cell suspensions were pelleted and resuspended in 80 μL of 1% LMP agarose. The 
resuspended cells were immediately transferred to microscope slides precoated with 1% normal 
melting-point agarose, covered with coverslips, and chilled over ice for 20 minutes. The 
coverslips were removed and the slides placed in lysis solution (10 mM Tris, 100 mM EDTA, 
2.5 M NaCl [pH 10], 1% Triton-X) over ice for 60 minutes. Lysis solution was removed, and the 
slides were rinsed three times with distilled water. The slides were then irradiated with 5 Gy 
(Cs137 source) γ-irradiation to induce random double-strand DNA breaks. After irradiation, DNA 
was alkaline-denatured by immersion of slides in cold 3 M NaOH, 10 mM EDTA for 30 
minutes. Electrophoresis was conducted in the same buffer at 25 V (0.8 V/cm) for 40 minutes at 
room temperature. The slides were incubated in neutralization buffer (0.4 mM Tris, pH 7.5) for 
10 minutes and then stained with SYBR gold (Invitrogen) in TE (10 mM Tris-HCl, 1 mM EDTA 
[pH 8.0]). Coverslips were placed over the slides which were allowed to dry overnight protected 
from the light.  DNA from individual cells was visualized using an epifluorescence microscope 
(TE2000; Nikon, Melville, NY) with a 10× objective (Pan Fluor; Nikon). Photography and 
analysis of the samples were performed in a masked fashion. Images were captured with a 12-bit 
digital camera (SPOT; Diagnostic Instruments, Sterling Heights, MI). All comet analysis was 
performed using software designed for this purpose (CometScore software; TriTek Corp., 
Sumerduck, VA) which measures a wide range of fluorescence parameters for selected comets. 
The primary measurement, %DNA-in-head, reflected the relative distribution of DNA in each 
 41 
comet. In both the intact globe and cell culture studies, more than 1000 comets were analyzed in 
each of two independent experiments. 
 
-H2AX Detection 
Confluent CE cells grown on sterile glass coverslips were exposed to a single 30-minute 
treatment with 0.4 μg/mL MMC, rinsed, and continued in culture for 24, 48, or 72 hours. MMC-
treated CE cells were briefly rinsed in PBS and then fixed with 3% paraformaldehyde in PBS for 
20 minutes at room temperature. After the cells were rinsed with PBS, they were permeabilized 
with 0.1% Triton-X in PBS for 1 minute, rinsed with PBS, and stored in 50% glycerol in PBS 
(vol/vol) at 4°C until staining. Nonspecific binding was blocked with 10% heat-inactivated goat 
serum for 1 hour at room temperature. After they were washed with PBS, the CE cells were 
incubated overnight at 4°C with anti-γ-H2AX polyclonal rabbit antibody (AF2288; R&D 
Systems, Minneapolis, MN) diluted 1:800 in 1% bovine serum albumin (BSA) in PBS. The cells 
were washed and incubated with DAPI nuclear stain, 0.5 μg/mL and Alexa Fluor 488–
conjugated goat anti-rabbit IgG, 1 μg/mL (A-11094; Invitrogen) for 1 hour at room temperature. 
The coverslips were placed onto slides, and the nuclei were visualized with an inverted 
microscope (TE200-E Eclipse; Nikon) with a 40× oil objective (Nikon). A digital camera 
(CoolSnapHQ; Roper, Tucson, AZ) was used for image acquisition. Manual counting, 
processing, and analysis were performed (MetaMorph Software; Molecular Devices, Sunnyvale, 
CA). Fifteen images from each treatment group were analyzed in each of two independent 
experiments. 
 
Annexin V Detection 
Annexin V detection (TACS Annexin V-FITC Apoptosis Detection kit; R&D Systems) was 
performed on confluent CE cells grown in six-well culture plates 24 or 48 hours after a single 
30-minute treatment with 0.4 μg/mL MMC, according to the manufacturer’s protocol. Nuclei 
were counterstained with Hoechst 33342 dye at 1 μg/mL (Invitrogen). Cells were photographed 
and analyzed as for γ-H2AX detection. Ten images representing different locations throughout 
the culture were analyzed from each treatment group. 
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Statistics 
Statistical analysis was performed with one-way analysis of variance (ANOVA) followed by the 
Dunnett multiple comparison test (GraphPad Prism 4 software; GraphPad Software, San Diego, 
CA). The Dunnett test was used to compare values for MMC treatment groups with those of the 
control cultures. P < 0.05 was considered significant for all tests.  
2.3 RESULTS 
2.3.1 MMC in the cornea after a single topical treatment 
A single topical treatment of MMC (0.02%) for 2 minutes on a de-epithelialized cornea resulted 
in measurable MMC concentrations throughout the entire cornea (Fig 2.1).  Radial sections of 
MMC-treated corneas revealed concentrations of MMC from 1.05 μg/mL in the central area to 
0.37 μg/mL in the periphery (>8 mm), demonstrating the rapid diffusion of MMC from the 
central cornea to the periphery (Fig 2.1.A).  Coronal sections of MMC-treated corneas revealed 
the presence of MMC in all layers of the cornea after treatment, ranging from 1.05 μg/mL in the 
anterior stroma (1–200-μm section) to 0.37 μg/mL in the CE (601–800-μm section) (Fig 2.1.B).  
This concentration was similar to those found in the aqueous humor 30 minutes to 1 hour after 
MMC treatment in previous studies (Torres, Merayo-Lloves et al. 2006; Song, Kim et al. 2007).   
 
 
 
 
 
 
 
   
 
 
 
Figure 2.1:  Corneal concentration of MMC 2 minutes after a single topical administration of 0.02% 
MMC on a whole globe, as determined by growth inhibition bioassay. The zone of inhibition of E. coli 
growth was compared to a standard curve to determine MMC concentrations. (A) MMC concentration decreases 
radially, away from the site of application. (B) CE concentration is approximately 0.37 μg/mL at the depth of the 
endothelium (601–800 μm). Mean ± SEM. 
(A) (B) 
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2.3.2 Induction of DNA Cross-Linking in the CE 
Modified Comet Assay  We investigated the cross-linking effects of MMC treatment on goat 
CE by using a modification of the comet assay previously developed by McKenna et al. 
(McKenna, Gallus et al. 2003) to evaluate MMC-induced DNA cross-linking damage in RT4 
cells.  Fig 2.2.A is a representative image of the results of the comet assay illustrating staining of 
DNA from individual CE cells after fragmentation and denaturation. Distinct head and tail 
regions are seen in the DNA from each cell, representing DNA fragments with differing 
electrophoretic mobility. DNA fragments without cross-links are smaller and migrate more 
rapidly (i.e., in the tail portion of the comet). In contrast, DNA fragments with MMC-induced 
cross-links resist full denaturation in alkaline conditions and exhibit decreased electrophoretic 
mobility, thereby forming the head of the comet. Fig 2.2.B provides a representative image 
illustrating the increasing percentage of DNA remaining in the head (%DNA-in-head) of the 
comet as MMC treatment time increased. 
 
 
 
 
 
 
 
 
 
Figure 2.2: Single cell gel electrophoresis (modified alkaline comet assay) of CE cell DNA. 
(A) Representative images of individual CE cell DNA after electrophoresis show migration 
patterns with a comet-like appearance. (B) Individual comets are oriented with the head to the 
left. The image on the right of each shows a pseudocolor of the image with an overlaid graphic 
representation of staining intensity. This intensity is proportional to the amount of DNA at that 
location in the gel. Area under these curves was used calculate %DNA-in-head. With increasing 
length of treatment of MMC, more DNA was observed in the head of comets. 
(A) (B) 
No MMC 
6 sec 
12 sec 120 sec 
60 sec 
30 sec 
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MMC-Induced DNA Cross-Links in Intact Globes.  Quantitative analysis of images similar to 
those in  Fig 2.2, found that a single topical application of 0.02% MMC on intact whole globes 
caused DNA cross-linking in CE cells at all treatment times (Fig 2.3).  More than 1000 
individual comets were analyzed in each experiment. In experiment A, we used epithelial 
debridement followed by MMC treatments. The presence of the epithelial basement membrane 
did not prevent the cross-linking effects of MMC, as all treated groups had significantly more 
%DNA-in-head than did the untreated control  (Fig 2.3.A, ANOVA p<0.05, Dunnett’s p<0.01).  
In experiment B, we used epithelial debridement followed by laser ablation and MMC 
treatments. In these conditions, which emulate PRK protocols, all MMC treatment groups had 
significantly more %DNA-in-head when compared with the untreated control (Fig 2.3.B, 
ANOVA p<0.05, Dunnett’s p<0.01).  Experiment C was similar to experiment A, but MMC 
treatment was followed by a 24-hour incubation period to allow for repair. In this experiment, 
MMC-induced DNA cross-linking in the endothelium was not significantly reduced after 24 
hours, as all MMC treatment groups had significantly more %DNA-in-head than did the control  
(Fig 2.3.C, ANOVA p<0.05, Dunnett’s p<0.01).  Across all trials, there was also an apparent 
time response between the length of MMC treatment and amount of DNA cross-linking evident 
as %DNA-in-head.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* *
*
*
*
* *
* * * * * *
* *
(B) (A) (C) 
Figure 2.3: CE DNA cross-linking induced by MMC treatment of whole globes. %DNA-in-head was 
calculated for comets (as in Fig. 2.2 ) derived from CE cells after topical MMC treatment of intact goat 
eyes. (A) 0.02% MMC treatment followed epithelial debridement. (B) MMC treatment followed epithelial 
debridement and 75 μm stromal ablation. (C) Eyes treated with MMC after epithelial debridement (as in 
A) were incubated 24 hours at 37°C, to allow DNA repair. *Significant difference from control; ANOVA 
P < 0.0001, Dunnett P < 0.01. Mean ± SEM. 
 45 
MMC-Induced DNA Cross-Links in Cultured CE cells. Confluent monolayers of goat CE 
cells also exhibited significant DNA cross-linking similar to that shown in  Fig 2.3 in MMC-
treated intact globes. MMC concentrations ranging from 0.02 to 200 μg/mL all resulted in 
significant DNA cross-linking when compared with the untreated control (Fig 2.4, ANOVA 
p<0.05, Dunnett’s p<0.05).  Increasing the length of exposure to MMC at all concentrations, 
except 0.2 μg/mL, resulted in increased DNA cross-linking, similar to the results in intact globes.  
 
 
 
 
 
 
 
 
 
 
 
 
  
2.3.3 Persistent and Elevated -H2AX Staining after MMC Treatment 
 γ-H2AX nuclear foci represent phosphorylation at Ser139 of histone variant H2AX and are 
sensitive markers for DNA double-strand breaks (Sedelnikova, Pilch et al. 2003).  
Dephosphorylation of histone H2AX accompanies subsequent effective repair of the DNA 
damage (Chowdhury, Keogh et al. 2005).  As shown in Fig 2.5.A, CE cells treated with 0.4 
μg/mL MMC for 30 minutes developed γ-H2AX-positive nuclei, demonstrating the presence of 
DNA double-strand breaks. Recovery for 24, 48, and 72 hours after MMC treatment showed no 
decrease in the percentage of γ-H2AX-positive nuclei (Fig 2.5.B).  MMC treatment therefore 
produces a long-term activation of γ-H2AX in CE cells, a phenomenon previously reported to be 
transient in cells undergoing DNA repair (Downey M 2006).  
Figure 2.4: Sensitivity of CE cells to DNA cross-linking by MMC. Goat CE cells in culture were treated with a 
range of MMC concentrations, and DNA cross-linking was determined using the comet assay as described in Figure 
2.2 at three exposure times. (A) Ten-minute exposure to MMC at all concentrations induced significant DNA cross-
links compared to controls. (B) Thirty-minute exposure to MMC at all concentrations (except 0.02 μg/mL, Dunnett 
P > 0.05) induced significant DNA cross-links compared with controls. (C) Sixty-minute exposure to MMC at all 
concentrations induced significant DNA cross-links compared with the control. *Significant differences from 
control; ANOVA P < 0.0001, Dunnett P < 0.01. Mean ± SEM. 
*
* * *
*
*
* *
*
*
* *
*
*
*
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2.3.4 Effect of MMC on the Proportion of Apoptotic Cells 
 To examine the potential irreversible effects of MMC-induced DNA damage, we examined 
confluent CE cells for annexin V binding to phosphatidylserine flipping, an early signal of 
apoptosis. CE cells briefly treated with 0.4 μg/mL MMC for 30 minutes showed increased 
annexin V staining compared with the control (Fig 2.6.A).  MMC treatment increased the 
proportion of annexin V cells, with the number labeled becoming significantly different from the 
control at 24 and 48 hours after treatment (Fig 2.6.B).  Similar results were obtained after 
treating confluent CE cells with higher concentrations of MMC. 
 
Figure 2.5:  H2AX phosphorylation (γ-H2AX) induced by MMC treatment. (A) Confluent 
CE cells were treated with MMC at 0.4 μg/mL for 30 minutes and nuclei were stained with 
DAPI (blue) and anti-γ-H2AX antibody (green) at 24, 48, and 72 hours after treatment. (B) The 
proportion of nuclei with γ-H2AX staining was similar to that in (A). *Significant differences 
from control; ANOVA P < 0.0001, Dunnett P < 0.01. The control cells were assayed at 72 hours. 
Mean ± SEM. 
*
*
*
CTRL 24 hr 48 hr 72 hr 
(A) 
(B) 
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2.4 DISCUSSION 
Recent studies have demonstrated the presence of MMC in the anterior chamber after 
photorefractive keratectomy (Song, Kim et al. 2006; Torres, Merayo-Lloves et al. 2006; Song, 
Kim et al. 2007), dose-dependent corneal edema after a single application of MMC on the 
corneal surface (Chang 2004), and significant endothelial cell loss occurring within a few months 
after PRK with MMC (Morales, Zadok et al. 2006).  Our study has added new evidence of the 
effects of MMC on the CE, which DNA repair mechanisms did not appear to reverse. We 
confirmed both radial and coronal diffusion of MMC after a single topical treatment that 
extended to the CE. Using a sensitive, recognized measure of DNA cross-linking, the comet 
assay, we detected significant levels of cross-linked DNA in MMC-treated CE cells. In addition, 
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Figure 2.6:  MMC exposure initiates endothelial apoptosis. (A) Confluent CE cells were treated 
with MMC 0.4 μg/mL for 30 minutes and stained with Hoechst 33342 (blue) and annexin V-FITC 
(green) 24 and 48 hours later. Cells positive for annexin V-FITC are apoptotic. (B) The proportion 
of apoptotic cells after MMC treatment was significantly elevated above the untreated control. 
*Significant differences from control; ANOVA P < 0.0001, Dunnett P < 0.01. The control cells 
were assayed at 48 hours. Mean ± SEM. 
*
*
CTRL 24 hr 48 hr
(A)
(B) 
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we observed persistent DNA double-strand breaks and an increase in the proportion of apoptotic 
cells after a brief exposure to MMC.  
Our study design included three separate trials to examine the effects of MMC treatment 
on intact globes across a range of conditions while emulating a standard protocol of 
photorefractive keratectomy with intraoperative MMC treatment. It is important to emphasize 
that our MMC application times ranged from 6 to 120 seconds, including the range of currently 
recommended MMC application times. Our results showed that the presence or absence of the 
epithelial basement membrane and Bowman’s layer did not affect the ability for MMC to induce 
cross-links in CE DNA. Ablation of 75 μm of the stroma was within the range of ablation for 
human PRK and has been thought to facilitate MMC access to the CE (Song, Kim et al. 2007).  
In the eyes that underwent laser ablation, we observed the greatest absolute difference between 
the control and the 6-second treatment; however, there was no other evidence of increased risk. 
Finally, allowing the excised corneas 24 hours to repair the MMC-induced DNA damage 
produced an observable difference between treatment times less than and greater than 60 
seconds. However, even with time for repair of the DNA cross-links, all treatment groups had 
significantly more cross-linked DNA than the untreated controls.  
The effects of MMC concentration and treatment times on DNA cross-linking in CE cells 
were better defined in the cell culture experiments (Fig 2.4).  The cross-linking effects of MMC 
were evident across a wide range of concentrations and even 10-fold below the amounts we 
detected in the CE after a single topical treatment (Fig 2.1).    Although there is continuous 
turnover of aqueous humor content and significant decrease in MMC concentration over time 
(Song, Kim et al. 2006; Torres, Merayo-Lloves et al. 2006; Song, Kim et al. 2007), we found that 
even the brief 10-minute exposure to 0.02 μg/mL MMC was long enough to induce significant 
DNA cross-linking in cultured CE cells (Fig 2.4.A).   
Despite evidence that human CE appears protected from UV irradiation damage the 
ability of these cells to repair other DNA damage such as MMC-induced cross-linking is 
essentially unknown. McKenna et al. (McKenna, Gallus et al. 2003) found in the bladder tumor 
cell line RT4 that almost all MMC-induced cross-links were repaired within 24 hours, reversing 
the characteristic changes in DNA migration in the modified comet assay. In contrast, we 
observed no reversal of the %DNA-in-head proportion after 24 hours in culture. In fact the 
proportion of cross-linked DNA in most treatment conditions actually increased 24 hours after 
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MMC treatment (compare Fig 2.3.A and 2.3.C). We also observed significant γ-H2AX positive 
nuclei in MMC-treated confluent cultures (Fig 2.5). This histone becomes phosphorylated at the 
site of double-strand DNA breaks and is dephosphorylated during repair. Our observation that 
MMC induces γ-H2AX phosphorylation is consistent with the comet data indicating DNA 
damage induced by MMC. The presence of phosphorylated γ-H2AX foci is believed to represent 
a signal for repair and to stimulate recruitment of DNA repair enzymes. Phosphorylation of γ-
H2AX in most systems is transient, however, and dephosphorylation occurs after repair has been 
completed (Chowdhury, Keogh et al. 2005).  The persistence of the activated γ-2HAX in CE 
cells is an unusual observation. It suggests that little or no DNA repair of the induced breaks 
occurs in these quiescent cells. The nonproliferative state of the CE may limit its ability to 
initiate and repair MMC-induced cross-links, leaving it increasingly vulnerable to DNA damage. 
Current models of DNA cross-linking repair suggest that the coordinated action of several DNA 
repair pathways, including nucleotide excision repair and double-strand break repair, may not be 
as efficient in nonreplicating cells, since they are initiated during active DNA replication 
(McHugh, Spanswick et al. 2001).  In repair-deficient mammalian cells, only 40 DNA cross-
links per cell have been estimated to be lethal (Lawley and Phillips 1996).  Additional studies are 
needed to evaluate the capacity to repair MMC-induced DNA cross-links in the CE.  
The presence of DNA cross-linking in the CE is likely to be associated with the 
decreased endothelial cell density, endothelial apoptosis, and potential corneal edema observed 
in previous studies (Sihota, Sharma et al. 1998; Fukuchi, Hayakawa et al. 2002; Chang 2004; 
Mietz, Roters et al. 2005; Morales, Zadok et al. 2006; Mohammadpour, Jabbarvand et al. 2007).  
Evidence of MMC-induced apoptosis was found in rabbit CE after epithelial debridement and 
MMC treatment for 2 minutes (Chang 2004).  Given the ocular penetration profile of a single 
topical application of MMC as well as our evidence of MMC-induced DNA cross-links and 
apoptosis in cultured CE cells (Fig 2.6), it is probable that in vivo the CE layer is at risk to 
MMC-induced DNA damage and potential apoptosis. Because the human CE is nonproliferative 
in vivo, it is already considered fragile to insults and responds only through cell enlargement and 
migration as a means of repair (Joyce 2003).  When CE cell density decreases below the level of 
1000 cell/mm2, the number of pump sites per cell progressively increases; however, pump 
function is eventually inadequate to maintain the balanced hydration of the stroma and corneal 
edema ensues (Crawford, Ernst et al. 1995).  Disruption of the normal function of CE with a 
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genotoxic stressor such as MMC may eventually accelerate this pathologic process.  
Recent acknowledgment of MMC toxicity has led to the development of methods to limit 
corneal exposure, mostly through reductions in concentration and exposure times. Efforts to 
reduce the initial recommendation of 120 seconds to shorter exposure times (de Benito-Llopis, 
Teus et al. 2007; Goldsberry, Epstein et al. 2007) as well as lower concentrations (Lane, Swale et 
al. 2003; Thornton, Puri et al. 2007) have since been in practice.  Despite these efforts, it is 
noteworthy that we observed significant DNA cross-linking after as few as 6 seconds of MMC 
exposure and at concentrations well below what has been detected in the CE and aqueous humor. 
Our results suggest that current practices in MMC application during refractive surgeries may be 
increasing the potential for long-term and permanent effects on the health of the CE. 
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3.0  AGE-RELATED DYSTROPHIC CHANGES IN CORNEAL ENDOTHELIUM 
FROM DNA REPAIR DEFICIENT MICE 
3.1 INTRODUCTION 
The cornea is a remarkably transparent tissue that provides protection from 
environmental exposures and is critical for refracting incoming light.  It is composed of three 
tissue layers (epithelium, stroma, and endothelium) each with distinct properties and functions. 
The corneal endothelium (CE) is the innermost and single cell layer that functions to maintain 
proper hydration of the corneal stroma and to allow nutrient and waste exchange with the 
aqueous humor.  Functional CE cells are indispensable for maintaining corneal transparency. 
However, this single layer of cells is also very fragile and does not regenerate in vivo (Joyce 
2003). Loss of CE cells as a consequence of disease or acute trauma therefore leads to 
irreversible corneal edema and blindness (Bourne and McLaren 2004).  There is also a steady 
loss of CE cells in all individuals with aging, at a rate of 0.6% of central cell density per year 
(Bourne and McLaren 2004). Currently, corneal transplantation is the only therapeutic option for 
corneal edema (Bourne and McLaren 2004).  In 2009, >42,000 individuals in the U.S.A. required 
a corneal transplant, with CE degeneration being a major cause of the need for transplant 
(Ghosheh, Cremona et al. 2008). The majority of corneal transplantation recipients are >60 years 
old. Hence, discovering the driving force behind spontaneous loss of CE cells with aging is 
critically important. 
Aging-related changes of CE cells include progressive polymegathism (increased cell 
size to compensate for the loss of cell number), pleomorphism (variability in cell morphology), 
decreased ability to pump fluid from the corneal stroma, and increased permeability attenuating 
their function as a barrier (Bourne and McLaren 2004). In contrast to corneal epithelial cells and 
keratocytes (Hassell and Birk 2010), human CE cells have very limited proliferative potential in 
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vitro. CE cells from older donors (>50 years) have decreased proliferative capacity compared to 
cells from younger donors (<30 years) (Senoo and Joyce 2000). Furthermore, CE cells display 
numerous features of senescent cells including increased expression of the cyclin-dependent 
kinase inhibitors p21CIP1 and p16INK4a (Enomoto, Mimura et al. 2006), senescence-associated 
-galactosidase staining (Mimura and Joyce 2006; Song, Wang et al. 2008), and decreased 
sensitivity to mitogenic stimulation ex vivo (Joyce 2005).  Inhibition of p21 and p16 expression 
leads to increased CE proliferation ex vivo, demonstrating that these G1/S cell cycle inhibitors 
mediate replicative senescence (Joyce and Harris 2010).  
It remains poorly understood why CE lacks regenerative ability.  The age-related increase 
in senescence markers suggest that CE cells may have been exposed to endogenous stimuli that 
drive senescence. Senescence stimuli include critically short telomeres, DNA damage and 
activated oncogenes (Campisi and d'Adda di Fagagna 2007).  Whereas telomeres do not appear 
to be a driving force behind CE senescence (Konomi & Joyce 2007), DNA damage does 
accumulate in CE cells as demonstrated by an increase in the presence of 8-hydroxy-2'-
deoxyguanosine (8-OHdG), an endogenous oxidative DNA lesion, in corneal buttons from older 
donors compared to younger (Joyce, Zhu et al. 2008). Furthermore, H2AX foci, a marker of 
DNA double-strand breaks and cellular senescence, are increased in CE from older donors 
(Joyce, Harris et al. 2010). Endogenous genotoxins that could drive age-dependent accumulation 
of oxidative lesions include reactive oxygen species (Haigis and Yankner 2010), which are a by-
product of oxidative phosphorylation. Because CE cells require high metabolic activity for 
continuous pump function, they may be exposed to greater oxidative stress than other cell types, 
and therefore prone to premature senescence (Joyce 2003; Joyce 2005; Mimura and Joyce 2006; 
Joyce, Zhu et al. 2008; Joyce, Harris et al. 2010). Exogenous sources of genotoxic stress to CE 
cells include the UV component of sunlight (Kolozsvari, Nogradi et al. 2002), exposure to DNA-
damaging drugs during ocular procedures such as mitomycin C (MMC) (Roh, Cook et al. 2008), 
and free radicals generated during routine cataract surgery (Takahashi 2005).  
 To determine the effects of endogenous DNA damage on the CE, we characterized 
corneal tissues of DNA repair-deficient Ercc1‐/ mice (Niedernhofer, Garinis et al. 2006).  
ERCC1-XPF is a highly conserved heterodimeric endonuclease essential in nucleotide excision 
repair of helix-distorting DNA lesions, interstrand crosslink repair and the repair of some double-
strand breaks (Niedernhofer, Odijk et al. 2004; Ahmad, Robinson et al. 2008). Mice engineered 
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to express reduced levels of this nuclease display numerous symptoms and pathologies 
associated with advanced age and model a human progeroid syndrome (Weeda, Donker et al. 
1997; Niedernhofer, Garinis et al. 2006).  Using a genetic mutant defective in nuclear DNA 
repair allowed us to uniquely focus on the biological impact of endogenous DNA damage. This 
eliminates variables such as protein, membrane, lipid and mitochondrial damage, which 
confound experiments that employ using electrophilic genotoxins in normal hosts. 
In this study we used a combination of imaging and histology to identify significant 
differences between CE of adult (4.5-6 mth-old) Ercc1‐/ and normal littermate mice.  
Remarkably, many of the observed changes in Ercc1-/ mice were also observed in old (24-34 
mth-old) normal mouse CE.  These results provide direct experimental evidence that failure to 
repair endogenous DNA damage can drive aging and degeneration of the CE. 
3.2 MATERIALS AND METHODS 
Mice    
Ercc1-/Δ were bred in an f1 background by crossing inbred mice heterozygous for each mutant 
allele in a C57Bl/6J and FVB/n genetic background. This prevents strain-specific pathology yet 
allows analysis of genetically identical mutant animals. Mice were given a unique identifier by 
ear punch. Genomic DNA was isolated from ear tissue using NucleoSpin 96 Tissue (Macherey-
Nagel) and the genotype determined by PCR as previously described (Ahmad, Robinson et al. 
2008). Wild-type (WT) littermates were used as young normal controls. Old WT mice were 
either in the same genetic background or purchased from NIA (f1 C57Bl/6; CJH, 34 mth-old 
males). Animal husbandry and experimental procedures were approved by the University of 
Pittsburgh IACUC. 
 
Spectral Domain Optical Coherence Tomography (SD-OCT) Imaging   
Mice were anesthetized with an intraperitoneal injection of ketamine (Ketaject, Phoenix 
Pharmaceuticals, St. Joseph, MI; 80 mg/kg) and xylazine (Xyla-ject, Phoenix Pharmaceuticals, 
St. Joseph, MI; 5 mg/kg) and imaged as previously described (Gabriele, Ishikawa et al. 2010). 
Pupils were dilated using Tropicamide (1%; Falcon Pharmaceuticals, Fort Worth, TX).  A 
 54 
custom contact lens was applied to the cornea to aid in focusing for retinal images. Mice were 
secured on a custom stage for imaging of the cornea and retina/optic nerve head. Volumetric 
images were acquired in both eyes (1.5x1.5x2.0 mm scans, 250x250 A-scans, 1024 pixels in 
depth, 4 repeated A-scans) at each location (Bioptigen, Inc, Durham, NC).  
 
Gross Imaging 
Gross photos of mouse eyes were taken with a Leica MZFLIII high-resolution stereo 
fluorescence biomicroscope (Leica Microsystems Inc., Bannockburn, IL). Mice were 
anesthetized, as described above and immobilized with a three-point stereotactic mouse 
restrainer. Each whole cornea was focused, and images were obtained at a magnification of 25X. 
 
Corneal Endothelial Confocal Imaging  
Imaging of mouse central CE was accomplished by corneal confocal microscopy (Confoscan3; 
Nidek Technologies America, New Orleans, LA). Mice were sacrificed by CO2 inhalation 
followed by cervical dislocation and immediately immobilized on a custom secure platform. A 
40X objective optically coupled to the cornea with transparent gel (Viscotears; Novartis 
Ophthalmics, Duluth, GA) was focused onto the CE surface. The software (NAVIS; Lucent 
Technologies, Murray Hill, NJ) captured images from the CE through the corneal epithelium 
every 1.6 μm and stored them as an image stack for analysis of corneal thickness. Image stacks 
were inspected individually to determine the stromal-endothelium and stromal-epithelium 
transitions. Central thickness of the stroma was determined by counting the number of images 
from the epithelial peak scatter to endothelial peak scatter × 1.6 m as previously described (Du, 
Carlson et al. 2009). Manual cell counting and area determination were performed with ImageJ 
(National Institutes of Health; http://rsb.info.nih.gov/ij/).  Statistical analyses were carried out by 
ANOVA with Prism Graph Pad software (Prism; Graph Pad Software, San Diego). 
 
Histology and Immunohistochemistry 
Mouse eyes were enucleated using fine forceps. For paraffin sections, whole globes were 
injected with 2% paraformaldehyde (PFA) (Electron Microscopy Sciences, Hatfield, PA) and 
immersed in 2% PFA at 4oC until processing.  Eyes were processed and embedded in paraffin 
wax.  Eight m thick serial sections were used for analysis.  For corneal wholemount staining, 
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similar fixation was performed for 48 hours at 4oC in 2% PFA and then corneas were dissected 
from the globes. The corneas were rinsed in PBS, and stored at 4°C in 50% glycerol and 50% 
PBS (v/v) until further processing. For wholemount CD45 staining, corneas were washed in PBS 
and incubated in anti-mouse CD16/CD32 Fc γ III/II (BD Pharmingen, San Jose, CA) at 1:100 for 
30 minutes to block nonspecific binding. Anti-mouse CD45-FITC (BD) was added at 1:100 and 
incubated overnight at 4°C. After multiple washes with PBS, phalloidin-546 (Invitrogen) was 
added at 1:50 together with 4′,6-diamidino-2-phenylindole (DAPI) (0.5 μg/ml) (Roche Molecular 
Biochemicals, Indianapolis, IN) and then incubated for 1 hour at room temperature. For ZO-1 
staining, tissue was blocked in 10% heat-inactivated goat serum for 1 hour at RT followed by 
overnight incubation with anti-mouse ZO-1 (Invitrogen).  Secondary antibody Alexa Fluor 488-
conjugated goat anti-mouse (1:2,500) (Invitrogen-Molecular Probes, Eugene, OR) together with 
DAPI was added for 1 hour at RT. Omission of the primary antibody served as a negative 
control. The stained wholemounts were placed in aqueous mounting medium (Thermo Fisher 
Scientific, Pittsburgh, PA) on coverslip-bottom dishes and examined using an Olympus 
FluoView FV1000 confocal microscope (Olympus, Tokyo, Japan). 
 
Scanning Electron Microscopy 
Excised corneas were fixed overnight in 2.5% glutaraldehyde in PBS at 4oC. Corneas were 
washed three times in PBS, post-fixed for 1 hour in aqueous 1% osmium tetroxide, and then 
washed three times in PBS. Corneas were dehydrated through a graded ethanol series (30-100%), 
further dehydrated by three additional 15 minute washes with absolute ethanol. Next, the corneas 
were washed in heximethyldisilizane (HMDS) for 15 minutes and then removed to air dry.  
Corneas were then mounted onto aluminum stubs, grounded with silver paint, and sputter coated 
with 3.5 nm gold/paladium (Cressington Sputter Coater Auto 108, Cressington, Watford, UK).  
Images were taken using a JEOL JSM-6335F scanning electron microscope (Peabody, MA) at 3 
kV. 
 
Transmission Electron Microscopy and Descemet’s Membrane Thickness 
Corneas were fixed in cold 2.5% glutaraldehyde (Taab Chemical) in 0.1 M PBS (Fisher), pH 7.3.  
The corneas were rinsed in PBS, post-fixed in 1% osmium tetroxide (Electron Microscopy 
Sciences) with 0.1% potassium ferricyanide (Fisher), dehydrated through a graded series of 
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ethanol (30% - 90% - Reagent Alcohol, Fisher, and 100% - Ethanol 200 Proof, Pharmco) and 
embedded in Epon (Dodecenyl Succinic Anhydride, Nadic Methyl Anhydride, Scipoxy 812 
Resin and Dimethylaminomethyl, Energy Beam Sciences).  Using only central corneal regions, 
semi-thin (300 nm) sections were cut on a Reichart Ultracut, stained with 0.5% Toluidine Blue 
(Toluidine Blue O and Sodium Borate, Fisher) and examined under the light microscope.  
Ultrathin sections (65 nm) were stained with 2% uranyl acetate (Uranyl Acetate dihydrate, 
Electron Microscopy Sciences, and methanol, Fisher) and Reynold’s lead citrate (Lead Nitrate, 
Sodium Citrate and Sodium Hydroxide, Fisher) and examined on Jeol 1011 transmission electron 
microscope.  >10 measurements of DM thickness per image were made from multiple images at 
5,000X magnification using ImageJ software.  Averages and standard deviations were calculated 
from 4 WT mice (7 eyes total) and 5 hypomorphs (9 eyes total) and compared using Student’s t-
test with a p<0.05 significance. 
 
TUNEL Assay 
Paraffin sections were processed for TUNEL staining per the manufacturer’s protocol (Roche, 
Indianapolis, IN).  Briefly, sections were permeabilized in freshly prepared 0.1% Triton X-100 
and 0.1% sodium citrate then rinsed in PBS.  TUNEL reaction mixture (enzyme and buffer) was 
added to sections which were allowed to incubate for 60 minutes at 37oC in a humidified 
atmosphere in the dark.  The negative control included no enzyme treatment and the positive 
control included DNAse treatment prior to TUNEL staining.  Sections were analyzed by 
fluorescence microscopy using  488 nm excitation. 
 
3.3 RESULTS 
3.3.1 Ercc1-/ mice have normal eye development 
Ercc1-/ develop normally, but after reaching sexual maturation (at 8 wks of age) begin to 
display symptoms associated with aging, including dystonia, ataxia, loss of muscle mass, 
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kyphosis and ultimately incontinence (Gregg, Robinson et al. 2011).  By this age, in contrast to 
age-matched controls, the Ercc1-/ mice have already developed tissue-specific degeneration and 
pathology similar to natural aging (Vo, Seo et al. 2010; Goss, Stolz et al. 2011; Gregg, Robinson 
et al. 2011).  We did not detect any ocular developmental or structural defects in Ercc1-/ mice 
based on gross morphology (Fig. 3.1.A), histology (Fig. 3.1.B), or in vivo SD-OCT imaging of 
the anterior segment and retina/optic nerve head (Fig. 3.1.C).  Images of gross morphology 
demonstrated normal orbits, fully developed iris with symmetric pupils and clear margins, 
normal conjunctival tissue, and non-vascularized corneas (Fig. 3.1.A).  Anesthesia-induced 
cataracts occurred in both Ercc1-/ and age-matched WT mice as previously reported (Gabriele, 
Ishikawa et al. 2010), making it difficult to evaluate differences in lens transparency between 
animals (Fig. 3.1.A).  Histological sections revealed the presence of apparently normal ciliary 
body, lens, retina, and optic nerve structures in Ercc1-/ mice (Fig. 3.1.B).  These observations 
support the conclusion that the DNA repair-deficient mice undergo normal ocular 
development.     Therefore any cellular differences observed between the eyes of WT and age-
matched Ercc1-/ mice are likely the result of post-natal degenerative processes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WT ‐/ 
WT ‐/ 
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3.3.2 Dystrophic changes in CE from Ercc1-/ and naturally old WT mice. 
To examine the morphology of the CE layer, we used confocal microscopy and corneal 
wholemount staining.  Normal adult mice exhibited uniform CE cell shape and size (Fig. 3.2.A, 
left image). In contrast, Ercc1-/ mice displayed dystrophic changes including severe 
polymorphism and polymegathism (Fig. 3.2.A, middle image).  These dystrophic changes were 
similar to the changes observed in the old WT mice (Fig. 3.2.A, right image).    Polymorphism 
and polymegathism were also observed by corneal wholemount immunostaining (Fig. 3.2.B) 
using antibodies to ZO-1 to highlight cell-cell junctions and DAPI to stain nuclei.  Large 
WT 
‐/ 
WT 
‐/ 
Figure 3.1: Ocular developmental and eye structure is normal in progeroid Ercc1‐
/ mice. 
(A) Representative images of eyes from age-matched WT and Ercc1‐
/ mice illustrating normal 
development of ocular structures in the mutant animals. (B) H&E sections of the entire globe 
from WT and Ercc1‐
/ mice. (C) In vivo SD‐OCT of the anterior segment (top) and retina/optic 
nerve head (bottom) from WT and Ercc1‐
/ mice.  
(C) 
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polyploid, binuclear CE cells were also observed in Ercc1-/ mice and old WT animals, but not 
young WT adults (Fig. 3.2.C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.3 Decreased cell density with normal overall corneal thickness in Ercc1-/ and 
naturally old WT mice 
  Aging-related CE polymorphism and polymegathism indicate compensation for cell loss 
in the CE cell layer (Bourne and McLaren 2004).  To determine if this was the case in the Ercc1-
/ mice, we used images generated by corneal confocal microscopy to measure CE cell density 
and size in Ercc1-/, WT littermates, and old WT mice.  The CE cell density is significantly 
lower in Ercc1-/ mice compared to WT littermate controls (Fig. 3.3.A).  Similarly, Ercc1-/ mice 
WT  OLD WT
Figure 3.2: Premature onset of aging-related dystrophic changes in Ercc1‐
/ mouse CE. (A) 
Confocal microscopy images of the CE from a 6 mth-old WT mouse, 6 mth-old Ercc1‐
/ mouse and an 
old WT mouse (24 mth). (B) Wholemount immunostaining of the same specimens with ZO‐1 (green) to 
highlight cell junctions and DAPI (blue) nuclei. Scale bars = 20m. (C) Representative images with 
large polyploid binuclear cells (red asterisk) in mutant and aged animals. Scale bars = 20m.   
  
WT ‐/ OLD WT
OLD WT 
* 
* 
* 
* 
* 
(A) 
(B) 
(C) 
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had significantly increased mean cell size (Fig. 3.3.B). Changes similar to the Ercc1-/ mice were 
found in old WT mice, compared to young WT animals (Figs. 3.3.A,B). This is consistent with 
prior studies on aged WT C57BL/6 mice (Jun, Chakravarti et al. 2006).  The dystrophic changes 
and decreased cell density, however, did not appear to affect overall central corneal thickness 
measured by SD-OCT (Fig. 3.3.C) or central stromal thickness measured by confocal 
microscopy (Fig. 3.3.D), as there were no significant differences between progeroid Ercc1-/ 
mice, their young-adult WT littermates or old WT mice.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.4 Increased Descemet’s membrane thickness and abnormal posterior banded collagen 
in Ercc1-/ mice. 
Descemet’s membrane (DM) is continuously secreted by CE cells throughout life and 
increased DM thickness is observed in aging humans (Johnson, Bourne et al. 1982) and mice 
(Jun, Chakravarti et al. 2006).  Ultrastructurally, DM is comprised of an anterior banded zone 
Figure 3.3: Loss of cell density in Ercc1‐
/ mouse CE.  (A-B) Quantitative image analysis of confocal images 
used to calculate (A) cell density (cells/mm
2
) and (B) cell area (m 2) of 4.5-6 mth-old Ercc1‐/ mice, normal 
littermate (WT), and old WT mice  (34 mths of age). Error bars represent the standard deviation from analysis of 2 
images (left and right eyes) from the indicated number of mice (n). An asterisk indicates significant difference 
relative to adult WT (p<0.05 for both ANOVA, Dunnett’s). (C) Thickness of central corneas measured (in arbitrary 
pixels) from in vivo SD‐OCT imaging. (D) Central corneal stromal thickness (m) measured from confocal 
images.  
p<0 00
(G)
*
*
*
*
(A) 
(B) 
(C) 
(D) 
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(ABZ) secreted during early development and a posterior non-banded zone (PNBZ) that accounts 
for age-dependent DM thickening.  In certain disease states affecting the CE, banded collagen, 
believed to be Type VIII, can be observed in the PNBZ (Levy, Moss et al. 1996; Zhang, Bell et 
al. 2006).  We prepared TEM sections from central cornea to measure central DM thickness and 
observe changes in DM.  In Ercc1-/ mice, the DM thickness was significantly increased 
compared to WT littermates (Fig. 3.4.A,B).  The DM was also thicker in old mice (Fig. 3.4.A, 
right image) as previously reported (Jun, Chakravarti et al. 2006).   Interestingly, we also 
identified focal areas of DM defects in 34 mth-old WT mice (Fig. 3.4.C, white arrows).  These 
DM defects were not observed in either the Ercc1-/ mice or WT littermates.  A closer 
examination of DM from Ercc1-/ mice revealed areas of increased banded collagen (Fig. 3.4.E, 
white arrows) compared to WT littermates (Fig. 3.4.D, white arrows).  Notably, this banded 
collagen was located posteriorly (closest to the cell layer) in the Ercc1-/ mice indicating more 
recent synthesis in contrast to the WT mice with more anteriorly located banded collagen, as has 
been previously reported(Jun, Chakravarti et al. 2006).   
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3.3.5 Presence of posterior projections arising from CE of Ercc1-/ mice. 
Confocal image z-stacks were used to generate 3D corneal reconstructions.  Figure 3.5.A 
demonstrates the presence of numerous heterogeneous lesions above the surface of the CE 
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Figure 3.4: Premature thickening and abnormal deposition of Descemet’s membrane in Ercc1‐
/ 
mice. (A) Representative TEM images displaying thickness of Descemet’s membrane (DM) in WT (left), 
Ercc1‐
/ (center) at 4.5 mths of age, and old WT at 24 mths (right). The orientation from top to bottom is 
CE cell (CE), Descemet’s membrane (DM, black arrow), posterior stroma (ST). Magnification = 
10,000X. Scale bar = 2m. (B) Graph shows average thickness+SD from central DM as measured from 4 
WT mice (7 eyes total) and 5 Ercc1‐
/ mice (9 eyes total).  Asterisk indicates statistically significant 
difference (Student’s t-test, p<0.05).  (C) DM defects in 34 mth old WT mice.  Arrows indicate regions of 
abnormal DM. (D-E) Representative TEM images displaying collagen banding of Descemet’s membrane 
(DM) in (D) WT and (E) Ercc1‐
/ mice at 4.5 mths of age. The orientation from top to bottom is stroma 
(ST), Descemet’s membrane (DM), CE cell (CE). White arrows indicate areas of banded collagen.  Scale 
bars indicate 1 m in left images and 500 nm in right images.  Inset in right image of Ercc1‐/  mice (E) 
shows magnified area of interest (white box) and scale bar at 500 nm. 
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monolayer in Ercc1-/ mice but not in their age-matched WT littermates. The lesions resemble 
corneal guttae, and were also observed in old WT CE.  These posterior projections had variable 
size, shape, and reflectivity.  The 3D reconstructions revealed that many of the projections in 
Ercc1-/ mice originated from the CE layer and projected into the anterior chamber (Fig. 3.5.B).  
However, we did not observe focal excrescences arising directly from Descemet’s membrane in 
our Periodic acid-Schiff (PAS) stained paraffin (Supplemental Fig. S.1) or TEM sections (Fig. 
3.3) of Ercc1-/ mice.  Thus, the posterior projections in Ercc1-/ mice are most likely of cellular 
origin.   
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Figure 3.5: Premature onset of posterior projections originating from Ercc1‐
/ CE. (A) Representative 
confocal images of CE from adult WT (left, 6 mths; far right, 34 mths), and Ercc1‐
/ (middle, 4.5 mths) 
mice. Scale bar = 100 m. (B) 3D reconstructions of corneas with the CE surface (facing left side of image) 
from the same mice.  
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3.3.6 Presence of CD45+ cells on Ercc1-/ mice CE. 
The heterogeneous nature of the posterior projections (Fig. 3.5) in Ercc1-/ CE indicated 
the possibility that other cells interact with CE cells such as keratic precipitates (Guthoff, Zhivov 
et al. 2009).   We observed occasional leukocytes in proximity to CE in histological sections of 
Ercc1-/ mouse corneas (Fig. 3.6.A), which were not found in their WT littermates.  Wholemount 
immunostaining using CD45 as a general marker of leukocytes confirmed the presence of 
immune cells attached to the CE cell surface (Fig. 3.6.B).  These CD45-positive cells were of 
various sizes and projected from the CE monolayer into the anterior chamber (Fig. 3.6.B, bottom 
image projection).  Although not specific for cell type, SEM showed the presence of potential 
immune cells interacting with Ercc1-/ CE cells (Fig. 3.6.C).   
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Figure 3.6: Inflammatory cells interact with Ercc1‐
/ mice CE. (A) H&E sections of Ercc1‐/ mice CE 
revealing immune cells interacting with the CE. (B) Wholemount sections stained for CD45 (green) to detect 
leukocytes, phalloidin (red) and DAPI (blue). (C) Representative SEM image of the immune cells 
(pseudocolored green) interacting with CE from Ercc1‐
/ mice.
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3.3.7 CE cells are lost by apoptosis in Ercc1-/ mice. 
To probe the mechanism by which CE cells are lost in Ercc1-/ mice, we performed 
TUNEL staining of the CE layer. TUNEL staining of the CE layer confirmed the presence of 
apoptotic cells in Ercc1-/ mice but not WT littermates (Fig. 3.7.C).  Immunostaining of 
wholemount sections for actin (Fig. 3.7.A)  and histological sections (Fig. 3.7.B) revealed 
apoptotic cell extrusion, which is a process that removes dying cells from monolayers while 
maintaining barrier function (Rosenblatt, Raff et al. 2001).  SEM captured the presence of a late-
stage extruded apoptotic CE cell in the vicinity of a putative leukocyte (Fig. 3.7.D).  
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Figure 3.7: Apoptosis of CE in Ercc1‐
/ mice.  (A) Representative confocal image (upper left) of the CE from an Ercc1‐/ 
mouse showing a cell being extruded. Wholemount staining (upper right) with phalloidin (red) and DAPI (blue). 
Reconstruction from z-stack of images (lower panel). (B) H&E section demonstrating extruding CE cells. (C) TUNEL assay 
on paraffin sections. The right image is a positive control using DNAse pre‐treatment. WT demonstrates some superficial 
squamous epithelial cell apoptosis. The bottom image is cornea from Ercc1‐
/ mice. The arrows indicate TUNEL‐positive 
cells. (D) SEM of extruding CE cell (pseudocolored red) and putative interacting immune cell (pseudocolored green).  
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3.4 DISCUSSION 
In this study we demonstrated aging-related dystrophic changes in CE from DNA repair-
deficient Ercc1-/ mice.  Remarkably, 4.5-6 mth-old Ercc1-/ mice spontaneously developed 
degenerative changes typically seen in 2-3 yr-old WT mice.  The prominent parallels between 
the Ercc1-/  and old WT mouse CE are increased polymorphism and polymegathism, 
polyploidy, decreased cell density,  increased Descemet’s thickness, and the presence of 
posterior projections that are most likely apoptotic CE cells and/or interacting leukocytes.. This 
reflects a 4-6X acceleration of the appearance of aging-related changes in the CE due to DNA 
repair deficiency. 
Many of the dystrophic changes seen in the Ercc1-/ and old WT mouse CE signify 
compensatory responses to cellular damage and loss and are also observed in human CE as a 
consequence of aging, trauma, disease or surgery (Bourne and McLaren 2004).  For example, to 
accommodate for increasing cell loss, the remaining CE cells flatten, increase in size, and alter 
their morphology to cover the acellular area.  The polyploid binuclear cells observed in young 
adult Ercc1-/ and old WT mice are also increased in aged and wounded human CE (Ikebe, 
Takamatsu et al. 1986).  Increased polyploidy is positively correlated with exposure to cellular 
stress, senescence, and aging and is frequently observed in cells of liver, heart, and vascular 
tissues (Storchova and Pellman 2004).  Increased DM thickness and changes in matrix 
composition are observed in disease states affecting the CE such as diabetes (Rehany, Ishii et al. 
2000) , Fuchs’ corneal endothelial dystrophy (Levy, Moss et al. 1996; Zhang, Bell et al. 2006), 
and iridocorneal endothelial syndrome (Levy, McCartney et al. 1995).   
An intriguing finding in our study was the presence of the “guttae-like” posterior 
projections in Ercc1-/ mice.  Although these projections resembled guttae seen in Fuchs’ corneal 
endothelial dystrophy, considered a premature aging disease of the CE (Bergmanson, Sheldon et 
al. 1999), we did not find any histological evidence that they were excrescences originating from 
Descemet’s membrane.  Wholemount staining further distinguished our projections from corneal 
guttae.  Although we observed increased Descemet’s thickness in Ercc1-/ mice, focal areas of 
extracellular matrix-based guttae, as were seen in 34 mth-old WT mice, were not detected in the 
progeroid mutant mice.  The posterior projections in the Ercc1-/ mice appear instead to be 
apoptotic cells extruding from the CE monolayer or occasional CD45-positive leukocytes on the 
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surface of the CE.  Interestingly, there were no histopathological signs of acute or chronic 
inflammation throughout the Ercc1-/ mouse corneal layers.   Thus we hypothesize that 
senescence-associated secretory phenotype (SASP), which is driven by the accumulation of 
persistent DNA damage (Rodier, Coppe et al. 2009), is responsible for leukocyte accumulation.  
This process may facilitate the removal of damaged and apoptotic CE cells. 
ERCC1-XPF deficient mice and humans display accelerated aging of numerous tissues 
including the skin, liver, kidney, brain, spinal cord, peripheral nerves, bone, and the 
hematopoietic system (McWhir, Selfridge et al. 1993; Weeda, Donker et al. 1997; Niedernhofer, 
Garinis et al. 2006; Lawrence, Sacco et al. 2008; Vo, Seo et al. 2010).  Because ERCC1-XPF is 
an essential nuclease involved in numerous DNA repair pathways, a single DNA lesion driving 
tissue degeneration and premature aging has not been definitely identified. Deficiency in the 
nucleotide excision repair (NER) pathway alone does not lead to accelerated aging because 
NER-deficient Xpa-/- mice display normal life span and do not display early onset of aging-
related symptoms or pathologies (Dolle, Busuttil et al. 2006; Niedernhofer, Garinis et al. 2006; 
Grillari, Katinger et al. 2007).   Thus, it has been hypothesized that DNA interstrand crosslinks, 
which are extremely cytotoxic and for which ERCC1-XPF is required for repair (Niedernhofer, 
Odijk et al. 2004), are the primary lesions that drive the premature aging observed in ERCC1-
deficient mice and potentially contribute to normal aging (Weeda, Donker et al. 1997; Dolle, 
Busuttil et al. 2006; Niedernhofer, Garinis et al. 2006; Grillari, Katinger et al. 2007).  
Endogenous ICLs may arise as downstream byproducts of chronic oxidative stress and lipid 
peroxidation, which, for example, enhances the formation of malondialdehyde, a potent DNA 
crosslinking agent (Niedernhofer, Daniels et al. 2003; Grillari, Katinger et al. 2007).  ICLs in CE 
may also be due to exogenous exposures to genotoxins such as the use of mitomycin C used 
during refractive procedures. Similar to the findings here, we established that therapeutic doses 
of mitomycin C rapidly induce DNA lesions (Roh, Cook et al. 2008).  
Evidence from the current study supports a mechanism in which unrepaired nuclear DNA 
damage leads to CE cell death via apoptosis. This loss of cells in the CE monolayer, in turn 
drives the changes in CE cell morphology. Furthermore, the notion that DNA damage is driving 
force for these pathological changes is consistent with the elevated expression of senescence 
markers in CE cells from aged donors (Mimura and Joyce 2006; Joyce, Zhu et al. 2008; Song, 
Wang et al. 2008). 
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 Fuchs’ endothelial dystrophy is an idiopathic primary degenerative disease of the CE.  
Like aging-related degenerative changes, there is growing evidence for oxidative stress and 
oxidative DNA damage in both the nuclear and mitochondrial genomes of CE cells driving this 
degenerative disease (Jurkunas, Bitar et al. 2010).  While the genetic components of Fuchs’ 
dystrophy are currently under investigation, it will also be important to determine the stimuli and 
downstream cellular mechanisms (i.e. oxidative stress and apoptotic mechanisms) that propel CE 
degeneration in Fuchs’ dystrophy.  
In summary, our study provides strong genetic evidence that the CE is sensitive to 
unrepaired endogenous DNA damage. With this information future targeted approaches aimed at 
protecting, preventing, or reversing the effects of DNA damage may help to preserve or even 
enhance CE integrity.  In addition, the study establishes that the Ercc1-/ mice are a rapid and 
accurate model system of aging-related degenerative changes of the CE for testing therapeutic 
strategies.  
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4.0  RAPID CHANGES IN CONNEXIN-43 IN RESPONSE TO GENOTOXIC STRESS 
STABILIZE CELL-CELL COMMUNICATION IN CORNEAL ENDOTHELIUM 
Chapter 4 is adapted, with copyright permission from the Association for Research in Vision and 
Ophthalmology, from a published article.   Roh DS, Funderburgh JL. Rapid changes in 
connexin-43 in response to genotoxic stress stabilize cell-cell communication in corneal 
endothelium.  Invest Ophthalmol Vis Sci 2011 Jul 15;52(8):5174-82.  Note that the figure 
numbers have changed, the “data not shown” are now supplemental figures found in the 
appendix, and section 4.3.6 and corresponding figure 4.9, and additional discussion were not 
included in the original manuscript.   
4.1 INTRODUCTION 
The corneal endothelium (CE) is a monolayer of neural crest–derived cells that is 
essential for corneal transparency. Located at the posterior surface of the cornea, the CE 
separates the cornea from the aqueous humor, relying on cell– cell junctions to control corneal 
hydration. The CE is a fragile cell layer that is vulnerable to the effects of intraocular surgery, 
systemic and ocular disease, and topical drugs (Bourne 2003; Bourne and McLaren 2004).  In 
addition, endogenous oxidative stress appears to play a significant role in the degeneration of CE 
with age (Joyce, Zhu et al. 2009; Joyce, Harris et al. 2010) and in Fuchs’ dystrophy (Jurkunas, 
Rawe et al. 2008; Jurkunas, Bitar et al. 2010).  Human CE does not regenerate in vivo, so 
existing cells must compensate for cell loss to maintain the pump and barrier functions required 
for corneal homeostasis. It is clear that surviving cells respond to CE cell loss by spreading to 
cover the posterior corneal surface. This spreading is associated with thinning of the cell layer 
(Joyce, Meklir et al. 1990) but the full range of physiological responses of the CE to cell loss has 
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not been characterized. CE function is dependent on the cell– cell junctions, which maintain the 
integrity of this monolayer. The goal of the present study was to examine how CE cells mediate 
these junctions in response to genotoxic stressors. 
Gap junctions are intercellular channels composed primarily of the connexin family of 
proteins. These channels provide rapid intercellular transfer of small signaling molecules, such as 
nucleotides, inositol trisphosphate (IP3), glutathione, and Ca2+ between connected cells 
(Alexander and Goldberg 2003).  Such gap junction intercellular communications (GJIC) 
function in the maintenance of tissue homeostasis and influence cellular survival and death in 
response to oxidative stress (Lin, Yang et al. 2003; Ramachandran, Xie et al. 2007; Hutnik, 
Pocrnich et al. 2008) metabolic stress (Albright, Kuo et al. 2001; Lin, Yang et al. 2003), 
ischemia reperfusion injury (Nakase, Fushiki et al. 2003; Garcia-Dorado, Rodriguez-Sinovas et 
al. 2004), and genotoxic stress (Tekpli, Rivedal et al. ; Lin, Yang et al. 2003). Connexins may 
also mediate cell survival by GJIC-independent mechanisms in addition to functions associated 
with gap junctions (Decrock, Vinken et al. 2009).   
With a half-life of 1.5 to 5 hours, connexin proteins respond rapidly to physiologic 
changes by altering gap junction coupling between cells. The Cx43 C-terminus contains 14 
documented phosphorylation sites (Lampe and Lau 2004), and different phosphorylated species 
of Cx43 can be distinguished experimentally by SDS-PAGE.  Aggregation of Cx43 into 
functional gap junction plaques, opening of the junctional pores, and Cx43 degradation have all 
been linked to site-specific phosphorylation of the Cx43 protein (Berthoud, Minogue et al. 
2004).  Given the pervasive role of connexins in maintenance of cell and tissue homeostasis, we 
hypothesized that exogenous genotoxic stress would alter homeostasis-regulating proteins such 
as Cx43 in the CE.  Previously, we reported DNA damage in goat CE after brief doses of the 
DNA interstrand cross-linking agent mitomycin C (MMC) during procedures emulating 
photorefractive keratectomy (Roh, Cook et al. 2008).  In this study, we identified specific 
changes that occur in Cx43 and in GJIC in CE as a result of genotoxic stress induced by 
exposures such as MMC. Determining how CE cells respond to various stressors may provide 
opportunities for CE protection and preservation. 
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4.2 MATERIALS AND METHODS 
Cell culture and reagents 
Primary bovine CE cells were isolated as previously described (Roh, Cook et al. 2008) and 
cultured in low glucose Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Carlsbad, 
CA) supplemented with 10% fetal bovine serum and antibiotics/antimycotics in a humidified 5% 
CO2, 37°C environment. Passage 1 to 4 cells, split 1:4, were used and grown 2 to 3 days past 
confluency for every experiment unless otherwise indicated. At least 24 hours before treatment 
with MMC, cycloheximide, forskolin, and epidermal growth factor (all from Sigma, Saint Louis, 
MO), the medium was changed to serum-free DMEM containing no antibiotics/antimycotics. 
MMC was added to cells by changing medium with prewarmed media containing 5 M freshly 
diluted MMC. Primary bovine corneal fibroblasts were isolated and grown as previously 
described (Long, Roth et al. 2000). 
 
Immunofluorescence 
Cells were fixed in 3.2% paraformaldehyde (PFA) solution (Electron Microscopy Science, 
Hatfield, PA) in PBS for 20 minutes at room temperature. Permeabilization with 0.1% Triton X-
100 (Thermo Fisher, Pittsburgh, PA) in PBS for 1 minute was followed by blocking with 10% 
heat-inactivated goat serum in PBS for 1 hour at room temperature. Cells were incubated with a 
polyclonal rabbit anti-Cx43 antibody to the C terminus (Invitrogen), monoclonal mouse anti-
Cx43 to the C terminus (Millipore, Billerica, MA), or monoclonal mouse anti-zonula occludens- 
1 (ZO-1; Invitrogen) diluted 1:200 in 1% bovine serum albumin (BSA) in PBS solution 
overnight at 4°C. After multiple washes in PBS, cells were incubated for 1 hour at room 
temperature with species appropriate Alexa-conjugated secondary antibodies (Invitrogen) diluted 
to 0.8 g/mL in 1% BSA in PBS containing 0.5 g/mL 4’,6-diamidino-2-phenylindole (DAPI; 
Invitrogen). Cells were observed on a laser scanning confocal microscope (Olympus Fluoview 
FV1000, Olympus, Center Valley, PA) and images captured and processed using Olympus 
Fluoview software. To quantify plaque size and intensity, ImageJ (developed by Wayne 
Rasband, National Institutes of Health, Bethesda, MD; available at 
http://rsb.info.nih.gov/ij/index.html) was used to manually trace Cx43 plaques in three separate 
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high magnification confocal images. Area and intensity values were calculated and compared 
with the Mann–Whitney U test. 
 
Immunoblotting 
Cells were lysed directly in 1X SDS sample buffer [1.6% sodium dodecyl sulfate, 0.06M Tris, 
5.5% glycerol, and 0.002% bromophenol blue], scraped into tubes, heated at 95°C for 5 minutes, 
then sonicated until solubilized. For alkaline phosphatase treatment of cell lysates, cells were 
lysed in RIPA buffer (Thermo Fisher) [25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% 
sodium deoxycholate, 0.1% SDS] containing protease inhibitor cocktail (Sigma), sonicated, and 
incubated with 0.1 U/L cell lysate of calf alkaline phosphatase (Sigma) for 1 hour at 37°C. 
Protein concentration was determined by Bio-Rad DC Protein Assay (Bio-Rad, Hercules, CA) 
and then 2-mercaptoethanol was added to a final concentration of 1% to the lysates and heated at 
70°C for 20 minutes. An equal amount of protein was added to precast 4–20% gradient or 10% 
polyacrylamide gels (Bio-Rad) and electrophoresis was performed for 1 hour at 200 V. Protein 
was transferred to PVDF membrane (Millipore) and blocked for 1 hour at room temperature in 
0.2 M Tris, 0.15 M NaCl, 0.01% thimeresol, 0.2% Tween-20, pH 7.4 (TTTBS) for ECL 
detection or with fluorescent blocker (Millipore) for Odyssey infrared imaging (LI-COR, 
Lincoln, NE). Membranes were incubated with the following primary antibodies as indicated: 
mouse anti-Cx43NT1, which recognizes the N-terminal region of Cx43 (Fred Hutchinson Cancer 
Center, Seattle, WA); rabbit anti-Cx43, which recognizes the C-terminal region of Cx43 
(Invitrogen); mouse anti-ZO-1 (Invitrogen); and mouse anti--tubulin (Sigma), all diluted in 1% 
BSA in TTTBS or fluorescent blocker. Secondary antibodies included horseradish peroxidase 
(HRP)-conjugated goat anti-mouse and anti-rabbit antibodies (Santa Cruz Biotechnology, Santa 
Cruz, CA) for enhanced chemiluminescence (ECL) detection and IRDye800 and IRDye680 
labeled secondary antibodies (LI-COR) for infrared imaging. Where indicated, blots were 
stripped for 15 minutes at room temperature (Restore Western Blot Stripping Buffer, Thermo 
Fisher Scientific, Rockford, IL). Chemiluminescent signal was visualized with ECL substrate 
(Millipore) followed by detection and capture of 16-bit images with a Bio-Rad FX imager (Bio-
Rad), and fluorescent signal was detected with Odyssey infrared imaging system (LI-COR). 
Densitometry was performed using digital analysis software for ECL (Bio-Rad Quantity One) 
and fluorescent detection (LI-COR) followed by appropriate statistical analysis for comparisons 
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with GraphPad (GraphPad Software Inc., La Jolla, CA). All forms of Cx43 (phosphorylated and 
nonphosphorylated) were quantified in densitometry. 
 
Immunoprecipitation 
Cells were lysed directly in cold coimmunoprecipitation buffer [0.1% Nonidet P40, 25 mM Tris 
pH 7.4, 150 mM NaCl, 1 mM EDTA] containing HALT protease and phosphatase inhibitors 
(Thermo Fisher) and briefly sonicated until solubilized. Lysates were precleared with magnetic 
protein G beads (Millipore) for 1 hour at room temperature to remove any nonspecific binding of 
cell proteins to beads. The beads were discarded and then cleared lysates were incubated with 1 
g antibody per 500 g of lysate using a rabbit polyclonal anti-Cx43 antibody (Invitrogen) 
overnight at 4°C. Beads were then washed multiple times with lysis buffer and heated at 95°C 
for 5 minutes in 1X SDS sample buffer with 2-mercaptoethanol. A magnetic rack was used to 
separate the beads from lysate before loading for SDS-PAGE separation. Mouse anti-ZO-1 
(Invitrogen) and rabbit anti-Cx43 (Invitrogen) antibodies were used for immunoblotting. 
 
Triton X-100 insolubility 
Cells were lysed in cell lysis buffer containing 1% Triton X-100 and 1 mM EDTA with protease 
inhibitors (Sigma) and then chilled on ice for 30 minutes with mixing. Cell lysates were spun at 
10,000 g for 30 minutes at 4°C. The soluble fraction was removed and the Triton X-100 
insoluble pellet was further dissolved in 1X SDS buffer followed by sonication. Both the 
insoluble and soluble fractions were used for immunoblotting. 
 
Live-cell imaging 
CE cells grown on Bioptech dishes (Bioptechs Inc., Butler, PA) to 70% to 80% confluency were 
transfected with 1 g of Cx43–GFP plasmid (gift of Professor Matthias Falk, Lehigh University) 
using Lipofectamine 2000 (Invitrogen). This construct was previously described to have GFP at 
the most C-terminal end of Cx43 (Falk 2000), and 24 hours after transfection, cells expressing 
the Cx43–GFP fusion protein were imaged with the Nikon Eclipse TE200-E microscope (Nikon 
Instruments Inc., Melville, NY) on a heated stage with 5% CO2. Images were captured using 
software (Metamorph, Molecular Devices, Sunnyvale, CA) every 2 minutes over a 4- to 6-hour 
period after treatment with MMC or medium alone. To determine internalization and degradation 
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frequency, Cx43–GFP assembled into cell surface plaques were identified and followed frame-
by-frame exactly 24 hours after transfection. Plaques were counted if they were internalized 
and/or degraded by reduced fluorescent signal over a 3-hour timeframe. Comparison of the 
frequency of internalization/degradation events between medium and MMC-treated cells was 
performed using the Fisher exact test. A 2 x 2 contingency table was analyzed with GraphPad, 
with P < 0.05 being considered statistically significant. 
 
Gap junction intercellular communication assays 
Lucifer yellow (LY) dye (Sigma) scrape-load assays were performed by scraping confluent 
monolayers of CE cells with a sterile pipette tip in the presence of 1 mg/mL LY in warm PBS. 
After 2 minutes, cells were rinsed to remove LY dye solution and cells were immediately fixed 
in 3.2% PFA without permeabilization. Images were captured using a Nikon epifluorescent 
microscope. Dye transfer images were analyzed using ImageJ software by measuring the 
distance of dye transfer from the scrape wound at 10 different sites per image. Average distances 
were then analyzed with ANOVA and a post-hoc Tukey’s test for multiple comparisons. P < 
0.05 was considered statistically significant. For fluorescent recovery after photobleaching 
(FRAP), cells grown on 35-mm coverslip-bottom dishes were loaded with 1 M of Calcein-AM 
(Invitrogen) for 30 minutes at 37°C. Cells were allowed to recover for 1 to 2 hours then treated 
with 5 M MMC for 15 minutes. Individual cells were photobleached using a laser scanning 
confocal microscope (Olympus) and images of dye recovery were captured. ImageJ software was 
used to measure dye intensity in image stacks. Photobleached cells were normalized to control 
unbleached cells. Data were exported into GraphPad for exponential curve fitting and calculation 
of rate constants (k). Half-life of dye recovery (t1⁄2) was calculated based on the formula: t1/2 = 
ln(2)/k. The Student’s t test was used for statistical comparison of t1⁄2. 
 
Live-cell assay for apoptosis (not included in original publication) 
Cells were plated at equal density and grown to confluency in 24-well plates.  Twelve hours 
prior to imaging medium was switched to serum- and antibiotic/antimycotic-free medium.  Cells 
were loaded with 5 M caspase 3/7 detection reagent (CellEvent Caspase 3/7, Invitrogen) and 
then treated with 50 M MMC, 10 M AGA, or medium.  This dye is non-fluorescent until a 
DEVD peptide sequence is cleaved by activated caspase 3/7. Then the dye binds DNA producing 
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a fluorogenic response indicative of apoptosis.  Live-cell images were captured over a 18 hour 
period with the Nikon Eclipse TE200-E microscope on a heated stage with 5% CO2. Images 
were captured using software (Metamorph, Molecular Devices) every hour using FITC 
excitation/emission filters.  The number of caspase 3/7-positive cells, as indicated by nuclear 
fluorescence, was automatically counted in Metamorph and the mean of three individual wells 
was plotted over time. 
4.3 RESULTS 
4.3.1 Genotoxic stress to CE generates rapid changes in the Cx43 abundance and 
localization.  
We previously reported the rapid induction of DNA lesions after brief exposure to low 
levels of MMC in CE cells (Roh, Cook et al. 2008).   Within a similar timeframe, low dose 
MMC exposure induced an increase in total cellular Cx43 levels as detected by immunoblotting 
(Fig. 4.1.A). Increases occurred in each of the three characteristic protein bands representative of 
differentially phosphorylated Cx43 species present in most eukaryotic cells. The phenomenon 
was highly repeatable, with total cellular Cx43 increasing somewhat more than twofold 60 to 90 
minutes after treatment. These results were confirmed using two Cx43 antibodies targeting 
different regions of Cx43, the C-terminal (Fig. 4.1.A, top) and the N-terminal (Fig. 4.1.A, 
bottom).  The use of antibodies targeting different regions of the protein reduces the possibility 
that the observed quantitative changes result from epitope masking. Alkaline phosphatase (AP) 
treatment of whole cell lysates before electrophoresis dephosphorylates Cx43 collapsing the 
characteristic multiple bands into a single faster moving band (Fig. 4.1.B).   The rapid and 
transient increase in Cx43 was maintained after AP treatment, indicating that total levels of 
Cx43, independent of phosphorylation state, occurred. A similar transient increase in cellular 
Cx43 was observed after exposure to other genotoxic agents, including ultraviolet-C radiation, 
etoposide, and hydrogen peroxide (Supplemental Fig. S.2)      
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Figure 4.1:   Rapid accumulation of Cx43 protein in response to genotoxic stress with mitomycin C.  Cells 
were treated with prewarmed media containing 5 µM MMC for indicated times in minutes.  (A)  Western blot for 
total Cx43 using C-terminal antibody (top) and N-terminal antibody (bottom) from independent experiments.  Blots 
were stripped and reprobed for a-tubulin as a loading control.  Quantification to right is ratio of Cx43/ -tubulin 
normalized to values at the “0” timepoint.  Asterisks indicate statistically significant differences from time “0” 
(ANOVA, p<0.05; Dunnett’s multiple comparison test, p<0.05). Blots are representative of eight independent 
experiments and the mean fold change + SEM is shown in the graph. (B) Alkaline phosphatase (AP) treatments of 
cell lysates were followed by immunblotting.  Quantification in graph below is the ratio of Cx43/ -tubulin 
normalized to “0” for either AP- or AP+.  Differences between “-AP” and “+AP” at each time point were not 
statistically significant (2-way ANOVA, p>0.05). Blot is representative of three independent experiments and the 
mean fold change + SEM is shown in the graph. 
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Immunostaining of CE cells (Fig. 4.2.A) revealed increased Cx43 at cell– cell interfaces, 
with an increased size of the punctate staining in this locale suggestive of increased accumulation 
of Cx43 in gap junction plaques. Staining also increased in perinuclear regions of the treated 
cells, suggesting recently synthesized Cx43 in transit to the cell surface to be increased as well. 
Cell fractionation of the treated cells found increased Cx43 largely in the Triton X-100 
detergent-insoluble fraction (Fig. 4.2.C).    Association with gap junction plaques confers 
detergent insolubility on connexin (Musil and Goodenough 1991); therefore, increases in 
insoluble Cx43 in response to MMC is consistent with immunostaining results, suggesting that 
MMC induces transport of the increased Cx43 into cell– cell junctional plaques. Similar changes 
were not observed in other cell– cell junction proteins, such as ZO-1, cadherin, and -catenin, 
based on immunoblotting (Supplemental Fig. S.3)   
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Quantitative image analysis of cells treated with MMC confirmed a significant increase 
in both the gap junction plaque area and Cx43 signal intensity compared to medium alone (Fig. 
4.2.B) after 60 minutes of treatment with MMC. Previous studies have shown that interactions 
between Cx43 and the tight junction protein ZO-1 can regulate the size of Cx43 gap junctions.  
(Giepmans and Moolenaar 1998; Hunter, Jourdan et al. 2003; Hunter, Barker et al. 2005; Rhett, 
Jourdan et al. 2011) . To explore the potential involvement of ZO-1, we used 
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Figure 4.2: Changes in Cx43 gap junction plaque size and intensity after genotoxic stress. (A) Cells were 
treated with prewarmed media containing 5 M MMC for the indicated time in minutes then stained for Cx43 
(green). DAPI (nuclei). Orange arrows indicate apparent gap junction plaques.(B) Gap junction plaques were 
imaged by confocal microscopy and analyzed for area m2) and Cx43 fluorescence intensity (arbitrary units) after 
60 minutes of 5 M MMC (n = 25 plaques) or medium alone (n = 25 plaques). Individual data points are shown 
along with the median. Area and intensity distributions were compared for statistically significant differences 
using the Mann–Whitney U test (area, P <0.01; intensity, P < 0.0001). Similar results were obtained in three 
independent experiments. (C) Western blot for 1% Triton X-100 soluble and insoluble Cx43. Quantification below 
is insoluble Cx43 normalized to “0.” Asterisks indicate statistically significant differences from time “0” 
(ANOVA, P < 0.05; Dunnett’s multiple comparison test, P < 0.05). Results are representative of three independent 
experiments and the mean fold change + SEM is shown in the graph. Scale bar: (A) 20 m. 
(B) 
(C) 
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coimmunoprecipitation (Co-IP) and colocalization to examine changes in Cx43:ZO-1 association 
after MMC treatment. Co-IP revealed a relative decrease in the abundance of ZO-1 
immunoprecipitating with Cx43 after 60 minutes of MMC treatment  (Fig. 4.3.A).  This 
alteration was also evident in images staining for ZO-1 and Cx43 (Fig. 4.3.B).  Large Cx43 gap 
junction plaques displaying reduced ZO-1 co-localization occasionally were evident in untreated 
cells (Fig. 4.3.B), however these were present with significantly higher frequency in MMC-
treated cells.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.2 MMC treatment increases Cx43 stability. 
Connexin protein half-life ranges from 1.5 to 5 hours in many cell types and organ 
systems (Musil, Cunningham et al. 1990; Beardslee, Laing et al. 1998).  Treatment of cultured 
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Figure 4.3: MMC induces alteration in Cx43 association with ZO-1. Cells were treated with prewarmed 
media containing 5 M MMC for 60 minutes or media alone (CTRL). (A) Coimmunoprecipitation with a 
rabbit polyclonal anti-Cx43 was performed followed by immunoblotting with mouse monoclonal anti-ZO-
1. The blot was stripped and reprobed for Cx43. Quantification below is the ratio of ZO-1:Cx43, which is 
normalized to “CTRL.” Denatured heavy chain immunoglobulin G (IgG) is indicated as HC IgG. Asterisks 
indicate a statistically significant difference (Student’s t-test, P < 0.001). Results are representative of three 
independent experiments and mean fold change to “CTRL” + SEM is shown below. (B) Representative 
confocal images of a large gap junction plaque after MMC treatment. In the higher magnification inset 
(below), the areas of Cx43:ZO-1 colocalization are highlighted in white. Cx43 (green), ZO-1 (red), DAPI 
(blue). Scale bar, 10 m. 
 80 
CE with 10 g/ml cycloheximide (CHX) to inhibit protein synthesis was used to examine decay 
rates of Cx43.  Treatment of cultured CE with 10 g/mL cycloheximide (CHX) to inhibit protein 
synthesis was used to examine decay rates of Cx43. In the untreated control, the half-life of 
decay was in the expected range of 1 to 2 hours (Fig. 4.4.A, left).  Treatment with MMC, 
however, stabilized the Cx43, delaying degradation for up to 120 minutes (Fig. 4.4.A, right).  
After this period of stability, however, the decay rate returned to one similar to that of untreated 
cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: The stability of preexisting Cx43 is altered after MMC treatment. Cells were treated with 
prewarmed media containing 10 g/mL CHX with or without 5 M MMC for indicated times in minutes. Blot 
shows total Cx43 using a C-terminal–specific antibody. Blots were stripped and reprobed for -tubulin as a 
loading control. Quantification below is ratio of Cx43/ -tubulin normalized to the zero time (0) for “CHX” or 
“CHX + MMC.” Asterisks indicate statistically significant differences between “CHX” and “CHX + MMC” (2-
way ANOVA, P <0.01; Bonferroni multiple comparisons, P < 0.05). Results are representative of three 
independent experiments and mean fold change + SEM is shown in the graph.
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4.3.3 Gap junction internalization is decreased after MMC treatment. 
Degradation of Cx43 present in cell surface plaques occurs via processes involving the 
internalization of small and/or large endocytic double-membrane vesicles (Segretain and Falk 
2004; Piehl, Lehmann et al. 2007; Falk, Baker et al. 2009). These processes can be followed 
directly by micrography using fluorescently tagged Cx43 (Falk 2000; Lauf, Giepmans et al. 
2002; Falk, Baker et al. 2009).  We examined this internalization and degradation of Cx43 after 
MMC treatment by live-cell imaging of CE that had been transiently transfected with a Cx43–
GFP fusion protein (Hunter, Jourdan et al. 2003; Hunter, Barker et al. 2005).  Figure 4.5 shows a 
series of images from live-cell video micrography after Cx43–GFP in MMC-treated cells or 
medium-only controls. Sixty-three individual plaques were identified and followed in the videos 
starting 24 hours after transfection at the time of MMC treatment. The presence or absence of 
each of these was scored 3 hours later to assess the relative stability of the plaque-associated 
Cx43 under the two conditions (Fig. 4.5.A).  In medium-treated control transfected cells, 40 of 
46 (89.6%) disappeared after 3 hours, whereas in the MMC-treated samples, only 8 of 17 
(52.9%) of the plaques had been internalized and vanished (Fig. 4.5.B). This significant (P < 
0.01) difference in plaque stability suggests that the reduced degradation of Cx43 identified in 
Fig 4.4   relates to alterations in the mechanism by which cells endocytose and degrade the gap 
junction plaques. 
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INTERN/DEGRADE   NO CHANGE % DEGRADED 
CTRL 40 6 86.9 
MMC 9 8 52.9 
TOTAL 49 14 (p<0.01) 
 
 
 
 
 
 
 
4.3.4 Genotoxic stress increases forward trafficking of Cx43 into gap junctions.  
To distinguish MMC effects in the formation of new membrane-associated Cx43 from its effects 
on Cx43 internalization/degradation, we examined transfer of Cx43 from the endoplasmic 
reticulum (ER) compartment to the cell surface after an 8-hour block with brefeldin A (BFA). 
BFA has been used in previous studies to investigate gap junction assembly because of its 
reversible inhibition of vesicle transport from the ER to the Golgi and subsequently to the cell 
surface (Laird, Castillo et al. 1995; Lauf, Giepmans et al. 2002).  When BFA is removed, the 
transport of proteins is restored and the accumulation of proteins at the cell surface becomes 
briefly representative of the rate at which this forward trafficking process is occurring. 
Therefore, gap junction formation can be assessed after BFA removal. As shown in Fig 4.6, BFA 
treatment significantly reduced Cx43 at the cell surface (Fig. 4.6.A, BFA). After BFA washout 
and a 2-hour recovery, Cx43 appeared at the cell surface in gap junction plaques and in the 
perinuclear compartment in both control and MMC-treated cells (Fig 4.6.A, BFA + 2hr, BFA + 
MMC + 2hr). However, the presence of MMC led to a clear increase of Cx43 in plaques at the 
cell– cell interfaces (Fig 4.6.A, BFA + MMC + 2hr). These plaques were significantly larger 
than those formed without MMC (Fig. 4.6.B). 
 
Figure 4.5: Genotoxic stress results in reduced internalization of Cx43 plaques. Seventy percent to 80% 
confluent cells were transfected with a Cx43–GFP plasmid. (A) Twenty-four hours after transfection, cells were 
treated with either medium (“CTRL,” upper figures) or medium with 5 M MMC (“MMC,” lower figures) and 
live-cell imaging was performed. Images were captured every 2 minutes over a 4- to 6-hour period after treatment. 
Images are stills of Cx43–GFP plaques over time in minutes. “CTRL” images illustrate an example of internalized 
and degraded plaques. MMC images illustrate a long-lived plaque. (B) To determine internalization and 
degradation frequency, Cx43–GFP assembled into cell surface plaques were identified and followed frame-by- 
frame exactly 24 hours after transfection. Plaques were counted if they were internalized and/or degraded by 
reduced fluorescent signal over a 3-hour timeframe. Statistical comparison of the frequency of 
internalization/degradation events between medium “CTRL” and MMC treated cells was performed using Fisher’s 
exact test, P < 0.01. Results are from two independent live-cell experiments tracking a combined 63 plaques (46 
CTRLs, 17 MMCs). Scale bar: (A) 20 m. 
(B) 
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Figure 4.6: MMC induces increased assembly of gap junction plaques. Confluent 
monolayers were treated with prewarmed media containing 5 g/mL BFA for 8 hours 
followed by washout with warm medium and a 2-hour recovery. Five M MMC was 
added as indicated during the 2-hour recovery period. (A) Representative confocal 
images of Cx43 (green) before treatment (NOTX), after 8 hour BFA (BFA), after 
recovery (BFA + 2hr), and after recovery in the presence of MMC (BFA + MMC + 
2hr). DAPI (nuclei). (B) Gap junction plaques were imaged by confocal microscopy and 
analyzed for area (m2) and Cx43 fluorescence intensity (arbitrary units) similar to 
Figure 2B. BFA + 2hr (n = 25 plaques) or BFA + MMC + 2hr (n = 25 plaques). 
Individual data points are shown along with median. Area and intensity distributions 
were compared using the Mann–Whitney U test (area, P < 0.0001; intensity, P < 
0.0001). Similar results were obtained in three independent experiments. 
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4.3.5 Gap junction communication is stabilized by MMC treatment. 
LY dye, which transfers from cell to cell via gap junction channels, was used to assess 
the temporal rate of GJIC during a 2-minute incubation after scrape loading. As shown in Fig. 
4.7.A, no significant differences were observed in the amount of dye transferred or the distance 
the dye moved comparing control and MMC-treated cells (Fig. 4.7.A).   FRAP using Calcein 
AM, a similarly gap junction permeable dye, also revealed identical transfer kinetics between 
control and MMC-treated CE cells (Fig. 4.7.C).   Forskolin is an agent known to maximize GJIC 
and markedly increases scrape-loaded dye transfer in many cell types (Dowling-Warriner and 
Trosko 2000; Paulson, Lampe et al. 2000; Romanello, Moro et al. 2001). In CE cells, however, 
forskolin produced no significant increase on the dye transfer rate (Fig. 4.7.A, far right panel).  
Both forskolin and MMC, however, increased dye transfer rates in primary bovine corneal 
fibroblasts (Fig. 4.7.B) suggesting that CE cells may be communicating via gap junctions at near 
maximal levels, making further increases in GJIC undetectable.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  CTRL   MMC FORSKOLIN
(A) 
 85 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CTRL FORSKOLINMMC
* *
Figure 4.7: MMC and forskolin do not significantly increase GJIC. (A) Confluent 
monolayers were treated with prewarmed media containing 5 M MMC, 10 M 
forskolin, or medium alone (“CTRL”) for 30 minutes Medium was replaced with 1 
mg/mL Lucifer yellow (LY) dye in PBS and scrape-load dye transfer assay was 
performed as described in the Methods section. Ten individual sites were measured 
along different regions of the scrape wound for distance of LY dye transfer to 
determine cell– cell communication as shown in the graph below. Data points are 
mean distance + SD. There was no statistically significant difference between 
treatments (ANOVA, P = 0.3). (B) Confluent monolayers of bovine corneal fibroblasts 
were treated similar to (A). Asterisks indicate statistically significant differences 
(ANOVA, P < 0.001); Dunnett’s test: medium versus Forskolin (P < 0.01), medium 
versus MMC (P < 0.01). (C) FRAP was performed after loading confluent CE 
monolayers with 1 M calcein AM and observing dye recovery. Half-life of recovery 
in seconds (t1⁄2) shown on the y-axis was compared between untreated (n = 4 cells) and 
MMC-treated (n = 4) cells. Mean + SD t1⁄2 shown. No statistically significant 
difference was found between treatments (Student’s t test, P = 0.8). 
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To determine whether the increased Cx43 at the cell surface induced any alteration in gap 
junction function of CE cells, we inhibited GJIC using epidermal growth factor (EGF). EGF 
treatment has been shown to decrease GJIC in cultured cells through activation of the mitogen-
activated kinase pathway (Abdelmohsen, Sauerbier et al. 2007).  This response was clearly 
detected in CE cells using the LY dye transfer assay (Fig. 4.8). MMC-treated cultures partially 
rescued the EGF-induced GJIC inhibition, suggesting that increases in cell surface Cx43 induced 
by MMC are indeed functional in promoting intercellular communication. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: MMC treatment generates GJIC resistant to EGF-mediated downregulation. (A) 
Confluent monolayers were pretreated for 60 minutes with either prewarmed media containing 5 M 
MMC or medium (“CTRL”) alone. Medium was replaced with 100 ng/mL EGF for an additional 30 
minutes and then GJIC was assessed with a scrape-load dye transfer assay as described in the Methods 
section. Ten individual sites were measured along different regions of the scrape wound for distance of 
LY dye transfer to determine cell– cell communication as shown in the graph. Data points are mean 
distance + SD of the dye transfer. ANOVA was used for statistical comparison among treatment groups (P 
< 0.0001). Tukey’s multiple comparison test reported untreated versus MED + EGF (P < 0.001), 
untreated versus MMC + EGF (P > 0.05), MED + EGF versus MMC + EGF (P < 0.001). Results are 
representative of two independent experiments. 
 
p>0.05
UNTREATED CRTL+EGF MMC+EGF 
p<0.001 p<0.001
 87 
4.3.6 GJIC protects against genotoxic stress-induced apoptosis 
After we observed stabilization of GJIC during genotoxic stress, we assessed the role of 
GJIC in genotoxic stress-induced apoptosis. 18-alpha-glycerrhetinic acid (AGA) was used to 
inhibit GJIC during a high dose (50M) of MMC.  Cells were loaded with a fluorescent indicator 
of caspase 3/7 activation.  The dye is non-fluorescent until apoptosis-induced activation of 
caspase 3/7 which cleaves the dye, translocating it to the nucleus and initiating its fluorescence.   
Live-cell imaging of confluent monolayers of equal cell numbers followed the progression of 
apoptosis.  The combination of inhibition of GJIC with genotoxic stress (AGA+MMC) lead to an 
earlier onset of apoptosis compared to MMC alone (Fig. 4.9). 
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Figure 4.9:   GJIC effect on acute genotoxic stress-induced apoptosis.  CE cells were 
seeded at equal density then grown to confluency. Confluent CE cells were loaded with a 
fluorescent indicator of caspase 3/7 activity and imaged by live-cell imaging during acute 
genotoxic stress with 50 M MMC.  10 M 18-GA (AGA) was used to inhibit GJIC.  
The number of caspase 3/7 positive cells, indicative of apoptosis, was calculated from 
live-cell images from each timepoint.  The mean number of caspase 3/7-positive cells + 
SEM is show in the graph from three independent cultures for each time point. 
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4.4 DISCUSSION 
The CE is a nonregenerating tissue in which the total number of cells declines throughout 
life. As a result of damage or various acute stressors, this process can occur more rapidly. With 
cell loss, CE cells spread and flatten, covering a greater area. Apart from this process, little of the 
physiologic response to stressors in these cells is known, particularly regarding how cell– cell 
junctions are maintained. In the present study, we document several novel observations regarding 
how CE cells respond to an acute stress: Cx43 rapidly accumulates in detergent-insoluble 
plaques at cell– cell junctions; the plaques are stabilized, showing reduced endocytosis and 
degradation; transport of Cx43 from the ER to the cell surface is increased; and gap junction 
communication is stabilized against downregulation by EGF. These observations describe a 
previously unidentified response of CE cells to stress, rapidly increasing the abundance of 
functional gap junctions in the tissue.  
The mechanism mediating this response is not straightforward. In initial experiments, we 
found no statistically significant increase in Cx43 mRNA (Supplemental Fig. S.4 therefore, the 
rapid change in Cx43 abundance in response to MMC seemed likely to involve decreased Cx43 
degradation. A temporary halt to Cx43 degradation after MMC treatment was indeed observed 
(Fig 4.4) as was a significant reduction in endocytosis and dispersion of plaque-associated Cx43 
(Fig 4.5), providing a mechanism that could be responsible for the observed increase in total 
cellular Cx43. Cx43 stabilization has been described in other cell types in response to stress. 
Long-lived gap junctions after arsenite and heat-shock exposure were observed in in CHO and 
S180 cell lines (VanSlyke and Musil 2005).   In the case of CHO cells, cell surface Cx43 was 
stabilized by a mechanism dependent on functional proteasomal action (VanSlyke and Musil 
2005).  The CE response to MMC observed in this study could, therefore, be typical of a 
generalized cellular mechanism by which cells stabilize GJIC in response to stress.    
Another potential effector of GJIC stabilization is ZO-1. ZO-1 is present in gap junctions, 
binding the C-terminal intracellular region of Cx43 (Giepmans and Moolenaar 1998). We 
observed Cx43 but not ZO-1 to increase in response to MMC, and subsequently found a 
decreased association of ZO-1 with Cx43 by coimmunoprecipitation (Fig. 4.3).   There is reason 
to believe that this reduced ZO-1:Cx43 ratio could contribute to the stress-induced Cx43 plaque 
stabilization. Association of Cx43 with ZO-1 has been linked to an increased endocytosis of 
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Cx43 (Barker, Price et al. 2002; Segretain, Fiorini et al. 2004; Bruce, Rothery et al. 2008); 
therefore, reduced association of Cx43 with Z0–1 in gap junction plaques (such as we observed) 
could delay or prevent Cx43 endocytosis and internalization. ZO-1 may also have an effect on 
the gap junction plaque size (Fig. 4.2).   ZO-1 has been reported to regulate gap junction size by 
limiting access of ZO-1-associated Cx43 into preexisting gap junctions (Giepmans and 
Moolenaar 1998; Hunter, Jourdan et al. 2003; Hunter, Barker et al. 2005; Rhett, Jourdan et al. 
2011). Reduced ZO-1 association with cell surface Cx43 is therefore consistent with the 
increased gap junction plaques we observed. 
The in vitro CE layers used in this study did not appear to restrict the intercellular 
transmission of dyes via gap junctions (Fig. 4.7). However, in the presence of EGF—an agent 
that disrupts GJIC—it was clear that GJIC in MMC-treated cells was more resistant to this 
inhibition than control cells (Fig. 4.8).  Therefore, the rapid alterations in Cx43 protein in 
response to genotoxic stress produce a cell– cell communication array that is more robust than 
that in nonstressed cells. This response gains relevance in light of the documentation that 
exposure to genotoxic stressors releases cytokines and growth factors(Prise and O'Sullivan 2009; 
Chang, Chou et al. 2010; Chen and Chang 2010; Novakova, Hubackova et al. 2010) that could 
compromise GJIC in the CE.  
The tight junctions in CE cells serve to control movement of water and nutrients into the 
cornea (Srinivas 2010), but there is not yet a clearly demonstrated role for gap junctions in 
corneal physiology. Our results suggest that alterations in Cx43 may serve as survival factor for 
CE cells. In other biologic systems in which cells are subjected to physical stress or injury, gap 
junction coupling activation results in the mediation of injury or increased survival (Chew, 
Johnson et al. 2010; Qi, Chi et al. 2011). In the CE, upregulation of Cx43 mRNA and protein, via 
release of ciliary neurotrophic factor and its receptor, promote CE cell survival during oxidative 
stress and ex vivo corneal storage (Koh, Celeste et al. 2008; Koh, Cheng et al. 2009) (Koh 2002).  
Also, point mechanical stimulation of CE cell monolayers results in a Cx43-dependent increase 
in ATP release and calcium-wave propagation between cells (Gomes, Srinivas et al. 2006).  
Therefore, Cx43 and GJIC provide a response in CE to changes in cellular environment that is 
likely to represent a survival response.  
The rapid rate at which CE responds to MMC suggests a mechanism not reliant on 
changes in gene expression but instead on posttranslation modifications of Cx43. Cx43 C-
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terminal phosphorylation controls multiple aspects of this protein, including channel gating, 
subcellular localization, secondary structure, and stability (Solan and Lampe 2009).   Increased 
phosphorylation of Cx43 C-terminal, for example is responsible for decreased ZO-1 binding  
(Chen, Pan et al. 2008).   Site-specific Cx43 phosphorylation has also been linked to 
internalization and degradation of this protein (Solan and Lampe 2007).   Casein kinase 1 is a 
likely candidate for an active participant in the response to MMC. Phosphorylation of Cx43 by 
casein kinase 1 has been proposed to stimulate incorporation of Cx43 into gap junction plaques 
(Cooper and Lampe 2002) and it appears to exert a general role in regulating the stability of its 
numerous substrates (Knippschild, Gocht et al. 2005).  In addition, casein kinase 1 acutely 
responds to genotoxic stress resulting in increased kinase activity, changes in subcellular 
location, and increased mRNA and protein levels (Knippschild, Milne et al. 1997; Knippschild, 
Gocht et al. 2005; Alsheich-Bartok, Haupt et al. 2008; Inuzuka, Tseng et al. 2010). 
In conclusion, we have documented rapid changes in Cx43 in response to genotoxic 
stress and identified the changes in binding partners and reduced degradation of Cx43. 
Mitomycin C is widely used in ocular surgery, and we recently showed that such treatment 
generates DNA cross-linking in CE (Roh, Cook et al. 2008).  MMC, however, may not be the 
only genotoxic agent to which these cells are exposed. The high metabolic rate of the CE 
generates reactive oxygen species, which are capable of DNA damage (Cadet, Douki et al. 2003) 
and as a possible consequence, CE exhibits an accumulation of DNA modifications with 
increasing age (Joyce, Zhu et al. 2009; Joyce, Harris et al. 2010).  The implications of the 
stabilization of Cx43 and GJIC on CE cell homeostasis/survival are yet to be fully elucidated but 
may serve to protect against detrimental effects of natural DNA damage and acute stress 
generated by agents such as MMC or ultraviolet light. Future areas of interest include 
determining the functional consequences of stabilized cell surface Cx43 and GJIC on CE cell 
viability. One potential function influencing cell survival may be to increase the intercellular 
transfer of cytoprotective molecules that increase survival and function of interconnected cells 
and/or disperse cytotoxic molecules and prevent their accumulation in any one cell. 
(Additional discussion not included in original publication).  The live-cell assay for 
apoptosis demonstrated a key finding by establishing GJIC as protective during genotoxic stress 
in CE cells.  Fig. 4.9 shows that inhibition of GJIC accelerates genotoxic stress-induced 
apoptosis in CE cells.  Therefore, the rapid accumulation of Cx43 in gap junctions and the 
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preservation of GJIC serves to enhance survival of the CE during acute genotoxic stress.  The 
mechanisms that mediate survival through cell-cell communication may involve the dispersion 
of toxic molecules or spreading of survival factors. Although we did not test for changes in 
secondary messengers, intracellular Ca2+ and cAMP may be factors mediating survival.  Ca2+ is 
thought to be the “killing messenger” that can propagate from cell to cell via gap junctions 
(Decrock, Vinken et al. 2009; Decrock, Vinken et al. 2011).  Enhanced GJIC may prevent any 
one cell from accumulating high intracellular Ca2+ concentrations, which would normally lead to 
cell death.  Alternatively, increased GJIC may allow for spreading of cAMP which has been 
shown to protect CE cells from staurosporine-induced apoptosis (Li, Allen et al. 2011).  
Interestingly, GJIC has been shown to decrease at the early onset of apoptosis which involved 
increased removal of gap junctions (Wilson, Close et al. 2000; Kalvelyte, Imbrasaite et al. 2003).  
Preventing the breakdown of gap junctions and/or the enhancement of GJIC may be an approach 
to improving the survival of CE cells during stress.  
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5.0  CASEIN KINASE 1 DELTA AS A REGULATOR OF CONNEXIN-43 AND GAP 
JUNCTION INTERCELLULAR COMMUNICATION DURING GENOTOXIC STRESS 
5.1 INTRODUCTION 
The gap junction protein connexin-43 (Cx43) is tightly regulated by phosphorylation of 
its intracellular C-terminus in conditions of both homeostasis and stress. Cx43 phosphorylation 
rapidly alters protein structure and conformation which has immediate impacts on localization, 
stability, binding partners, channel permeability, and the ability to form gap junctions (Solan and 
Lampe 2009).  Numerous kinases have been implicated in Cx43 phosphorylation, each having a 
distinct effect on the life cycle of Cx43.  The initial phosphorylation event can occur within  
minutes of synthesis and the maturation of the P0 to the P1 and P2 forms is believed to involve 
protein kinase A (PKA) and casein kinase 1, respectively (Solan and Lampe 2007).  Stimulus-
induced phosphorylation by other kinases such as src, Erk1/2, and protein kinase C (PKC), leads 
to distinct P0, P1, and P2 forms of Cx43 that drive channel closure and rapid disassembly of gap 
junctions (Lampe and Lau 2004).  As Cx43 and GJIC are integrated with cell function, survival 
and death, understanding how the kinases and subsequent phosphorylation impacts gap junctions 
can help to enhance cellular responses during stress. 
The delta isoform of casein kinase 1 (CK1) was reported to be involved in the assembly 
of gap junctions and in vitro specifically phosphorylated serines 325, 328, 330 of Cx43 (Cooper 
and Lampe 2002).  Mutation of these residues prevented the formation of gap junctions and an 
antibody generated against these sites localized to gap junction plaques exclusively (Lampe, 
Cooper et al. 2006).  This Cx43 phosphorylation site has been linked with responses to cell and 
tissue injury.  Ischemic-damaged heart tissue and hearts from a mouse model of 
oculodentodigital dysplasia (Cx43 mutation) with severe arrhythmias contained low levels of 
serine 325, 328,330 phosphorylation (Lampe, Cooper et al. 2006; Kalcheva, Qu et al. 2007).  
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Knock-in mice expressing a phosphomimetic version of these residues were resistant to 
ischemia-induced cardiac remodeling of gap junctions.  In contrast, the phosphomutant knock-in 
mice were susceptible to stress-induced arrhythmias and gap junction remodeling (Remo, Qu et 
al. 2011).  Therefore, it appears that phosphorylation of Cx43 by CK1plays a unique and 
significant role in gap junction formation, stability and resistance to remodeling during stress and 
injury. 
Our previous study (Roh and Funderburgh 2011) reported rapid changes in corneal 
endothelial (CE) Cx43 after acute genotoxic stress.  This response  included accumulation of 
Cx43 in gap junctions and stress-stabilized GJIC that was resistant to subsequent cytokine 
exposure (Roh and Funderburgh 2011).   We later found that GJIC inhibition significantly 
accelerated genotoxic stress-induced apoptosis in CE cells and hypothesized that stabilization of 
Cx43 may be an important protective response.  In this study we sought to determine a role for 
CK1 in genotoxic stress-stabilized gap junctions in CE, a fragile cell layer especially vulnerable 
to the effects of genotoxic stress (Joyce, Zhu et al. 2009; Joyce, Harris et al. 2010).  Because  
CK1 is also  involved in  DNA damage signaling (Knippschild, Milne et al. 1997; Sakaguchi, 
Saito et al. 2000; Alsheich-Bartok, Haupt et al. 2008; Inuzuka, Tseng et al. 2010), we 
hypothesized that CK1 may link DNA damage responses to changes in Cx43.  If Cx43 and 
GJIC stabilization have potential to preserve CE survival during stress then determining targeted 
methods to specifically modulate these processes will be beneficial in protecting CE from injury. 
5.2 MATERIALS AND METHODS 
Cell culture and reagents 
Primary bovine CE cells and human corneal fibroblasts were isolated and cultured as previously 
described (Roh and Funderburgh 2011). HeLa cells (ATCC, Manassas, VA) were grown in 
DMEM containing 10% fetal bovine serum.   Mitomycin C (MMC), brefeldin A (BFA), 
etoposide, cycloheximide (CHX), CKI-7, (all from Sigma, St. Louis, MO), PF670462 (Tocris 
Bioscience, Ellisville, MO), were freshly diluted in pre-warmed media and applied to cells.  
UVC treatments were performed using a UV light source (UVP, LLC., Upland, CA) with a UVC 
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filter.  Cells were grown on 35-mm dishes and media was removed and saved in a separate 
container during UVC exposure then replaced immediately after.  Intensity (Joules/m2) was pre-
calculated using a UV meter (UVX Radiometer, UVP, LLC.).    
 
Reverse Transcription Polymerase Chain Reaction (PCR) 
Cells were collected by centrifugation after scraping into cold saline, RNA was isolated using 
RNeasy mini kit (Qiagen, Germantown, MD), and reverse transcribed to cDNA as previously 
described (Du, Funderburgh et al. 2005).   Custom designed primers for bovine CK1 (gene 
CSNK1D) were: 5’ (GTTCCTTGCGTTTTGACGAT) and 3’ (GTGTCTCAACCGCTCCTCTC) 
which gave an expected 185 base pair product.  PCR was carried out for 30 cycles of 15 minutes 
at 95°C and 60 minutes at 60°C after an initial incubation at 95°C for 10 minutes in an ABI7700 
thermocycler (Applied Biosystems, Carlsbad, CA).  PCR products were run on pre-cast DNA 
gels (BioRad, Hercules, CA) for 1 hour at 100V and bands were visualized with SYBR Gold 
(Invitrogen, Carlsbad, CA) under UV light.   
 
Cx43 constructs 
A cDNA construct (pGEX-2T, GE Life Sciences, Piscataway, NJ ) encoding a GST fusion 
protein with the complete C-terminus of rat Cx43 (amino acids 236-382) was a kind gift of Dr. 
Steven Taffet, State University of New York Health Science Center, Syracuse, NY.  The GST 
construct was transformed into BL21 Escherichia coli and expression was induced with 100 M 
Isopropyl β-D-1-thiogalactopyranoside (IPTG).  GST fusion protein was purified with pre-
washed magnetic glutathione beads (Thermofisher, Pittsburgh, PA).  A cDNA construct 
(pEGFP-N1, Clonetech, Mountain View, CA) encoding full-length rat Cx43 fused with a C-
terminal GFP was a kind gift of Dr. Matthias M. Falk, Lehigh University, Bethlehem, PA.  This 
construct was further modified by PCR mutagenesis to mutate all serine residues 325, 328, 330 
to alanines or aspartates. Primers were used to introduce mutations and included:  
Serines  Alanines (GCA) 
A-Front: GGGCAGGCCGGAGCAACAATTGCAAACGCACACGCCCAGCCGTTCGAT 
A-Back: GCTGGGCGTGTGCGTTTGCAATTGTTGCTCCGGCCTGCCCCATGCGATTT 
B-Front: GCGCACTGCAGGCCACCATGGGTGACTGGAGTGCCTT 
B-Back: CGCGCGGATCCGCAATCTCCAGGTCATCAGGCCGAGGCC 
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Serines  Aspartates (GAC) 
A-Front: GGGCAGGCCGGAGACACAATTGACAACGACCACGCCCAGCCGTTCGAT 
A-Back: GCTGGGCGTGGTCGTTGTCAATTGTGTCTCCGGCCTGCCCCATGCGATTT 
B-Front: GCGCACTGCAGGCCACCATGGGTGACTGGAGTGCCTT 
B-Back: CGCGCGGATCCGCAATCTCCAGGTCATCAGGCCGAGGCC 
 
PCR was performed to create two fragments (reaction 1: B-Front + A-Back; reaction 2: B-Back 
+ A-Front), which were then combined with PCR (reaction 3: B-Front + B-Back), cut with pstI 
and BamHI and ligated into empty pEGFP-N1 vector pre-cut with pstI and BamHI.  All 
mutations were verified by DNA sequencing.  The resulting constructs were further modified to 
remove the GFP tag from the C-terminus by using the following primer which introduced stop 
codons: 
A-Back_STOP: CTTCTCTCCGGCCGCGGATCCTTAAATCTCCAGGTCATCAGGCCGAGGCC 
 
PCR was performed to copy the Cx43 encoding sequences and  introduce the stop codons.  The 
resulting products were cut with PstI and Not1.  In addition, PstI and Not1 were used to excise 
the sequence encoding GFP from the pEGFP-N1 vector followed by DNA ligation with the cut 
PCR products.  Mutations were verified by DNA sequencing.  
 
Immunostaining 
Cells were grown on 35 mm dishes, fixed in 3.2% paraformaldehyde (PFA) (Electron 
Microscopy Science, Hatfield, PA), permeabilized with 0.1% Triton X-100 (Thermofisher), and 
blocked as previously described (Roh and Funderburgh 2011).  For staining of detergent 
insoluble proteins, cells were rinsed with saline and then covered with ice-cold 1% Triton X-100 
in PBS for 30 minutes on ice, rinsed with PBS, and then fixed with PFA.  Primary antibodies 
used for staining included rabbit polyclonal anti-Cx43 (Invitrogen), rabbit polyclonal anti-pCx43 
serine 325, 328, 330, mouse monoclonal anti-Cx43 (Millipore, Billerica, MA), and goat 
polyclonal anti-CK1 (OriGene, Rockville, MD). 
 
Immunoblotting 
Cells were lysed in 1X SDS sample buffer, heated at 95o C, and sonicated until solubilized as 
previously described (Roh and Funderburgh 2011).  Primary antibodies used for immunoblotting 
were diluted in fluorescent blocker (Millipore) and included rabbit polyclonal anti-Cx43 
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(Invitrogen), rabbit polyclonal anti-pCx43 serine 325, 328, 330, mouse monoclonal anti-Cx43 
(Millipore), and goat polyclonal anti-CK1 (OriGene). Secondary antibodies included IRDye800 
and IRDye680 labeled secondary antibodies (LI-COR, Lincoln, NE) for infrared imaging.  
Fluorescent signal was detected with Odyssey infrared imaging system (LI-COR).   
Densitometry was performed using digital analysis software fluorescent detection (LI-COR). 
 
Triton X-100 insolubility 
Cells were lysed in cell lysis buffer containing 1% Triton X-100 and 1 mM EDTA with protease 
inhibitors (Sigma) and then chilled on ice for 30 minutes with mixing. Cell lysates were spun at 
10,000 g for 30 minutes at 4°C. The soluble fraction was removed and the Triton X-100 
insoluble pellet was further dissolved in 1X SDS buffer followed by sonication.  
 
Co-immunoprecipitation  
Cells were lysed directly in cold coimmunoprecipitation buffer [0.1% Nonidet P40, 25 mM Tris 
pH 7.4, 150 mM NaCl, 1 mM EDTA] containing HALT protease and phosphatase inhibitors 
(Thermo Fisher) and briefly sonicated until solubilized. Lysates were precleared with magnetic 
protein G beads (Millipore) for 1 hour at room temperature to remove any nonspecific binding of 
cell proteins to beads. The beads were discarded and then cleared lysates were incubated with 1 
g antibody per 500 g of lysate using a rabbit polyclonal anti-Cx43 antibody (Invitrogen) or 
goat polyclonal anti-CK1 (OriGene) overnight at 4°C. Beads were then washed multiple times 
with lysis buffer and heated at 95°C for 5 minutes in 1X SDS sample buffer with 2-
mercaptoethanol. A magnetic rack was used to separate the beads from lysate before loading for 
SDS-PAGE separation.  
 
In vitro kinase assay 
~5-10 g of GST-Cx43-CT fusion proteins bound to glutathione magnetic beads (Thermofisher) 
were incubated with ∼5,000 units of purified recombinant CK1δ (New England Biolabs, 
Ipswich, MA) in 10 μl reactions containing 5 μM ATP, [γ-32P]ATP (PerkinElmer Life Sciences 
Blu002, ∼1 μCi),  and 1× CK1 reaction buffer (50 mM Tris-HCl, 10 mM MgCl2, 5 mM 
dithiothreitol, pH 7.5).  Reactions were incubated at 30° C for 20 minutes followed by several 
washes in 1X CK1 reaction buffer using a magnetic rack to isolate the magnetic glutathione-
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bound GST proteins. Phosphorylated protein was eluted in 1× SDS sample buffer, heated at 
95°C for 5 minutes, and analyzed by SDS-PAGE on 10% pre-cast polyacrylamide gels (BioRad).   
Incorporation of [γ-32P]ATP was detected by autoradiography of dried Coomassie-stained gels.  
For “cold” kinase assays, similar steps were taken with the exception of omission of [γ-32P]ATP 
and detection of phosphorylated Cx43 serine 325, 328, 330 was done through immunoblotting 
with the pCx43 antibody (described below) and a mouse anti-GST antibody (GenWay, San 
Diego, CA).  Inhibition of CK1 activity during kinase assays was achieved with the addition of 
3 M PF670462 to the reaction mixture.  
 
Generation and validation of a phosphospecific Cx43 antibody 
Custom peptides were synthesized (ProSci Inc., Poway, CA) to generate an antibody that 
recognized Cx43 phosphorylated on serines 325, 328, 330 as previously reported (Lampe, 
Cooper et al. 2006).  The phosphopeptide sequence (phosphorylated residues indicated by 
underlined residue and ‘(P)’) was: CQAGS(P)TIS(P)NS(P)HAQ and the cognate non-
phosphopeptide sequence was: CQAGSTISNSHAQ which is conserved peptide sequence across 
multiple species  including human, mouse, rat, and  bovine.  A commercial antibody production 
company (ProSci) was used to generate rabbit serum against the phosphopeptide.  
Phosphorylation-specific antibody was affinity purified by linking the phosphorylated peptide 
and the corresponding nonphosphorylated version to SulfoLink columns (Thermofisher) and 
passing the serum first over a 2-ml column prepared with the nonphosphorylated peptide two 
times followed by a phosphopeptide-SulfoLink column according to the manufacturer's 
instructions. After washing, phosphorylation-specific antibody was eluted from the column with 
0.1 M glycine-HCl, pH 2.8 and fractions were immediately neutralized with 1M Tris-HCl, pH 
8.5.  Antibody was concentrated using a spin column, dialyzed with PBS, and aliquoted and 
stored at -20o C until use.  ELISA compared reactivity to the phosphopeptide and cognate 
nonphosphopeptide.  96-well plates were coated with 10 g/ml of each peptide dissolved in 50 
mM carbonate binding buffer.  Plates were blocked with 0.1% BSA in PBS with 0.02% 
thimerosal and serum was added in dilutions of 1:5,000, 1:25,000, 1:125,000 in triplicate.  Goat 
anti-rabbit HRP (Santa Cruz Biotechnology, Santa Cruz, CA) was used with QuantaBlue 
substrate (Pierce) to detect antibody binding.  Relative fluorescence at 325/420 nm was measured 
using a fluorometer.  Calf intestinal alkaline phosphatase (AP) (Sigma) treatment of cell lysates 
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was performed as previously described (Roh and Funderburgh 2011) prior to SDS-PAGE to 
determine the phosphospecificity of the custom antibody.  Similar AP treatment was used in 
immunostaining.  Hela cells were transfected with Cx43 constructs using Lipofectamine 2000 
(Invitrogen) and analyzed by immunoblotting 24 hours after transfection. 
 
RNAi of Cx43 
Three siRNA oligonucleotides targeting bovine Cx43 (GJA1, NM_174068) were synthesized 
and included: 1) CCCACAUCAGGUGGAGUGUUUCCUU, 2) 
GGAGACAGAAACAAUUCUU, 3) CCGCAAUUACAACAAACAA (Invitrogen). Scrambled 
control siRNA oligonucleotide sequence was GGAACAGAAACUAUGACUU. Cells grown in 
serum-free medium were transfected with mixtures of all three  siRNAs using Lipofectamine 
2000 (Invitrogen) and assessed 48 hours later through immunoblotting with antibodies for pCx43 
and total Cx43. 
 
RNAi of CK1 
Pre-designed GFP-labeled shRNA constructs (pGFP-V-RS, OriGene) targeting human CK1 
(CSNK1D, NP_001884.2) were used to manipulate CK1 expression in human corneal 
fibroblasts.  Sequences were the following: shRNA 72 
(GGCAGCGGCTCCTTCGGAGACATCTATCT), shRNA 73 
(TGCAGGAGAAGAGGTTGCCATCAAGCTTG). Scrambled shRNA 
(GCACTACCAGAGCTAACTCAGATAGTACT) served as a control.  shRNA plasmids were 
transfected with Lipofectamine 2000 (Invitrogen) and assessed 48 hours later through 
immunostaining with antibodies for pCx43 and CK1 (OriGene). 
 99 
5.3 RESULTS 
5.3.1 CK1 expression in CE 
Expression of CK1 was examined by PCR and was detected in cultured bovine CE cells 
(Fig. 5.1.A).  Immunostaining with a CK1-specific antibody demonstrated localization 
throughout the cell, particularly in the peri-nuclear compartment, nucleus, and at the cell 
membrane (Fig. 5.1.B).  Immunoblot analysis of Triton X-100 detergent soluble and insoluble 
fractions showed that a majority of CK1 is located in detergent-soluble portions of the CE cell 
(Fig. 5.1.C).  
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Figure 5.1:   Expression of CK1 in bovine CE.   (A) PCR data of bovine CSNK1D.  Expected 
product size is 185 bp. Negative control excluded cDNA.  (B) Immunostaining showing expression and 
localization of CK1 (green) and DAPI (nuclei).  Negative control for staining included no primary 
antibody (NO 1o). (C) Immunoblot with CK1 antibody from 1% Triton X-100 insoluble and soluble 
fractions. 
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5.3.2 Increases in CK1 after genotoxic stress 
CK1 is responsive to genotoxic stress through potential increases in mRNA, protein, 
and/or kinase activity as well as changes in substrate interactions (Knippschild, Milne et al. 
1997; Sakaguchi, Saito et al. 2000; Alsheich-Bartok, Haupt et al. 2008).  We observed increases 
in the total levels of CK1 protein based on immunoblotting from CE cells after MMC (Fig. 
5.2.A) or UVC radiation (Fig. 5.2.B) exposure.  Confirming this finding with immunostaining, 
the increase in CK1 was particularly evident in the peri-nuclear compartment and nucleus (Fig. 
5.2.C).  Notably, these increases were within the same timeframes we previously observed 
changes in Cx43 levels (Roh and Funderburgh 2011).  
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Figure 5.2:   MMC and UVC treatment increases levels of CK1.  Confluent CE monolayers were treated 
with (A) 5 µM MMC or (B) 20 J/m2 UVC for the indicated time in minutes then assessed for CK1 levels 
through immunoblotting. (C) Immunostaining for CK1 after 60 minutes of treatment with medium (CTRL), 5 
µM MMC or 20 J/m2 UVC.  CK1 signal is pseudocolored and reflects intensity according to color scale shown 
(blue=lowest; white=highest). DAPI labels nuclei (gray scale). 
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5.3.3 Cx43: CK1 localization in homeostatic and genotoxic stressed CE  
In order to further characterize the interaction between CK1 and Cx43 we used co-
immunoprecipitation studies.  IP with the Cx43 antibody demonstrated interaction with CK1 
and conversely IP with the CK1 antibody demonstrated interaction with Cx43 (Fig. 5.3.A).  
CK1 interacted with all forms (P0, P1, P2) of Cx43 despite being reported to only 
phosphorylate the P2 form (Cooper and Lampe 2002).  To observe this interaction in vivo dual 
immunostaining with both antibodies was performed.  This demonstrated Cx43:CK1 co-
localization in the peri-nuclear compartment as well as around the edges of some membrane-
localized gap junction plaques (Fig. 5.3.B).  To assess whether this interaction was dynamic after 
exposure to genotoxic stress we treated cells with 5M MMC for 60 minutes after which,  Co-IP 
showed an increase in the relative amount of CK1 associated with Cx43 (Fig. 5.3.C).  
Immunostaining after exposure to various genotoxic stressors demonstrated that this increased 
interaction was in both the peri-nuclear and membrane compartments (Fig. 5.3.D).  
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5.3.4 Antibody against Cx43 phosphorylated on serines 325, 328, 330 
We created a peptide-based phosphospecific polyclonal rabbit antibody to Cx43 
phosphorylated on serines 325, 328, 330 (named pCx43) to distinguish Cx43 specifically 
phosphorylated on this site.  ELISA was used to test antibody specificity to a phosphopeptide 
and its cognate non-phospho counterpart.   ELISA results demonstrated high reactivity with the 
phosphopeptide and negligible reactivity towards the nonphosphorylated peptide (Fig. 5.4.A).  
Immunoblotting simultaneously with two antibodies, the pCx43 antibody and total Cx43NT1 
antibody, demonstrated that the pCx43 antibody recognized a portion of the P2 form of Cx43 
(Fig. 5.4.B).  Alkaline phosphatase (AP) treatment of cell lysates prevented antibody reactivity in 
immunoblotting (Fig. 5.4.C).  In addition, expression of Cx43 constructs in Hela cells (which do 
not endogenously express Cx43) with these serines mutated to alanines or aspartates abolished 
pCx43 reactivity (Fig. 5.4.E) demonstrating the phosphospecific nature of antibody reactivity.     
We observed a prominent P0-like band that was evident in immunoblotting, even in non-
Cx43 expressing Hela cells. Detergent fractionation of cell lysates demonstrated that the pCx43 
was mostly the P2 form in insoluble fractions (gap junction-associated Cx43) while the P0-like 
band was in the soluble fraction (Fig. 5.4.D).  To determine the identity of this P0 band, we 
knocked down Cx43 with siRNA and did not observe similar decreases in the “P0” band (Fig. 
5.4.F).  In addition, immunoprecipitation from human corneal fibroblasts followed by peptide 
CTRL MMC ETOP UVC 
(D) 
Figure 5.3:   Dynamic interaction of Cx43 and CK1 in CE cells.  (A) IP experiments demonstrating 
that Cx43 and CK1  interact in CE cell lysates.  Upper blot uses Cx43 as IP-antibody and lower is 
reverse using CK1 as IP-antibody.  (B) Immunostaining showing CK1 (red) and Cx43 (green) in CE 
cells.  Areas of co-localization (white).  (C) Co-IP after 60 minutes of 5 M MMC exposure or medium 
alone (CTRL).  Quantification is CK1/Cx43 then normalized to CTRL.  Mean ratio  + SEM from three 
experiments below. (D) Dual immunostaining similar to (B) after 60 minute exposure to 5 M MMC, 
20 M etoposide, or 20 J/m2 UVC.   
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mass fingerprinting was not able to detect connexin in this band.  Therefore, pCx43 reacted with 
a soluble protein that migrated in a similar position as the P0 form of Cx43, but was not Cx43. 
Immunostaining with the pCx43 antibody demonstrated localization at CE cell-cell 
interfaces co-localizing with a total Cx43 antibody (Fig. 5.4.I).  This staining excluded the peri-
nuclear compartment in CE cells that was evident with total Cx43, however, included filament-
like cytoplasmic staining (Fig.5.4.I).  Detergent extraction prior to staining eliminated the 
filamentous staining and demonstrated that the pCx43 antibody primarily recognized Cx43 in 
detergent-insoluble gap junction plaques (Fig. 5.4.J).  Antibody reactivity during 
immunostaining could be prevented by AP treatment (Fig. 5.4.G) as well as pre-incubation with 
the phosphopeptide (Fig. 5.4.H).   
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Figure 5.4:   pCx43 antibody.  (A) ELISA results testing pCx43 antibody reactivity against phosphopeptide and 
nonphosphopeptide.  Results are mean+SD of triplicates of increasing antibody dilutions. (B) Dual immunoblotting 
with total Cx43NT1 (red) and pCx43 (green) antibodies.  Areas of overlay appear yellow.  P2, P1,P0 represent 
different forms of Cx43.(C) Alkaline phosphatase (AP) treatment of cell lysates and resulting pCx43 reactivity. (D) 
pCx43 reactivity after 1% Triton X-100 fractionation. (E) pCx43 reactivity in Hela cells transfected with Cx43 
constructs.  Wildtype (WT), Alanine (ALA), Aspartate (ASP) designate mutations in serines 325, 328, 330. (F) 
pCx43 reactivity after siRNA treatment against Cx43. pCx43 bottom band represents decreased exposure.  
Quantification below is ratio of pCx43 or Cx43NT1 to -tubulin. (G) Immunostaining after AP treatment. pCx43 
(green).  (H) Immunostaining after incubation of antibody with phosphopeptide.  (I) Dual immunostaining with total 
Cx43 (green) and  pCx43 (red) in primary bovine CE.  Overlay appears yellow. (J)  Immunostaining after detergent 
extraction. pCx43 (red).  DAPI stains nuclei blue in all images. 
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5.3.5 CK1 phosphorylates Cx43-CT on serines 325, 328, 330 
In order to test the phosphorylation of Cx43 by CK1, we used recombinant 
CK1(rCK1, lacking the autoregulatory C-terminus, in an in vitro kinase assay with 
recombinant Cx43 C-terminus fused to GST (GST-Cx43CT).  rCK1phosphorylated the C-
terminus as indicated by autoradiography (Fig. 5.5.A, reaction 3) but did not phosphorylate GST 
alone (Fig. 5.5.1, reaction 2).  This was inhibited by incubating the reaction with PF670462 (Fig. 
5.5.A,  reaction 4), which specifically inhibits both the  forms of CK1 (Cheong, Hung et al. 
2011). Using GST-Cx43CT as a substrate, rCK1created an epitope specific for the pCx43 
antibody (Fig. 5.5.b, reaction 2) that was inhibited by incubation with PF670462 (Fig. 5.5.B, 
reaction 3). 
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Figure 5.5:   Recombinant CK1 phosphorylates Cx43 on specific residues in 
vitro.    (A) Kinase assay testing 32P incorporation into Cx43 C-terminal. 1) GST-
Cx4CT alone (no rCK1), 2) GST alone + rCK1, 3) GST-Cx43CT + rCK1, 4) 
GST-Cx43CT + rCK1 + PF670462.  Upper is autoradiograph image of P and 
lower is Coomassie stained gel.  (B) “Cold” kinase assay testing phosphorylation of 
C-terminal serine 325, 328, 330.  1) GST-Cx43CT alone (no rCK1), 2) GST-
Cx43CT + rCK1, 3) GST-Cx43CT + rCK1 + PF670462.  Upper is immunoblot 
using pCx43 antibody and lower is immunoblot with GST antibody. 
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5.3.6 CK1 inhibitors reduce gap junction formation and Cx43 stability in CE 
To determine the effect of CK1inhibition on Cx43, PF670462 (specific for CK1) 
was used in CE cell cultures.   Western analysis after 8 hour incubation with PF670462 
demonstrated both reduced pCx43 and total levels of Cx43 (Fig. 5.6.A).   Similar results were 
found with immunostaining as there was decreased Cx43 (Fig. 5.6.B).  Therefore, it appeared 
that CK1-mediated phosphorylation of Cx43 controlled Cx43 stability.  To further test this we 
used cycloheximide chase experiments and found that including PF670462 decreased Cx43 
abundance at a greater rate than with cycloheximide alone (Fig. 5.6.C).  Next, to further 
distinguish CK1’srole in gap junctions formation, cells were treated with brefeldin A followed 
by washout in the presence of PF670462.  Cell surface Cx43 had reduced serine 325, 328, 330 
phosphorylation with PF670462 and demonstrated string-like distribution of Cx43 unable to 
make larger aggregates like controls (Fig. 5.6.E).   This was confirmed as PF670462  reduced 
Cx43 incorporation into the gap junction-associated detergent insoluble fraction (Fig. 5.6.D). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTX
pCx43 
Cx43 
OVERLAY 
-tub 
1 3 6 1 3 6  
CHX CHX+PF670462
 
0
0.5
1
1.5
0 1 3 6
CHX
CHX+PF
CONTROL 8hrs +PF670462 
0.33 
0.43 
1.00 
1.00 
pCx43 
total Cx43 
CTRL PF (A) (B) 
(C) 
     pCx43 
    Cx43NT1 
  OVERLAY 
 
 
 107 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTX BFA+ BFA+2+PF
    Cx43NT1 
     pCx43 
 
 
1.00 0.18
1.00 0.36 0.56
0.59 0.19
0.44
(D) 
  OVERLAY  
(E)
BFA (5hrs) BFA+2hrs BFA+2hrs+PF670462
 
 
 
 
Figure 5.6:   CK1 controls Cx43 stability and gap junction formation.  (A) 8 
hour treatment with PF670462 followed by dual immunoblotting with total 
Cx43NT1 (red) and pCx43 (green) antibodies.  Areas of overlay appear yellow.  (B) 
Similar treatment as in (A) followed by immunostaining with total Cx43 antibody 
(green). (C) CE cells treated with cycloheximide (CHX) with or without PF670462 
for indicated times in hours.   Dual immunoblotting with total Cx43NT1 (red) and 
pCx43 (green) antibodies.  Areas of overlay appear yellow.  Graph to right is 
mean+SEM of total Cx43/tub from two independent experiments. (D) Detergent 
insoluble fractions after brefeldin A (BFA) treatment with or without PF670462.  
BFA was used for 5 hours then washed out for 2 hours. Dual immunoblotting with 
total Cx43NT1 (red) and pCx43 (green) antibodies.  Areas of overlay appear yellow.  
Quantification below is of pCx43 or total Cx43, normalized to control (NOTX).  (E) 
Similar experiment to (D) followed by immunostaining with total Cx43 (green) and 
pCx43 (red) antibodies.  Areas of overlay appear yellow and DAPI stains nuclei.  
White boxes are regions of interest magnified below.   
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5.3.7 shRNAs against CK1decreases pCx43 s325, 328, 330 in human corneal fibroblasts 
Although PF670462 primarily inhibits CK1, there is also potential for partial inhibition 
of CK1.  Therefore we used shRNAs specifically targeting CK1 to determine the effects on 
Cx43 phosphorylation.  We were unable to knockdown CK1 in bovine cells with these shRNAs 
despite adequate transfection efficiency.  Therefore, we used human corneal fibroblasts derived 
from corneoscleral rim donor tissue to observe the effects of CK1 knockdown.  Using 
immunostaining we observed marked decreases in CK1 in the peri-nuclear and nuclear 
compartments with two separate shRNAs targeting CK1(Fig. 5.7.A).  Scrambled control 
shRNA did not affect CK1.  Because our shRNAs were GFP-labeled we then examined shRNA 
positive cells for pCx43 serine 325, 328, 330.  The distribution of pCx43 was different from that 
of bovine CE cells being more peri-nuclear.  However, shRNA-positive cells demonstrated a 
clear reduction in pCx43 levels (Fig. 5.7.B).   
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5.3.8 Genotoxic stress increases levels of pCx43 s325, 328, 330 
Increases in total Cx43 were evident after genotoxic stress similar to our previous study 
(Roh and Funderburgh 2011).  In order to distinguish the specific phosphorylated forms of Cx43 
that were increased, we used our pCx43 antibody in immunoblotting and immunostaining after 
exposure to MMC and UVC. Dual staining with both total Cx43 and pCx43 antibodies 
demonstrated that large gap junction plaques were accumulating Cx43 phosphorylated on serines 
325, 328, 330 after exposure to MMC and UVC (Fig. 5.8.A,B).   We confirmed this result by 
SCRAM 
shRNA 72 
shRNA 74 
DAPI+pCx43 GFP+DAPI+pCx43 pCx43 alone 
SCRAM SCRAM 
shRNA 72 shRNA 72 
shRNA 74 shRNA 74 
(B)
Figure 5.7:   Effect of CK1 shRNA on pCx43.  Human corneal fibroblasts were transfected with two 
shRNAs (shRNA 72 or shRNA 74) targeting CK1 or a scrambled shRNA  (SCRAM).  shRNA-transfected 
cells are GFP  positive (green).  (A) Immunostaining for CK1 (red) and DAPI. (B) Immunostaining for 
pCx43 and DAPI.  Far right panels are grayscale to allow for easier viewing of CK1 or pCx43 alone.   
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immunoblotting with both antibodies and found an increased proportion of total Cx43 
phosphorylated on these residues after MMC. (Fig. 5.8.C).  
Although we established a role for CK1 in regulation of Cx43 in homeostasis, we 
wanted to determine if this genotoxic stress-induced Cx43 accumulation was in part mediated by 
CK1Using CK1 inhibitors during genotoxic stress we found that the CK1 inhibitor CKI-7 
prevented accumulation of Cx43 after MMC (Fig. 5.8.D).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A)
(C)
0 15 30
60 120 240
(B)
0 15 30 
60 120 240 
 111 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         pCx43 
pCx43/Cx43  
60 1203015 240 
 
+ MMC 
0 
Cx43 
 
 
1.00 1.16 1.26 1.58 1.70 1.34 
-tub 
Medium  5m MMC  5m MMC + 30m CKI-7  
(D)
(C)
Figure 5.8:   Genotoxic stress increases pCx43.  (A) CE cells treated with 5 
M MMC for indicated time in minutes.  Immunostaining of pCx43 (green) 
and total Cx43 (red).  Overlay appears yellow. DAPI stains nuclei.  (B) CE 
cells treated with 20 J/m2 followed by recovery indicated by time in minutes.  
Immunostaining of pCx43 (red) and total Cx43 (green).  Overlay appears 
yellow. DAPI stains nuclei.  (C) Similar treatment as in (A) followed by 
immunoblotting with pCx43 and total Cx43 antibodies.  Quantification is 
pCx43/Cx43/-tubulin and demonstrates increasing ratio.  (D) 60 minute 
treatment with 5 M MMC and 30 M CKI-7.  Immunostaining with total 
Cx43 (green) antibody.  DAPI stains nuclei.   
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5.4 DISCUSSION 
In this study we built upon our previous work characterizing genotoxic stress-induced 
changes in CE Cx43 and GJIC (Roh and Funderburgh 2011).  In order to discern a potential 
signaling mechanism that was involved in these rapid changes in Cx43 we focused on CK1.  
We characterized the relationship between Cx43 and CK1 in CE cells and then further 
DNA 
Damage 
Detection 
↑CK1 
activity, 
expression 
↑Cx43 phosphorylation at serines 325, 328, 330  
Maintenance  
of GJIC 
Pump 
Barrier 
Viability 
Homeostasis 
DNA 
repair 
Ubiquitination Degradation 
Internalization 
Figure 5.9:   Potential model of events.  In response to acute genotoxic stress, CE cells increase CK1 
activity and expression.  An unidentified  molecular switch may be  dephosphorylation of the C-terminal 
region of CK1 by protein phosphatases.  As the kinase activity and levels of CK1 increase, so does its 
association and phosphorylation of Cx43.  CK1 specifically phosphorylates serines 325, 328, 330 on the C-
terminus which alters the trafficking, conformation, and binding partners.  This phosphorylation allows for 
rapid accumulation into gap junction plaques and also prevents the binding of the cellular machinery 
involved in ubiquitination and internalization of cell surface Cx43. The rapid increase in gap junctions 
stabilizes intercellular communication from being disrupted allowing for the maintenance of CE functions.  
In addition, GJIC protects CE cells from DNA damage-induced apoptosis.  
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distinguished CK1’s role in regulating Cx43 in both homeostasis and after exposure to 
genotoxic stress.  Our key findings include: (1) genotoxic stress simultaneously increases CK1 
and (2) the presence of pCx43 in gap junction plaques; (3) CK1 is responsible for producing 
pCx43 in CE cells; (4) blocking CK1 reduces accumulation of Cx43 into large plaques 
associated with gap junctions; (5) reducing pCx43 via CK1 inhibition destabilizes Cx43 and 
gap junction plaques.  These findings lead to the conclusion that the upregulation and 
stabilization of Cx43 and GJIC in response to genotoxic stress (Roh and Funderburgh 2011) is 
mediated by a transient  increase in  CK1 and an  increased phosphorylation of specific residues 
in Cx43 by this kinase. 
CK1 has ubiquitous expression patterns in numerous tissues and cells that account for 
its diverse roles in cell processes (Knippschild, Gocht et al. 2005; Lohler, Hirner et al. 2009).  
Cell-specific CK1 distribution is dependent on its catalytic activity as kinase activity has been 
shown to regulate CK1 sub-cellular localization (Milne, Looby et al. 2001).  Genotoxic stress 
rapidly increased total levels of CK1 in CE cells (Fig. 5.2).   Immunostaining showed increased 
CK1 was most pronounced in the peri-nuclear compartment and also in the nucleus (Fig. 5.2.C).  
The nuclear accumulation of CK1 in CE cells may be involved in the DNA damage response as 
CK1 has roles in p53 and MDM2 phosphorylation after genotoxic stress (Knippschild, Milne et 
al. 1997; Alsheich-Bartok, Haupt et al. 2008; Inuzuka, Tseng et al. 2010).  The peri-nuclear 
accumulation may impact membrane trafficking of the many substrates of CK1 (Behrend, 
Stoter et al. 2000; Yu and Roth 2002; Yan, Spruce et al. 2007), including Cx43. 
We evaluated the relationship between Cx43 and CK1 in CE cells using biochemical 
assays and immunostaining under non-stressed and stressed conditions. Co-IP documented the 
interaction between Cx43 and CK1 in cell lysates (Fig. 5.3.A).  All forms of Cx43 were present 
in both IPs suggesting that CK1 is in complexes containing different forms of Cx43.  Genotoxic 
stress to CE cells resulted in increased co-localization with Cx43 (Fig. 5.3.D) and Co-IP 
demonstrated that the relative amount of CK1 associated with Cx43 increased after MMC 
treatment (Fig. 5.3.C).  This concentration of newly interacting Cx43 and CK1 may allow for 
increased downstream phosphorylation of Cx43 and influence subsequent gap junction 
formation.  
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To further characterize the functional consequences of CK1-mediated  phosphorylation 
of Cx43 (Fig. 5.5.A) in vivo we created, validated (Fig. 5.4) and used a phosphospecific antibody 
against Cx43 (pCx43).  A key finding that links CK1 specifically to the pCx43 sites was that 
CK1 created the epitope for our pCx43 antibody by phosphorylating serines 325, 328, 330 (Fig. 
5.5.B).  pCx43 and gap junction formation was consistently blocked with inhibition of CK1 
(Fig. 5.6).  We observed long, string-like Cx43 staining with PF670462 incubation compared to 
the normal rounded and punctate gap junction plaques (Fig. 5.6.E) which may result from 
reduced ability for aggregation. These specific serine residues may control the ability for Cx43 to 
aggregate into gap junctions as other proteins phosphorylated by CK1, such as tau, have 
increased aggregation after CK1 phosphorylation (Schwab, DeMaggio et al. 2000; Li, Yin et al. 
2004; Hanger, Byers et al. 2007).     In addition to gap junction formation, our results also 
suggest that CK1 phosphorylation controls overall Cx43 stability (Fig 5.6).  Thus, as nascent 
Cx43 becomes progressively phosphorylated and is targeted to the periphery of gap junction 
plaques, those Cx43 molecules not phosphorylated on serines 325, 328, 330 by CK1 may 
become destined for degradation instead of becoming incorporated into gap junctions.   
Genotoxic stress with MMC rapidly increases Cx43 in CE cells (Roh and Funderburgh 
2011) which we found to include Cx43 phosphorylated on serine 325, 328, 330 (Fig. 5.8).   We 
observed increases in CK1 after MMC and UVC treatment (Fig. 5.8) demonstrating a 
responsive nature of CE CK1 to genotoxic stress.  Therefore, it appears that CK1 may have a 
distinct role in accumulation of Cx43 after DNA damage in CE cells.    This may occur through 
two mechanisms.  First, CK1kinase activity may be elevated after genotoxic stress.  CK1 has 
been shown to have higher kinase activity after DNA damage which stabilizes p53 levels 
(Knippschild, Milne et al. 1997; Sakaguchi, Saito et al. 2000; Inuzuka, Tseng et al. 2010).  
Future studies assessing CK1 activity towards Cx43 would specifically link DNA damage with 
increased active Cx43 phosphorylation.  In a second potential mechanism CK1 expression may 
increase resulting in more interaction with Cx43, more phosphorylation, and enhanced gap 
junction assembly. This seems consistent with our data thus far as we had previously observed 
increased forward trafficking of Cx43 into gap junctions after MMC treatment (Roh and 
Funderburgh 2011).   
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The importance of phosphorylation of serine 325, 328, 330 and accumulation of Cx43 
may be to enhance survival and maintain homeostasis as outlined in a hypothetical model (Fig. 
5.9). The specific effects of increased serine 325, 328, 330 Cx43 phosphorylation may be to 
reduce interaction with internalization and degradative cellular machinery.  As we found in our 
previous study (Roh and Funderburgh 2011), the relationship between Cx43 and ZO-1 was 
significantly reduced after genotoxic stress which may be a result of increased serine 325, 328, 
330  phosphorylation.  Changes in structure, charge, or binding partners may decrease the ability 
of ZO-1 to bind to the C-terminus which would result in enhancement of the connexon to gap 
junction transition (Rhett, Jourdan et al. 2011).  Additionally, ubiquitination machinery which 
also controls Cx43 internalization and degradation (Kjenseth, Fykerud et al. 2010) may have 
reduced binding to Cx43 phosphorylated on serine 325, 328, 330.   Determining the binding 
prolife of Cx43 phosphorylated on serine 325, 328, 330 will help elucidate the machinery 
involved in this stabilization.  In conclusion, because stabilization of Cx43 and GJIC appears to 
be protective in CE cells, identifying and manipulating the specific signaling pathways to 
enhance Cx43 stability and gap junction formation may be an approach to protect CE cells 
during acute genotoxic stress.  
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6.0  OVERALL CONCLUSIONS & SIGNIFICANCE 
The corneal endothelium was recently characterized by the scientist and ophthalmologist 
William Bourne as “the single layer of cells responsible for corneal clarity and  maintain[ing] 
the window to the soul” (Bourne 2010).  This statement may have particular meaning to the over 
42,000 individuals who receive corneal transplants in the United States, many of which are the 
result of corneal endothelial dysfunction.  Professor Bourne goes on to state that “the reluctance 
[of the corneal endothelium] to divide is not understood” and that “future knowledge of the 
corneal endothelium will lead to improvements in the treatment of corneal disease” (Bourne 
2010).   It is becoming increasingly clear that there is a prominent role for DNA damage in the 
aging and fragility of the corneal endothelium and this knowledge will help us to understand new 
intricacies necessary to improve and develop treatments for corneal disease.    
The documentation of a novel exposure to genotoxic stress (mitomycin C) during 
photorefractive keratectomy highlights the need for clinician and patient awareness during ocular 
procedures. Common clinical and surgical practice can induce DNA damage and must be taken 
into consideration given the vulnerability of the corneal endothelium.  It is becoming more 
evident that the corneal endothelium is exposed to and impacted substantially by genotoxic stress 
from iatrogenic causes.  Surprisingly, there are still current recommendations on how to use 
MMC in refractive surgery despite the evidence that it can affect corneal endothelial DNA.   
The genetic mouse model of DNA repair deficiency further exemplifies the need to 
understand why the corneal endothelium succumbs to genotoxic stress in disease and aging.  
From this in vivo mouse study it is clear that the corneal endothelium is extremely sensitive and 
vulnerable to the effects of unrepaired endogenous DNA damage.  Therefore, it is likely that 
DNA damage has a considerable role in the non-proliferative state of the corneal endothelium.  
Remarkably, the mice in our study did not receive exogenous or environmental DNA damaging 
exposures yet the corneal endothelium prematurely developed age-related degenerative changes.   
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This further implicates the high metabolic nature of the corneal endothelium and the byproducts 
of this metabolism, namely reactive oxygen species and their downstream targets, in 
degenerative changes.    Chronic oxidative stress has been linked to the formation of endogenous 
DNA interstrand crosslinks believed to have role in aging.  DNA damage in corneal endothelium 
must be taken into consideration while efforts to enhance the proliferation of these cells may 
bring about increased cell death or drastic alterations in cell behavior due to the accumulation of 
unrepaired DNA damage over decades of life.  In addition, as corneal donor tissue from older 
donors is continuing to be used in corneal transplantations, the role of accumulating DNA 
damage should receive careful consideration in graft success and failure. 
Finally, a greater understanding of how corneal endothelial cells respond to stress at the 
cellular level is essential in developing new methods to preserve them.  In my studies I have only 
begun to implicate a role for gap junctions in protecting the corneal endothelium from injury and 
death in an acute setting.  Although I found that gap junction intercellular communication was 
protective over an eighteen-hour period, additional time points will be necessary to evaluate this 
response during longer exposures to genotoxic stress.  Further dissection of the molecular 
pathways driving this response and others can then be used as specific targets to preserve both 
the function and viability of these cells.  The amelioration of corneal endothelial aging and 
degeneration, which can be expected to follow from understanding basic stress responses, should 
have significant impact on the vision and well-being of people far and wide. 
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APPENDIX A 
SUPPLEMENTAL FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WT ‐/ 
  
Figure S.1:  PAS staining.  Periodic Schiff staining (PAS) of mouse corneas from 
wildtype (WT) and Ercc1-/ mice at 27 weeks.  Images below are magnification of 
upper images black boxes and highlight Descemet’s membrane (white arrows).  
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Figure S.2  Cx43 accumulation after genotoxic stress.  Confluent CE cells treated 
with 100 M H2O2, 20 J/m2 UVC, and 10 M etoposide for the indicated times in 
minutes.   Immunoblotting with a total Cx43 antibody and -tubulin antibody (not 
shown).  Quantification is ratio of Cx43/-tubulin 
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Figure S.4:  Cx43 expression after MMC.  Confluent CE cells treated 
with 5 M  MMC for the indicated times in minutes.    Quantitative RT-
PCR was used to quantify Cx43 expression.  Data is normalized to time 
“0”. 
Figure S.3:  Cell-cell junctions after MMC.  Confluent CE cells treated with 5 M  
MMC for the indicated times in minutes.   Immunoblotting with antibodies against ZO-
1, cadherins, -catenin, Cx43, and -tubulin. 
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